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Abstract 
 
Streptococcus pyogenes (Group A Streptococcus, GAS) is an important Gram positive 
human pathogen that produces a multitude of virulence factors, including cell-surface 
pili that were first described shortly before the beginning of this project. Pili in M1 GAS 
strain SF370 mediate adhesion to human tonsil and skin and are composed of a single 
major protein subunit (Spy0128) forming the pilus shaft and two minor subunits 
(Spy0125 and Spy0130), whose roles had not been defined. This thesis reports 
combined molecular microbiology and protein structure studies that provide insights in 
to the structures and functions of the M1 GAS strain SF370 pilus subunits.  
 
Recombinant Spy0125 (rSpy0125), rSpy0128 and rSpy0130 were purified to apparent 
homogeneity and low resolution structures were obtained using a combination of 
biophysical techniques. Novel intra-molecular isopeptide bonds discovered in the 
Spy0128 crystal structure, reported by others during this project, were examined here 
for their affects on GAS adhesion. This was achieved by combining site-directed and 
allele replacement mutagenesis to introduce point mutations into the spy0128 gene in 
the GAS chromosome. Comparison of parent and mutant strains showed that these 
bonds were not essential for adhesion of GAS to human keratinocytes in vitro, though 
the pattern of adhesion appeared altered.  
 
Most of the work in this project focused on Spy0125, which was first localized at the tip 
of the pilus and shown to act as the adhesin. Allele replacement mutagenesis confirmed 
that the adhesin resided within a stable c. 50 kDa polypeptide corresponding to the C-
terminal 2/3 of intact Spy0125. A recombinant version of this region, rSpy0125-CTR, 
was produced and its high resolution crystal structure determined. In addition to internal 
intra-molecular bonds similar to those recently found by others in Spy0128, the 
rSpy0125-CTR structure revealed an internal thioester bond between a Cys and a Gln 
residue that is unprecedented outside of complement and complement-like proteins. 
Whereas current paradigms of bacterial-host interactions suggest non-covalent forces 
are involved, the presence of a thioester in Spy0125 reveals for the first time that strong 
covalent forces may also play a role.  
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m
ol
ec
ul
es
 o
n 
th
e 
su
rf
ac
e 
of
 a
nt
ig
en
 p
re
se
nt
in
g 
ce
ll
s 
w
he
re
 
th
ey
 b
in
d 
an
d 
cr
os
s 
li
nk
 m
ul
ti
pl
e 
T
-c
el
l 
re
ce
pt
or
s 
at
 e
xt
er
na
l 
si
te
s,
 d
is
ti
nc
t 
fr
om
 t
ho
se
 i
nv
ol
ve
d 
in
 c
on
ve
nt
io
na
l 
an
ti
ge
n 
pr
es
en
ta
ti
on
 (
S
un
db
er
g 
et
 a
l.
, 2
00
2;
 M
cC
or
m
ic
k 
et
 a
l.
, 2
00
1)
. T
hi
s 
ac
ti
va
te
s 
la
rg
e 
nu
m
be
rs
 o
f 
T
 c
el
ls
 l
ea
di
ng
 t
o 
a 
cy
to
ki
ne
 ‘
st
or
m
’ 
ex
er
ti
ng
 t
he
 m
ai
n 
pa
th
ol
og
y 
of
 
S
T
S
S
. 
M
os
t 
st
ra
in
s 
pr
od
uc
e 
on
e 
or
 m
or
e.
 
D
if
fe
re
nt
 
co
m
bi
na
ti
on
s 
in
 d
if
fe
re
nt
 
st
ra
in
s  
 
S
pe
B
 
S
ec
re
te
d 
cy
st
ei
ne
 p
ro
te
as
e 
th
at
 i
s 
ab
le
 t
o 
de
gr
ad
e 
a 
la
rg
e 
nu
m
be
r 
of
 h
os
t 
se
ru
m
 p
ro
te
in
s 
(C
hi
an
g-
N
i 
an
d 
W
u,
 2
00
8)
 i
n 
ad
di
ti
on
 t
o 
a 
nu
m
be
r 
of
 G
A
S
 p
ro
te
in
s.
 C
le
av
ag
e 
of
 s
ur
fa
ce
 
as
so
ci
at
ed
 v
ir
ul
en
ce
 f
ac
to
rs
 s
uc
h 
as
 C
5a
 p
ep
ti
da
se
 a
nd
 t
he
 M
-p
ro
te
in
 m
ay
 o
cc
up
y 
th
e 
ho
st
 
im
m
un
e 
sy
st
em
 a
t 
a 
di
st
an
ce
 r
at
he
r 
th
an
 a
t 
th
e 
ce
ll
 s
ur
fa
ce
. S
pe
B
 h
as
 a
ls
o 
be
en
 s
ho
w
n 
to
 
de
gr
ad
e 
st
re
pt
oc
oc
ca
l 
su
pe
ra
nt
ig
en
s 
(N
oo
h 
et
 a
l.
, 2
00
6)
.  
A
ll
 G
A
S
 
st
ra
in
s 
 
Id
eS
/M
ac
 a
nd
 
E
nd
oS
 
D
eg
ra
de
 I
gG
 a
nt
ib
od
ie
s 
pr
ot
ec
ti
ng
 t
he
 o
rg
an
is
m
 f
ro
m
 o
ps
on
is
at
io
n 
an
d 
ph
ag
oc
yt
os
is
 (
vo
n 
P
aw
el
-R
am
m
in
ge
n 
an
d 
B
jo
rc
k,
 2
00
3)
. 
 
S
om
e 
st
ra
in
s 
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H
ya
lu
ro
ni
da
se
 
C
le
av
es
 t
he
 r
ep
ea
ti
ng
 d
is
ac
ch
ar
id
e 
of
 N
-a
ce
ty
lg
lu
co
sa
m
in
e 
an
d 
D
-g
lu
cu
ro
ni
c 
ac
id
 t
ha
t 
co
m
pr
is
es
 t
he
 h
ya
lu
ro
ni
c 
ac
id
 f
ou
nd
 w
it
hi
n 
hu
m
an
 c
on
ne
ct
iv
e 
ti
ss
ue
 a
nd
 t
he
 G
A
S
 c
ap
su
le
 
(H
yn
es
 a
nd
 W
al
to
n,
 2
00
0;
 S
an
ds
on
 e
t 
a
l.
, 1
96
8)
. P
ro
po
se
d 
to
 a
ct
 a
s 
a 
‘s
pr
ea
di
ng
 f
ac
to
r’
 f
or
 t
he
 
ba
ct
er
ia
 (
S
te
ve
ns
, 2
00
0)
 a
lt
ho
ug
h 
re
ce
nt
 e
vi
de
nc
e 
ha
s 
su
gg
es
te
d 
th
at
 h
ya
lu
ro
ni
da
se
 c
on
tr
ib
ut
es
 
to
 t
he
 s
pr
ea
d 
of
 p
ro
te
in
 v
ir
ul
en
ce
 f
ac
to
rs
 r
at
he
r 
th
an
 t
he
 b
ac
te
ri
a 
(S
ta
rr
 a
nd
 E
ng
le
be
rg
, 2
00
6)
. 
A
ll
 G
A
S
 
st
ra
in
s  
S
ec
re
te
d 
S
tr
ep
to
ki
na
se
 
A
ct
iv
at
es
 p
la
sm
in
og
en
 t
ha
t 
m
ay
 b
e 
fr
ee
 i
n 
pl
as
m
a 
or
 b
ou
nd
 t
o 
su
rf
ac
e 
as
so
ci
at
ed
 M
-p
ro
te
in
, 
G
A
P
D
H
 a
nd
 α
-e
no
la
se
 (
se
e 
be
lo
w
).
 P
la
sm
in
og
en
 i
s 
co
nv
er
te
d 
to
 p
la
sm
in
 w
hi
ch
 a
ct
s 
as
 a
 
pr
ot
ea
se
 o
n 
a 
w
id
e 
ra
ng
e 
of
 s
ub
st
ra
te
s,
 f
or
 e
xa
m
pl
e,
 d
is
so
lv
in
g 
bl
oo
d 
cl
ot
s 
w
hi
ch
 c
ou
ld
 
fa
ci
li
ta
te
 b
ac
te
ri
al
 s
pr
ea
d 
th
ro
ug
ho
ut
 h
um
an
 t
is
su
es
 (
S
ve
ns
so
n 
et
 a
l.
, 2
00
2)
.  
A
ll
 G
A
S
 
st
ra
in
s 
 
S
tr
ep
to
co
cc
al
 
in
hi
bi
to
r 
of
 
co
m
pl
em
en
t 
(S
IC
) 
B
in
ds
 s
ol
ub
le
 C
5b
-7
 m
em
br
an
e 
at
ta
ck
 c
om
pl
ex
 a
nd
 p
re
ve
nt
s 
it
s 
in
se
rt
io
n 
in
to
 t
he
 G
A
S
 
m
em
br
an
e 
(F
er
ni
e-
K
in
g 
et
 a
l.
, 2
00
1;
 A
ke
ss
on
 e
t 
a
l.
, 1
99
6)
. O
th
er
 p
os
si
bl
e 
ro
le
s 
fo
r 
S
IC
 
in
cl
ud
e 
in
hi
bi
ti
ng
 s
ec
re
to
ry
 l
eu
ko
cy
te
s,
 l
ys
oz
ym
es
, α
-d
ef
en
si
ns
 a
nd
 L
L
-3
7 
an
ti
-m
ic
ro
bi
al
 
pe
pt
id
es
 (
R
oo
ij
ak
ke
rs
 a
nd
 v
an
 S
tr
ij
p,
 2
00
7;
 F
ri
ck
 e
t 
a
l.
, 2
00
3;
 F
er
ni
e-
K
in
g 
et
 a
l.
, 2
00
2)
. 
V
er
y 
fe
w
 
G
A
S
 s
tr
ai
ns
 
 
D
N
as
e 
G
A
S
 a
re
 a
bl
e 
to
 c
ir
cu
m
ve
nt
 n
eu
tr
op
hi
l 
ex
tr
ac
el
lu
la
r 
tr
ap
s 
(N
E
T
s)
 b
y 
th
e 
pr
od
uc
ti
on
 o
f 
fo
ur
 
D
N
as
es
, t
he
 m
os
t 
po
te
nt
 o
f 
w
hi
ch
, D
N
as
e1
, i
s 
cr
uc
ia
l 
fo
r 
th
e 
ev
as
io
n 
of
 n
eu
tr
op
hi
l 
ki
ll
in
g 
(B
uc
ha
na
n 
et
 a
l.
, 2
00
6;
 B
ri
nk
m
an
n 
et
 a
l.
, 2
00
4)
.  
A
ll
 G
A
S
 
st
ra
in
s 
 
M
-p
ro
te
in
 
C
on
si
de
re
d 
to
 b
e 
th
e 
m
aj
or
 v
ir
ul
en
ce
 f
ac
to
r 
fo
r 
G
A
S
. C
om
po
se
d 
of
 f
ou
r 
re
pe
at
 r
eg
io
ns
; 
a 
hi
gh
ly
 c
on
se
rv
ed
 C
-t
er
m
in
al
 c
el
l 
w
al
l 
an
ch
or
in
g 
re
gi
on
 i
n 
th
e 
C
 a
nd
 D
 r
ep
ea
ts
, a
 v
ar
ia
bl
e 
B
 
re
pe
at
 r
eg
io
n 
an
d 
a 
hy
pe
rv
ar
ia
bl
e 
A
 r
ep
ea
t 
re
gi
on
 w
hi
ch
 c
on
fe
rs
 s
tr
ai
n 
sp
ec
if
ic
it
y 
(K
eh
oe
 e
t 
a
l.
, 1
99
6;
 F
is
ch
et
ti
, 1
98
9)
. M
-p
ro
te
in
 f
ac
il
it
at
es
 a
dh
es
io
n 
to
 h
os
t 
ce
ll
s 
an
d 
co
nt
ri
bu
te
s 
to
 
pe
rs
is
te
nc
e 
w
it
hi
n 
th
e 
ho
st
 t
hr
ou
gh
 r
es
is
ta
nc
e 
to
 p
ha
go
cy
to
si
s 
an
d 
re
cr
ui
tm
en
t 
of
 h
os
t 
pr
ot
ei
ns
. 
A
ll
 G
A
S
 
st
ra
in
s 
at
 l
ea
st
 
on
e  
 
E
nn
 a
nd
 M
rp
 
F
un
ct
io
na
ll
y 
re
la
te
d 
to
 M
-p
ro
te
in
. C
ou
ld
 p
la
y 
a 
ro
le
 i
n 
im
m
un
e 
ev
as
io
n.
 
A
ll
 s
tr
ai
ns
 
C
el
l 
w
al
l 
as
so
ci
at
ed
 
C
5a
 p
ep
ti
da
se
 
A
 s
er
in
e 
pr
ot
ea
se
, h
ig
hl
y 
sp
ec
if
ic
 f
or
 c
om
pl
em
en
t 
co
m
po
ne
nt
 C
5a
 w
hi
ch
 i
s 
a 
ke
y 
ch
em
ot
ac
ti
c 
pe
pt
id
e,
 c
le
av
in
g 
it
 b
et
w
ee
n 
H
is
67
 a
nd
 L
ys
68
, r
es
id
ue
s 
w
hi
ch
 a
re
 n
ot
 a
cc
es
si
bl
e 
on
 i
na
ct
iv
e 
C
5a
, t
hu
s 
re
du
ci
ng
 p
ha
go
cy
te
 r
ec
ru
it
m
en
t 
to
 t
he
 s
it
e 
of
 G
A
S
 i
nf
ec
ti
on
 (
C
le
ar
y 
et
 a
l.
, 1
99
2b
).
 
A
ll
 G
A
S
 
st
ra
in
s 
 
C
ap
su
le
 
C
om
po
se
d 
of
 h
ya
lu
ro
ni
c 
ac
id
 a
nd
 i
s 
a 
ke
y 
de
fe
nc
e 
m
ec
ha
ni
sm
 i
n 
pr
ev
en
ti
ng
 p
ha
go
cy
to
si
s 
(W
es
se
ls
 a
nd
 B
ro
nz
e,
 1
99
4)
. S
tr
ai
ns
 e
ng
in
ee
re
d 
to
 p
ro
du
ce
 n
o 
ca
ps
ul
e 
ar
e 
av
ir
ul
en
t 
an
d 
ea
si
ly
 
cl
ea
re
d 
(C
un
ni
ng
ha
m
, 2
00
0)
. A
 r
ol
e 
fo
r 
th
e 
ca
ps
ul
e 
in
 G
A
S
 a
dh
es
io
n 
to
 t
he
 C
D
44
 r
ec
ep
to
r 
on
  
ep
it
he
li
al
 c
el
ls
 h
as
 b
ee
n 
su
gg
es
te
d 
(S
to
ll
er
m
an
 a
nd
 D
al
e,
 2
00
8;
 S
ch
ra
ge
r 
et
 a
l.
, 1
99
8)
.  
 
L
ik
el
y 
by
 a
ll
 
G
A
S
 s
tr
ai
ns
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L
ip
ot
ei
ch
oi
c 
ac
id
 (
L
T
A
)  
B
el
ie
ve
d 
to
 f
ac
il
it
at
e 
a 
w
ea
k 
re
ve
rs
ib
le
 a
dh
es
io
n 
w
it
h 
ep
it
he
li
al
 c
el
l 
m
em
br
an
es
, p
ro
ba
bl
y 
th
ro
ug
h 
hy
dr
op
ho
bi
c 
in
te
ra
ct
io
ns
 (
S
el
a 
et
 a
l.
, 2
00
0)
. 
A
ll
 s
tr
ai
ns
 
C
el
l 
w
al
l 
as
so
ci
at
ed
 
E
xt
ra
 c
el
lu
la
r 
m
at
ri
x 
bi
nd
in
g 
pr
ot
ei
ns
 
In
cl
ud
e 
th
e 
fi
br
on
ec
ti
n 
bi
nd
in
g 
pr
ot
ei
ns
 (
F
bp
);
 P
rt
F
1 
(H
an
sk
i 
an
d 
C
ap
ar
on
, 1
99
2)
, P
rt
F
2 
(K
re
ik
em
ey
er
 e
t 
a
l.
, 2
00
4)
, s
er
um
 o
pa
ci
ty
 f
ac
to
r 
(C
ou
rt
ne
y 
et
 a
l.
, 2
00
9)
, F
bp
54
, F
ba
A
, S
fb
X
 
an
d 
ot
he
rs
 w
it
h 
te
n  
fi
br
on
ec
ti
n 
bi
nd
in
g 
pr
ot
ei
ns
 d
es
cr
ib
ed
 i
n 
to
ta
l,
 c
ol
la
ge
n 
bi
nd
in
g 
pr
ot
ei
ns
 
(C
pa
)  
(K
re
ik
em
ey
er
 e
t 
a
l.
, 2
00
5)
 a
nd
 l
am
in
in
 b
in
di
ng
 p
ro
te
in
s 
(L
bp
) 
(T
er
ao
 e
t 
a
l.
, 2
00
2)
. 
F
bp
-M
an
y 
 
C
pa
-S
om
e 
L
bp
-M
an
y 
 
P
ro
te
in
 G
-
re
la
te
d 
α
2M
- 
bi
nd
in
g 
(G
R
A
B
)  
B
in
d 
fr
ee
 α
2-
m
ac
ro
gl
ob
ul
in
 v
ia
 c
ri
ti
ca
l 
ar
gi
ni
ne
 r
es
id
ue
s 
on
 t
he
 p
ro
te
in
 s
ur
fa
ce
 (
G
od
eh
ar
dt
 e
t 
a
l.
, 2
00
4)
. T
he
 α
2-
m
ac
ro
gl
ob
ul
in
s 
ar
e 
br
oa
d 
ra
ng
e 
pr
ot
ea
se
 i
nh
ib
it
or
s 
w
hi
ch
 r
em
ai
n 
ac
ti
ve
 
w
he
n 
bo
un
d 
to
 p
ro
te
in
 G
R
A
B
 a
nd
 c
ou
ld
 p
ro
te
ct
 G
A
S
 s
ur
fa
ce
 p
ro
te
in
s 
fr
om
 h
os
t 
pr
ot
ea
se
s 
(G
od
eh
ar
dt
 e
t 
a
l.
, 2
00
4)
.  
F
ew
 s
tr
ai
ns
 
 
G
A
P
D
H
 a
nd
 α
-
en
ol
as
e  
U
su
al
ly
 f
ou
nd
 i
n 
th
e 
cy
to
pl
as
m
 a
nd
 h
av
e 
no
 N
-t
er
m
in
al
 s
ec
re
ti
on
 s
ig
na
l 
pe
pt
id
e 
bu
t 
ca
n 
be
 
re
le
as
ed
 f
ro
m
 t
he
 c
el
l 
by
 a
 c
ur
re
nt
ly
 u
ni
de
nt
if
ie
d 
m
ec
ha
ni
sm
 (
so
m
e 
su
sp
ec
t 
si
m
pl
y 
ce
ll
 l
ys
is
, 
w
hi
le
 o
th
er
s 
su
sp
ec
t 
a 
no
ve
l 
ac
ti
ve
 s
ec
re
ti
on
 m
ec
ha
ni
sm
).
 O
ft
en
 f
ou
nd
 t
ig
ht
ly
 a
ss
oc
ia
te
d 
w
it
h 
th
e 
ce
ll
 w
al
l 
(P
an
ch
ol
i 
an
d 
F
is
ch
et
ti
, 1
99
8;
 P
an
ch
ol
i 
an
d 
F
is
ch
et
ti
, 1
99
2)
. G
A
P
D
H
 b
in
ds
 
fi
br
on
ec
ti
n,
 l
ys
oz
ym
e,
 m
yo
si
n 
an
d 
ac
ti
n 
as
 w
el
l 
as
 w
ea
kl
y 
to
 p
la
sm
in
ge
n 
(P
an
ch
ol
i 
an
d 
F
is
ch
et
ti
, 1
99
2)
. α
-e
no
la
se
 b
in
ds
 p
la
sm
in
og
en
 a
nd
 c
ou
ld
 p
la
y 
a 
ro
le
 i
n 
ba
ct
er
ia
l 
sp
re
ad
 
(P
an
ch
ol
i 
an
d 
F
is
ch
et
ti
, 1
99
8)
.  
A
ll
 G
A
S
 
st
ra
in
s  
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 T
ab
le
 2
.3
 S
yn
th
et
ic
 o
li
go
n
u
cl
eo
ti
d
e 
p
ri
m
er
s 
u
se
d
 in
 t
h
is
 s
tu
d
y 
     
 
P
ri
m
er
a  
 
S
eq
u
en
ce
 (
5’
 t
o 
3’
)b
 
 
L
oc
at
io
n
 w
.r
.t
 n
u
cl
eo
ti
d
e 
1 
of
 s
p
ec
if
ie
d
 O
R
F
c  
 
 
P
u
rp
os
e 
 JP
01
 (
F
) 
 JP
01
 (
R
) 
 ct
ag
ga
tc
cA
A
G
A
C
T
G
T
T
T
T
T
G
G
T
T
T
A
G
T
A
G
 
 at
gt
tc
tc
ga
gT
T
A
A
C
C
A
C
C
A
C
T
C
A
A
A
A
G
A
T
T
 
 
 M
1 
S
py
01
25
: 
14
2 
to
 1
63
 
   
   
   
   
   
 
   
   
   
   
   
   
   
  7
90
 t
o 
80
7 
 
 C
lo
ni
ng
 M
1 
sp
y0
1
2
5
-N
T
R
 i
nt
o 
pE
T
28
a 
 JP
02
 (
F
) 
 JP
02
 (
R
)  
 ct
ag
ga
tc
cA
A
T
C
A
A
C
C
T
C
A
A
A
C
G
A
C
T
T
C
A
G
 
 at
gt
t c
tc
ga
gT
T
A
T
G
T
A
G
G
A
A
C
A
A
C
A
G
G
C
T
C
 
 
 M
1 
S
py
01
25
: 
85
6 
to
 8
77
 
    
   
   
   
   
   
   
  2
15
2 
to
 2
16
9 
 C
lo
ni
ng
 M
1 
sp
y0
1
2
5
-C
T
R
  
in
to
 p
E
T
28
a 
 JP
03
 (
F
) 
 JP
03
 (
R
) 
 JP
04
 (
F
)  
 JP
04
 (
R
)  
 
 tt
ac
at
ac
tg
ca
gC
T
T
T
A
A
A
G
C
A
A
T
A
T
T
T
T
C
T
C
A
 
 at
ta
gt
cg
ac
A
C
C
A
A
A
A
A
C
A
G
T
C
T
T
A
G
C
A
C
 
 at
ta
gt
cg
ac
A
A
T
C
A
A
C
C
T
C
A
A
A
C
G
A
C
T
T
 
 at
gt
t c
tc
ga
gA
A
T
C
T
G
T
T
T
T
C
C
A
T
C
A
A
T
A
A
 
 
 M
1 
S
py
01
25
: 
-1
22
 t
o 
-1
02
  
    
   
   
   
   
   
   
   
13
7 
to
 1
56
 
    
   
   
   
   
   
   
   
85
6 
to
 8
74
 
     
   
   
   
   
   
   
 1
11
5 
to
 1
13
4 
 
   
   
   
   
   
   
  
 C
on
st
ru
ct
in
g 
Δ
sp
y0
1
2
5
-N
T
R
 d
el
et
io
n 
in
 p
G
+
ho
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 JP
05
 (
F
) 
 JP
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 (
R
) 
 C
A
G
T
T
A
T
T
G
G
C
A
A
A
T
A
A
G
A
T
G
T
C
 
 C
A
A
G
C
A
G
G
T
G
A
T
G
A
A
G
T
G
G
A
 
 
 M
1 
S
py
01
25
: 
-3
50
 t
o 
-3
28
 
    
   
   
   
   
   
   
  2
57
9 
to
 2
59
8 
 S
eq
ue
nc
in
g 
pr
im
er
s 
to
 c
on
fi
rm
 Δ
sp
y0
1
2
5
-N
T
R
 
de
le
ti
on
 i
n 
ch
ro
m
os
om
e 
 
45 
   
 
P
ri
m
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a  
 
S
eq
u
en
ce
 (
5’
 t
o 
3’
)b
 
 
L
oc
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io
n
 w
.r
.t
 n
u
cl
eo
ti
d
e 
1 
of
 
sp
ec
if
ie
d
 O
R
F
c  
 
 
P
u
rp
os
e 
 JP
06
 (
F
)  
 JP
06
 (
R
)  
 JP
07
 (
F
) 
 JP
07
 (
R
) 
 tt
ac
at
a c
tg
ca
gG
T
T
A
T
G
T
A
T
A
A
T
G
G
A
C
A
T
C
C
A
C
A
A
 
 at
ta
gt
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ac
G
A
C
C
C
A
C
C
A
A
T
G
C
C
T
C
C
A
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gt
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ac
C
A
G
C
T
A
A
C
T
G
A
C
C
T
T
G
A
T
T
T
C
 
 at
gt
tc
tc
ga
gG
A
A
A
C
A
G
A
T
T
C
T
G
A
A
G
G
C
T
A
T
 
 
 M
1 
S
py
01
25
: 
47
2 
to
 4
95
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 t
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ro
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m
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Chapter 1. General introduction 
 
1.1 Introduction to Streptococcus pyogenes 
Streptococcus pyogenes (Group A Streptococcus, GAS) are Gram positive, non-motile, 
catalase negative cocci, 0.5-1.0 µM in diameter, which grow in chains. The organism is 
a facultative anaerobe which is aero-tolerant and a homo-fermenter, producing lactic 
acid. Optimal growth is achieved at 37oC in nutrient rich media.  
 
Diseases which were most likely to have been caused by GAS were recognised long 
before streptococci were first described; for example, erysipelas (from the Greek 
meaning red fire) has been described as long as there have been written records of 
disease. The term Streptococcus was first derived by Billroth (from the Greek: streptos, 
meaning chain, and kohkos, meaning berry) in 1874 (Denny, 2000). These organisms 
were recognised as being responsible for a great number of human infections during the 
last half of the 19th century (Denny, 2000). These included the greatly feared puerperal 
fever (‘childbed fever’), where outbreaks often had a mortality rate of 50% and scarlet 
fever with mortality rates of 25-30% (Denny, 2000). Severe post-streptococcal sequelae 
such as acute rheumatic fever (ARF) and acute glomerulonephritis (PSAGN) were first 
described over 100 years ago (Martin and Green, 2006). Associations between 
erysipelas, puerperal fever, scarlet fever and acute rheumatic fever with severe 
pharyngitis had been noted during the 19th century (Denny, 2000) but the significance of 
these were not originally understood. Consequently, bacteria isolated from these 
diseases were frequently named after the condition they caused (Streptococcus 
epidemicus, S. erysipelatus, S. puerperalis, S. scarlatinae, S. rheumaticus, S. pyogenes). 
It was not until detailed classification work had been carried out that it was discovered a 
single organism was able to cause all of these and a variety of other diseases. 
 
The first steps towards classification of these organisms came when the various kinds of 
haemolysis produced by different streptococci on blood agar plates were described. 
These were subsequently defined as; alpha (incomplete or partial), beta (clear zones of 
2-4 mm) and gamma (no) haemolysis (Gray, 1998). Streptococci isolated from the 
diseases described above all displayed β-haemolysis and the collective name S. 
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haemolyticus was used throughout the early 20th century. Around this time definitive 
studies in typing were carried out. One was ‘Lancefield sero-grouping’ to distinguish 
between β-haemolytic streptococci based on immunological differences in their cell 
wall polysaccharides (Lancefield, 1928b). There are now 15 recognised sero-groups (A-
O) based on polysaccharides (groups A, B, C, E, F and G), teichoic acids (groups D and 
N), or lipoteichoic acids (group H) (Nobbs et al., 2009). These groups do not include all 
streptococci however, with Streptococcus pneumoniae a notable example. Some 
Lancefield groups contain only a single species (such as Group A) whereas others 
contain several species (such as Group C). Most β-haemolytic streptococci isolated by 
Lancefield from serious human infection, belonged to Group A and it was decided to 
use the name Streptococcus pyogenes from the list of names outlined above for this 
organism.  
 
Lancefield also developed a second typing system to distinguish between Group A 
streptococcal strains, according to a protease-sensitive ‘M-antigen’ in the cell wall 
(Lancefield, 1928a). This method involved boiling the bacteria in hot-HCl to release the 
‘M-antigen’ prior to determining the specific M-antigen serotype (>80 were eventually 
defined) using standardised typing sera in capillary precipitin tests. At around the same 
time, another typing system based on antigenic differences in a trypsin resistant antigen, 
present in the cell wall, called the T antigen was developed (Griffith, 1934). Only 25 
serotypes of T antigen have been defined to date and it is common for a streptococcal 
strain to produce more than one serotype of T-antigen (Johnson and Kaplan, 1993). 
Although not as discriminating as M-typing, T-typing and various other typing systems 
(e.g. opacity factor typing) were useful in cases where M-typing could not be 
performed. For example, some GAS strains could lose expression of M-antigen when 
grown in vitro and a full set of M-typing sera (which were expensive to produce) were 
rarely available. 
 
Towards the end of the 1990’s M serotyping of GAS began to be superseded by a 
molecular biology approach based on sequencing of 160 bases at the 5’ end (the 
hypervariable region) of the M-protein (emm) genes (Beall et al., 1996). Isolates were 
considered to have the same emm type if they shared >95% identity over this region 
(Facklam et al., 1999). A recent epidemiological study of emm type distribution 
recorded a total of 205 emm types, of which the most common was emm1 
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(corresponding to M1) accounting for 18.3% of all isolates in the report (Steer et al., 
2009).  
 
1.2 GAS diseases  
The skin and mucous membranes of humans are the only known reservoirs for GAS. 
There have been isolated reports of GAS cultured from mice (Hook et al., 1960) and 
primates in captivity (Wilson and Salt, 1978) although the bacteria in these cases were 
probably passed on from humans. GAS can be carried asymptomatically on the skin and 
in the nasopharynx of up to 70% of the population, without the production of antibodies 
to GAS antigen (Pichichero and Casey, 2007; Stevens, 2000) but generally, GAS is 
associated with a wide variety of diseases (Table 1.1). These range from mild self 
limiting infections of the skin (impetigo) and pharynx (pharyngitis and tonsillitis) to 
much more severe infections of these and adjacent sites requiring intervention, and 
occasionally very severe invasive infections such as necrotizing fasciitis and 
streptococcal toxic shock syndrome (STSS). One of the most common GAS disease 
manifestations is pharyngitis. GAS are the most common cause of bacterial pharyngitis 
and the disease primarily affects children aged 5-15 years old. A conservative estimate 
of the number pharyngitis cases caused by GAS worldwide each year is 616 million 
(Carapetis et al., 2005b). Fortunately, GAS continues to remain sensitive to penicillin 
although studies carried out in the last 15 years show that the failure of penicillin to 
clear GAS infection in the pharynx is in the range of 20-40% (Pichichero and Casey, 
2007) in contrast to 4-8% treatment failure reported in the 1950’s (Wannamaker et al., 
1951; Denny et al., 1950). Many reasons have been suggested for the failure of 
penicillin treatment including the intracellular localisation of GAS into epithelial and 
macrophage-like cells in the pharynx (Molinari et al., 2000; Osterlund and Engstrand, 
1997; Osterlund et al., 1997; Osterlund and Engstrand, 1995; LaPenta et al., 1994), 
although the mechanism of GAS intracellular penetration are still unclear and GAS is 
believed to remain a predominantly extracellular pathogen. 
 
Pyoderma and non-bullous impetigo represent the second most common GAS 
presentation and are estimated to be responsible for 111 million cases of skin infection 
worldwide (Carapetis et al., 2005b). These diseases are considered highly infectious and  
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Table 1.1: Diseases caused by Streptococcus pyogenes. Adapted from Efstratiou,  
                 2000. 
 
 Type of disease Infection 
 
 
 
 
Suppurative 
 
Superficial 
 
Pharyngitis, skin and soft tissue infections, 
impetigo, erysipelas, vaginitis, post-partum 
infections 
  
Deep 
 
Bacteraemia, necrotizing fasciitis, deep soft tissue 
infections, cellulitis, myositis, peurperal sepsis, 
pericarditis, meningitis, pneumonia, septic arthritis. 
 
  
Toxin-mediated 
 
 
Scarlet fever, toxic shock-like syndrome. 
  
Immunologically 
mediated 
 
Acute rheumatic fever, post-streptococcal acute 
glomerulonephritis. 
 
 
 
secondary transmission of GAS to the pharynx from impetigo lesions has been reported 
(Bisno and Stevens, 2005). Deeper penetrations of GAS through the epidermis via cuts 
or abrasions can lead to erysipelas affecting superficial layers of the skin, or cellulitis 
which affects subcutaneous tissues (Bisno and Stevens, 1996). 
 
With the introduction of emm typing to distinguish GAS it was revealed that individual 
serotypes had a specific tissue tropism. That is, specific M types are associated with 
pharyngitis and others with pyoderma (Bisno, 1980). Five major emm patterns, A-E 
were suggested by the chromosomal arrangement of emm subfamily genes (Bessen et 
al., 1996). emm patterns A-C were most likely to cause throat infections while emm 
pattern D were found to be responsible for skin infections, with pattern E emm types 
able to cause infection at both sites (Bessen, 2009; McGregor et al., 2004).   
 
GAS are responsible for a number of post-streptococcal sequelae including PSAGN and 
ARF. These diseases result from prior infection with specific GAS serotypes. Clinical 
evidence suggests that PSAGN is caused by a subset of pyoderma associated, 
‘nephritogenic’ M types whereas ARF is caused by a subset of pharyngitis associated 
‘rheumatogenic’ strains (McShan et al., 2008). However, a recent study examining the 
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high rates of ARF in Aboriginal communities in Australia revealed that cases of 
pharyngitis were extremely rare while pyoderma was the main manifestation of GAS 
infection (McDonald et al., 2004). This suggested a prior throat infection may not be 
the sole cause of ARF, although this has yet to be proven. Both PSAGN and ARF are 
believed to be immunologically mediated, although the exact mechanisms remain to be 
determined. The mortality rate from PSAGN is reported to be around 1% (Carapetis et 
al., 2005b). ARF however, is a much more serious disease reportedly responsible for 
between 233,000 to 492,000 deaths a year. According to the World Health Organisation 
there are 15.6 to 19.6 million cases of ARF annually worldwide, 95% of which occur in 
the developing world (Carapetis et al., 2006; Carapetis et al., 2005a; Carapetis et al., 
2005b).  
 
The pattern of GAS infection in the last 150 years appears to be changing. Scarlet fever, 
erysipelas and puerperal sepsis were the most commonly described diseases caused by 
GAS during the late 19th century but these diseases are now extremely rare. However, 
their incidence appeared to decrease well before the introduction of sulfonamide and 
penicillin antibiotics. The improvement in living conditions throughout the 20th century 
is believed to have contributed significantly to the decreasing incidence of severe GAS 
disease. The practice of Semmelweis’ techniques also played a role in the falling rates 
of these diseases after a direct link between a lack of hand washing by physicians and 
puerperal fever was defined (Denny, 2000; Efstratiou, 2000). During the 1930’s, GAS 
were demonstrated to be associated with rheumatic fever by Coburn in the United States 
and Collis in England (Denny, 2000). Analogous to above, the frequency and mortality 
rates of rheumatic fever cases also declined over this period. These observations were 
all made before the introduction of widely available anti-bacterials. By the 1950’s GAS 
infections and rheumatic fever could be kept under control by primary prophylaxis 
where adequate treatment of pharyngitis with penicillin was shown to all but eliminate 
episodes of ARF (Denny, 2000). Secondary prophylaxis, the regular administering of 
penicillin over many years to people with a history of ARF, also greatly reduced the 
incidence of disease (Carapetis et al., 2006). This combination led to cases of severe 
GAS disease becoming rare, prompting a relaxation in the way that GAS pharyngitis 
was managed. During the late 1980’s the number of ARF cases began rising along with 
other extremely severe GAS infections. STSS (GAS infection associated with sudden 
onset of shock and multi organ failure) was often accompanied by a deep seated skin 
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and soft tissue infection, often called necrotizing fasciitis (Stevens et al., 1989), causing 
rapid necrosis of skin and underlying structures. In 60% of cases, GAS entry to the 
body prior to these diseases was most commonly through the pharynx, skin or vaginal 
mucosa (Bisno and Stevens, 1996; Chapnick et al., 1992). In sharp contrast to GAS 
diseases around 100 years ago, these two conditions affected people of all ages who had 
no pre-disposing conditions and were not immunocompromised (Bisno and Stevens, 
2005; Stevens et al., 2005).  
 
Reasons for the re-emergence of severe GAS infections in the late 1980’s are unclear. It 
has been proposed that during a period of mostly benign GAS infections throughout 
most of the 20th century, new subclones of GAS serotypes have evolved, acquiring new 
genes which improved their ability to infect humans (Aziz and Kotb, 2008), such as the 
hypervirulent M1T1 clone (Cleary et al., 1992a). The M1T1 strain differs in its genomic 
content from M1 GAS strain SF370 (Ferretti et al., 2001) used in this study, by up to 70 
kb of phage DNA (Cleary et al., 1998).   
 
1.3 GAS virulence factors 
 
GAS is an extremely versatile pathogen capable of causing a wide range of diseases at 
many different tissue sites within the human body. This is possible due to the multitude 
of virulence factors produced by GAS, some of which are listed in Table 1.2 and as 
indicated, a feature of GAS is that some virulence factors are produced by all strains 
while others are only produced by some. There is much heterogeneity between strains, 
even between the same virulence factor e.g. M-protein. As humans are the only known 
reservoir for GAS infection, the organism has evolved many different mechanisms to 
facilitate initial binding and persistence. This has led to what appears to be a degree of 
functional redundancy between some virulence factors, as a number of different 
proteins may exhibit similar effects. The expression of virulence factors is tightly 
controlled by a network of stand alone response regulators and two component systems 
which allow expression of specific virulence factors at specific stages of growth. It is 
also notable that GAS virulence factors are able to work synergistically to subvert the 
host immune response, such as release of C5a peptidase from the GAS cell wall by 
SpeB to tackle complement at a distance rather than at the bacterial surface. 
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Table 1.2: GAS virulence factors. 
 
Location Virulence factor Properties 
 Streptolysin S  
(SLS) 
2.8 kDa non-immunogenic polypeptide that inserts into cellular membranes leading to osmotic 
cell lysis. Also the primary factor causing the characteristic zones of 
GAS colonies on blood agar plates (Nizet, 2002). 
 Streptolysin O 
(SLO) 
57 kDa protein which is able to form extremely large pores of up to 30 nm containing up to 80 
monomers of SLO (Palmer et al., 1998; Kehoe et al., 1987). It was revealed that SLO pores 
were needed for the translocation and possible activation of an effector
adenine dinucleotide glycohydrolase (NADase) in a process termed cytolysin mediated 
translocation (Magassa et al., 2010; Madden et al., 2001).  
 NADase Possesses ADP-ribose cyclase activity, cleaving the nicotinamide-ribosyl bond of NAD, 
producing an intermediate that affects many cellular functions including signal transduction 
and gene expression eventually leading to cell death (Ghosh et al., 2010)
Secreted Streptococcal 
pyrogenic 
exotoxins; 
SpeA, SpeC, 
SpeG-M, SSA, 
and SMEZ 
Encoded by mobile phages except SpeG, SpeJ and SMEZ which are chromosomally located 
(Fraser and Proft, 2008). These superantigens exert their effect by binding major 
histocompatability complex class II molecules on the surface of antigen presenting cells where 
they bind and cross link multiple T-cell receptors at external sites, distinct from those involved 
in conventional antigen presentation (Sundberg et al., 2002; McCormick 
activates large numbers of T cells leading to a cytokine ‘storm’ exerting the main pathology of 
STSS. 
 SpeB Secreted cysteine protease that is able to degrade a large number of host serum proteins 
(Chiang-Ni and Wu, 2008) in addition to a number of GAS proteins. Cleavage of surface 
associated virulence factors such as C5a peptidase and the M-protein may occupy the host 
immune system at a distance rather than at the cell surface. SpeB has also been shown to 
degrade streptococcal superantigens (Nooh et al., 2006).  
 IdeS/Mac and 
EndoS 
Degrade IgG antibodies protecting the organism from opsonisation and phagocytosis 
Pawel-Rammingen and Bjorck, 2003). 
 
 
 
 
 
Hyaluronidase Cleaves the repeating disaccharide of N-acetylglucosamine and D-glucuronic acid that 
comprises the hyaluronic acid found within human connective tissue and the GAS capsule 
(Hynes and Walton, 2000; Sandson et al., 1968). Proposed to act as a ‘spreading factor’ for the 
bacteria (Stevens, 2000) although recent evidence has suggested tha
to the spread of protein virulence factors rather than the bacteria (Starr and Engleberg, 2006)
Secreted Streptokinase Activates plasminogen that may be free in plasma or bound to surface associated M
GAPDH and α-enolase (see below). Plasminogen is converted to plasmin which acts as a 
protease on a wide range of substrates, for example, dissolving blood clots which could 
facilitate bacterial spread throughout human tissues (Svensson et al.
 Streptococcal 
inhibitor of 
complement 
(SIC) 
Binds soluble C5b-7 membrane attack complex and prevents its insertion into the GAS 
membrane (Fernie-King et al., 2001; Akesson et al., 1996). Other possible roles for SIC 
include inhibiting secretory leukocytes, lysozymes, α-defensins and LL
peptides (Rooijakkers and van Strijp, 2007; Frick et al., 2003; Fernie
 DNase GAS are able to circumvent neutrophil extracellular traps (NETs) by the production of four 
DNases, the most potent of which, DNase1, is crucial for the evasion of neutrophil killing 
(Buchanan et al., 2006; Brinkmann et al., 2004).  
 M-protein Considered to be the major virulence factor for GAS. Composed of four repeat regions; a 
highly conserved C-terminal cell wall anchoring region in the C and D repeats, a variable B 
repeat region and a hypervariable A repeat region which confers strain specificity 
al., 1996; Fischetti, 1989). M-protein facilitates adhesion to host cells and contributes to 
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persistence within the host through resistance to phagocytosis and recruitment of host proteins.
 Enn and Mrp Functionally related to M-protein. Could play a role in immune evasion.
Cell wall 
associated 
C5a peptidase A serine protease, highly specific for complement component C5a which is a key chemotactic 
peptide, cleaving it between His67 and Lys68, residues which are not accessible on inactive 
C5a, thus reducing phagocyte recruitment to the site of GAS infection 
 Capsule Composed of hyaluronic acid and is a key defence mechanism in preventing phagocytosis 
(Wessels and Bronze, 1994). Strains engineered to produce no capsule are avirulent and easily 
cleared (Cunningham, 2000). A role for the capsule in GAS adhesion to the CD44 receptor on 
epithelial cells has been suggested (Stollerman and Dale, 2008; Schrager 
 
 Lipoteichoic 
acid (LTA) 
Believed to facilitate a weak reversible adhesion with epithelial cell membranes, probably 
through hydrophobic interactions (Sela et al., 2000). 
Cell wall 
associated 
Extra cellular 
matrix binding 
proteins 
Include the fibronectin binding proteins (Fbp); PrtF1 (Hanski and Caparon, 1992
(Kreikemeyer et al., 2004), serum opacity factor (Courtney et al., 2009)
and others with ten fibronectin binding proteins described in total, collagen binding proteins 
(Cpa) (Kreikemeyer et al., 2005) and laminin binding proteins (Lbp) 
 Protein G-
related α2M- 
binding 
(GRAB) 
Bind free α2-macroglobulin via critical arginine residues on the protein surface 
al., 2004). The α2-macroglobulins are broad range protease inhibitors which remain active 
when bound to protein GRAB and could protect GAS surface proteins from host proteases 
(Godehardt et al., 2004).  
 GAPDH and α-
enolase 
Usually found in the cytoplasm and have no N-terminal secretion signal peptide but can be 
released from the cell by a currently unidentified mechanism (some suspect simply cell lysis, 
while others suspect a novel active secretion mechanism). Often found tig
the cell wall (Pancholi and Fischetti, 1998; Pancholi and Fischetti, 1992)
fibronectin, lysozyme, myosin and actin as well as weakly to plasmingen 
Fischetti, 1992). α-enolase binds plasminogen and could play a role in bacterial spread 
(Pancholi and Fischetti, 1998). (Kang and Baker, 2010; Kline et al., 2010; Kreikemeyer et al., 
2010; Rego et al., 2010; Hendrickx et al., 2009; Budzik et al., 2008b; Craig and Li, 2008; 
Pelicic, 2008; Tendolkar et al., 2006; Sauer et al., 2002; Sjobring et al., 1994; Olsen et al., 
1989) 
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1.4 Secretion of proteins in Gram positive bacteria 
Up to 25-30% of all bacterial proteins are functionally active in the cytoplasmic 
membrane or outside of the cell (Driessen and Nouwen, 2008). These include the many 
virulence factors of GAS which must traverse the cell membrane and diffuse through 
the thick but largely porous cell wall before they can exert their effect. Unlike Gram 
negative bacteria where at least six quite distinct protein secretion systems have been 
defined (Gerlach and Hensel, 2007), in Gram positive bacteria most secreted proteins 
are translocated across the single cytoplasmic membrane (in an unfolded conformation) 
by the general secretion pathway (GSP or Sec pathway), which is found in all species. 
In some Gram positive species, a small minority of (pre-folded) proteins can be secreted 
by a distinct ‘TAT’ pathway, but homologues of key tat genes have not been found in 
GAS, so this is not discussed further here (Dilks et al., 2003).  
 
The main features of the GSP are shown in Figure 1.1. The signal recognition particle 
(SRP) pathway appears to be the major pathway for the secretion of proteins in bacteria 
and is found in all species. The bacterial SRP is homologous to the eukaryotic system 
involved in the translocation of proteins across the endoplasmic reticulum, although it is 
of a lower complexity (Driessen and Nouwen, 2008). The Bacillus subtilis SRP consists 
of a small cytoplasmic RNA (scRNA) molecule associated to fifty four homolog (Ffh) 
and is homologous to the eukaryotic SRP54 subunit (van Wely et al., 2001). Ffh has 
been shown to bind to FtsY (step 1, Figure 1.1), a bacterial homolog of the SRP 
receptor (Bernstein et al., 1989) which can interact directly with SecYEG (see below) 
(Angelini et al., 2005). In B. subtilis, Ffh appears to be a general targeting factor for 
secretory proteins. If depleted, the levels of extracellular proteins in the external milieu 
is reduced by up to 80% (Hirose et al., 2000). An alternative to SRP is SecB, 
extensively studied in Escherichia coli, although homologues are not found in GAS and 
many other species of bacteria. Moreover, it has recently been discovered that some 
Gram positive species (including S. pneumoniae, Streptococcus gordonii and 
Staphylococcus aureus) contain two copies of some components of the GSP including 
SecA and SecY, which may be required for the efficient secretion of distinct proteins 
(Bensing and Sullam, 2009; Rigel and Braunstein, 2008).  
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Figure 1.1: The general secretion pathway. 
 
 
Step 1: Secretory proteins are targeted by the SRP and delivered to FtsY through Ffh. 
Step 2: Three integral membrane proteins, SecY, SecE and SecG come together to form 
the SecYEG pore which can secrete proteins directly into the external milieu or, 
laterally through the complex directly into the cytoplasmic membrane (Papanikou et al., 
2007). A crystal structure of this complex from Methanococcus janaschii has revealed 
that SecE acts as a ‘clamp’ to hold both domains of SecY together while SecG localises 
at the periphery of the complex making only minimal contact with SecY (Van den Berg 
et al., 2004). Step 3: A cytosolic protein, SecA, is believed to be the motor responsible 
for translocating pre-proteins through SecYEG with continual binding and hydrolysis of 
ATP. SecA binds pre-proteins through their signal peptide, while the binding of ATP to 
SecA initiates translocation through the pore. Following hydrolysis, SecA dissociates 
from the partially inserted pre-protein, de-inserts, and then re-binds triggering an ATP-
independent translocation of ~2-2.5 kDa. ATP then rebinds and the process is repeated 
until the whole protein is translocated through the pore (van der Wolk et al., 1997). The 
precise mechanism for SecA dependant translocation however remains mostly 
unresolved (Driessen and Nouwen, 2008). Step 4: The SecYEG complex is able to 
loosely associate with other membrane complexes including the SecDFyajC complex 
which increases secretion efficiency, possibly by stabilising SecYEG (Duong and 
Wickner, 1997). Homologues to SecY/E/G, YajC, Ffh and FtsY were all identified in 
the GAS genome but homologues to SecD/F and SecB were not (Smith, 2004).  
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Proteins secreted by the GSP are distinguished from cytoplasmic proteins by an amino-
terminal secretion signal sequence (from here called signal peptide), which at some 
stage during secretion is cleaved off by a membrane associated signal peptidase, 
although it is not clear precisely when this occurs. Signal peptides usually consist of 20-
30 residues, although they can be much longer, and share common features even though 
they may exhibit little sequence homology (von Heijne, 1990). The N-terminal region 
(N-) contains 1-3 positively charged residues and is followed in sequence by a stretch of 
7-15 hydrophobic (H-) residues. The carboxy (C-) terminal region of the signal peptide 
is usually 3-7 residues in length, is hydrophilic, and contains the cleavage site for signal 
peptidases (see below) (Tjalsma et al., 2000; von Heijne, 1990). All three of these 
regions in Gram positive bacteria are longer than their Gram negative counterparts (von 
Heijne and Abrahmsen, 1989). GSP signal peptides contain a conserved sequence of 
small residues, commonly Ala-X-Ala (where X is any amino acid) at positions -3 and -1 
relating to the cleavage site. Alanine has also been found to be the most common 
residue at position +1 although all residues (excluding cysteine and proline) have been 
found at this position (Tjalsma et al., 2000). Once proteins have been translocated 
through the cytoplasmic membrane, the signal peptide is removed by a specialised 
serine protease enzyme called a signal peptidase. Type I signal peptidases are 
membrane associated enzymes located in close proximity to SecYEG translocons and 
its activity is crucial for cell viability in every species tested to date (Tuteja, 2005).  
 
1.5 Protein secretion in GAS 
 
GAS secrete more then 40 different proteins into the external milieu (Lei et al., 2000) 
and work on the GSP revealed that secretion of at least some proteins is located at a 
single microdomain called the ‘ExPortal’ (Rosch and Caparon, 2004). The proposed 
‘ExPortal’ is reported to be situated at the site of new wall synthesis at the coccal 
equator, and is specialised to contain the GSP translocons (Rosch and Caparon, 2004). 
The group associated with these studies concluded that SecA and HtrA (a surface 
associated protease which participates in folding reactions) were located at the 
‘ExPortal’, suggesting this region functions as an organelle to coordinate protein 
secretion (Rosch and Caparon, 2005; Rosch and Caparon, 2004). More recently 
however, Carlsson et al. (Carlsson et al., 2006) provided evidence that particular N-
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terminal signal peptides direct proteins to different sub-cellular regions of GAS. In 
contrast to above, their data indicated that SecA was found circumferentially distributed 
and not localised to a single site. Thus, the exact arrangement of the GSP in GAS is still 
unclear. It is possible that some proteins can be secreted from any part of the cell but it 
could be advantageous for wall proteins to be secreted at the site of new cell wall 
synthesis. The molecular basis for this however remains unknown. 
 
1.6 Gram positive cell walls 
Gram positive cell walls consist predominantly of very thick, highly cross linked layers 
of peptidoglycan with covalently attached anionic polymers (mainly teichoic acid and 
teichuronic acid), creating a negatively charged wall (Sarvas et al., 2004). Cell wall 
biosynthesis in Gram positive bacteria has been studied extensively for S. aureus 
although the pathway is almost identical for other Gram positives (Navarre and 
Schneewind, 1999). This pathway is summarised in Figure 1.2. Of particular interest in 
the present context is the lipid II precursor (X in Figure 1.2). This molecule includes an 
amino group that can participate in later transpeptidation reactions. Depending on the 
species, this can be either the ε-amino group of L-Lys in the penta-peptide moiety, or 
the equivalent in diaminopimelic acid which is employed in place of L-Lys in some 
species. Alternatively, when ‘cross bridges’ are attached at these sites (e.g. penta-
glycine in S. aureus as shown in Figure 1.2, or di-alanine in GAS), the terminal NH2 of 
the ‘cross bridge’ is available for subsequent transpeptidation reactions. Such 
transpeptidation reactions play a key role in strengthening the Gram positive cell wall 
(Nakagawa et al., 1984) and also, more relevant to this project, are the site of 
attachment for many cell wall proteins. 
 
14 
 
 
 
Figure 1.2: Schematic diagram of the cell wall biosynthetic pathway in the Gram      
                   positive Staphylococcus aureus. 
 
Panel 1: UDP-N-acetyl glucosamine (GlcNAc) together with enolpyruvate forms UDP-
N-acetylmuramic acid (MurNAc). Panel 2: Five amino acids are then added in 
sequence, L-Ala, D-isoGlu, L-Lys and D-Ala-D-Ala di-peptide to form Park’s 
nucleotide (Chatterjee and Park, 1964). Panel 3: This molecule is then phosphodiester 
linked to a lipid carrier molecule in the cytoplasmic membrane, displacing UDP to form 
lipid I (Anderson et al., 1967). Panel 4: Linkage to a UDP-GlcNAc molecule creates 
lipid II and further reactions add the penta-glycine cross bridge to the ε-amino group of 
L-Lys in the cell wall penta-peptide. Panel 5: Lipid II is translocated across the 
membrane where it becomes the substrate for penicillin binding proteins that catalyse 
two types of reaction; transpeptidations as mentioned in the text and transglycosylation 
where glycan strands (GlcNAc-MurNAc) are polymerised, extending between 5-30 
subunits in length (Tipper and Strominger, 1965). This pathway is highly similar to cell 
wall production in GAS, the major difference that GAS has a di-alanine cross bridge in 
place of penta-glycine attached to lipid II (X). Figure adapted from Navarre and 
Schneewind, 1999. 
2 
3 4 
5 
1 
X 
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1.7 Anchoring of proteins to the Gram positive cell wall 
 
In Gram positive bacteria, once secretory proteins have traversed the cytoplasmic 
membrane they are free to migrate through the peptidoglycan cell wall and out into the 
external milieu unless they have a mechanism for attachment. To date, a number of 
mechanisms for retaining and displaying proteins in the cell wall of Gram positive 
bacteria have been described. 
 
(i) Less common mechanisms are restricted to individual bacterial species. For example, 
LytA of S. pneumoniae binds to choline residues in teichoic and lipoteichoic acids 
present in the cell wall, which are anchored in the outer face of the cytoplasmic 
membrane by their lipid moiety (Holtje and Tomasz, 1975). A second uncommon 
mechanism for protein retention at the cell surface is exhibited by the InlB protein of 
Listeria monocytogenes. InlB also associates with LTA molecules in the outer face of 
the cytoplasmic membrane although in a different manner to that described above for 
LytA. InlB loosely associates with the polyglycerolphosphate backbone of LTA via 
three 80 amino acid tandem repeats in the C-terminus of the protein, starting with Gly-
Trp and called GW modules. Deletion of these residues leads to InlB secretion 
(Jonquieres et al., 1999; Braun et al., 1997). 
 
(ii) A more common mechanism employed by many bacteria to retain proteins on the 
outer surface of the cytoplasmic membrane is via an N-terminal diacyl-glycerol 
modification of a cysteine residue in pre-lipoprotein signal peptides. These signal 
peptides are generally shorter than those found in other proteins and contain a ‘lipobox’ 
conserved cleavage sequence of Leu-(Ala/Ser)-(Ala/Gly)-Cys (Tjalsma et al., 2000). 
During secretion, the cysteine of this motif is modified by a diacylglycerol transferase 
and following signal peptide cleavage by a distinct ‘Type II’ signal peptidase, the 
protein remains anchored in the cell membrane via the diacyl-glycerol modification 
(Tjalsma et al., 2000). Type II signal peptidases show very little sequence homology to 
other proteases and it has been proposed that they are unusual aspartate proteases with a 
catalytic triad of Asp-Thr/Ser-Gly (Tjalsma et al., 1999). In contrast to Type I, Type II 
signal peptidases are not critical for cell viability (Paetzel et al., 2000). 
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This process was first identified by Hantke and Braun (Hantke and Braun, 1973) in E. 
coli and was later discovered to be applicable to many Gram positive proteins such as 
BlaZ (Cossart and Jonquieres, 2000; Navarre et al., 1996; Wang and Novick, 1987; 
Nielsen and Lampen, 1982).  
 
(iii) A third and common mechanism is mediated by a specialised, membrane associated 
transpeptidase called sortase (as it sorts proteins to the cell wall). Since this is most 
relevant to this project, sortases and the wall sorting mechanism is described in more 
detail below.  
 
1.8 Sortases 
 
Many cell wall proteins in GAS and other Gram positive organisms are anchored 
covalently to the cell wall in a transpeptidation reaction at the outer surface of the 
membrane, by a membrane associated enzyme called the ‘general housekeeping’ sortase 
(usually, but not always, called SrtA) (Marraffini et al., 2006; Navarre and Schneewind, 
1999; Kehoe, 1994). All Gram positive bacteria have been found to possess a general 
sortase but some were found to express additional sortases which tended to be encoded 
by operons adjacent with the genes whose product the sortase anchors to the cell wall 
(see later). The SrtA of S. aureus is a 206 residue protein with an N-terminal membrane 
anchor (Mazmanian et al., 1999). The importance of this enzyme was highlighted when 
S. aureus SrtA defective mutants were almost completely cleared from lesions in mice 
while wild-type bacteria formed kidney abscesses (Mazmanian et al., 2000). This 
suggested a dramatic decrease in virulence and implicated a role for SrtA in 
pathogenesis. This enzyme is responsible for anchoring many important surface proteins 
and virulence factors to the cell wall and has subsequently become an attractive target 
for anti-microbials (Suree et al., 2009b; Maresso and Schneewind, 2008). Owing to its 
mechanism of action, SrtA is also being used in a number of biotechnology applications 
(Proft, 2010; Tsukiji and Nagamune, 2009). 
 
Proteins to be anchored by SrtA are synthesized as precursors with an N-terminal signal 
peptide and a C-terminal ‘stop transfer’ signal consisting of a membrane spanning (15-
20 residue) hydrophobic region followed by a (2-5 residue) charged tail (Blobel, 1980). 
17 
 
This sequence usually just delays secretion until SrtA can anchor it to the cell wall 
although this appears to be enough to retain and display the ActA protein of L. 
monocytogenes at the cell surface (Kocks et al., 1992; Blobel, 1980). When examining 
the C-terminal sequences of surface proteins from Gram positive cocci, a distinct motif 
located directly upstream of the stop transfer signal was revealed. This sequence 
consisting of Leucine-Proline-X-Threonine-Glycine (where X is any amino acid) was 
found to be highly conserved, even at the DNA sequence level (Fischetti et al., 1990). 
This discovery led to detailed studies of this so-called cell wall sorting signal (CWSS), 
using protein A from S. aureus as a model system. In a series of important experiments 
it was found that each component of the CWSS; the LPXTG motif, hydrophobic 
domain and positively charged tail were all required for efficient surface protein 
attachment to the cell wall (Schneewind et al., 1993; Schneewind et al., 1992). Further 
experiments showed the LPXTG motif of protein A was cleaved between the threonine 
and glycine residues by SrtA, and anchored covalently to the penta-glycine cross bridge 
of the staphylococcal lipid II precursor (Navarre et al., 1998; Ton-That et al., 1997; 
Schneewind et al., 1995; Navarre and Schneewind, 1994).  
 
1.9 General mechanism of sortase action 
 
Ton-That and colleagues showed that a conserved cysteine (Cys184 in S. aureus SrtA) 
was absolutely required as substitution of this residue to alanine abolished enzyme 
activity (Ton-That et al., 1999). In addition, the NMR structure of S. aureus SrtA 
revealed a histidine, His120 (Ilangovan et al., 2001) and a later crystal structure 
revealed an arginine residue, Arg197 (Zong et al., 2004) to be present in the active site 
of the enzyme close to the conserved cysteine residue. These residues are conserved in 
all SrtA enzymes and were shown to be required, as alanine substitution severely 
reduced enzyme activity (Marraffini et al., 2004; Ton-That et al., 2002). Mutation of a 
non-conserved tryptophan (Trp194 in S. aureus SrtA) to alanine did not abrogate 
attachment but was shown to reduce the kinetics of the reaction (Ton-That et al., 2002). 
In the two structures of S. aureus SrtA discussed above the proposed active site residues 
(Cys-His-Arg) are not present in conformations consistent with in vitro studies. Recent 
structures of the S. aureus SrtA in complex with an LPET peptide, solved by NMR 
(Suree et al., 2009a), and the GAS SrtA (Race et al., 2009) however, reveal that these  
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Figure 1.3: Schematic diagram of protein attachment to the cell wall via the  
                   action of SrtA. 
 
n: represents repeating units of MurNAc-GlcNAc. Step 1: Secreted proteins are 
synthesized as precursors containing all of the features described above. Step 2: 
Following translocation through the GSP the surface protein is held in the cytoplasmic 
membrane by its stop transfer signal, displaying its LPXTG motif for recognition by 
SrtA (represented in yellow). Step 3: The sulfhydryl group of the conserved cysteine 
residue in the sortase active site then cleaves the scissile peptide bond between the Thr 
and Gly of the LPXTG motif creating an acyl-enzyme intermediate with the carboxyl 
group of the Thr. Step 4: This acyl-enzyme intermediate is resolved by a free amino 
nucleophile provided by the cross bridge of the lipid II peptidoglycan precursor, 
forming an amide bond with the Thr carboxy terminus of the surface protein (Perry et 
al., 2002; Ton-That et al., 2000). His120 (S. aureus SrtA numbering) mentioned above, 
has been implicated in activating the conserved Cys (Ton-That et al., 2002), facilitating 
formation of the acyl-enzyme intermediate while Arg197 could stabilise the reaction 
(Marraffini et al., 2004). 
 
 
residues are present in the active site and probably contribute to catalysis of the LPXTG 
peptide.  
 
The current model describing sortase mediated attachment of surface proteins is 
outlined in Figure 1.3.  
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As more types of sortase were discovered, their nomenclature became confusing and 
this led to attempts to classify these enzymes. Dramsi et al. (Dramsi et al., 2005) 
described four classes of sortase as follows; (i) SrtA, the house-keeping sortase 
responsible for anchoring LPXTG motif containing surface proteins to the cell wall and 
has an N-terminal cytoplasmic membrane anchor; (ii) SrtB, contain an N-terminal 
membrane anchor and recognise motifs specific to the organism and sortase. In the 
present context this group are responsible for forming long polymeric pili in M1 GAS 
strain SF370 (section 1.14); (iii) SrtC have been found in corynebacteria, bacilli, 
clostridial, enterococcal and streptococcal species and have a C-terminal membrane 
anchor; (iv) SrtD have been found in bacilli, clostridial, actinomycetales and have also 
been attributed a role in pili formation in Bacillus cereus (Budzik et al., 2009a). 
 
1.10 Bacterial pili   
For invading pathogens the first step in establishing an infection often involves 
adhesion to specific tissues within or on the human body. Generally, there are two types 
of adhesion; those facilitated by non-specific, weak attractive forces, which are 
sufficient in areas that don’t experience strong shear forces; and specific adhesion, 
which involves binding to specific receptors by non-covalent associations. The net 
negative charges displayed at the surfaces of both bacterial and mammalian cells tend to 
repell these surfaces but this repulsive force can be minimised by positioning adhesive 
protein molecules well away from the bacterial cell surface. Consequently, adhesive 
molecules are often (though not always) positioned at the tips of long proteinaceous 
filaments called pili (Latin for ‘hair’), or fimbriae (Latin for ‘thread’ or ‘fibre’), which 
can extend from the bacterial surface for some distance. Pili were first discovered in the 
Gram negative E. coli using electron microscopy in the 1950’s (Duguid et al., 1955; 
Houwink and van Iterson, 1950) while Gram positive pili were first documented in the 
late 1960’s and early 1970’s by Yanagawa and colleagues in non-pathogenic strains of 
corynebacteria (Yanagawa and Honda, 1976; Kumazawa and Yanagawa, 1972; 
Yanagawa and Otsuki, 1970). Pili are composed of multiple copies of one or more 
subunits, which are held together by non-covalent interactions in Gram negative 
bacteria (Proft and Baker, 2009). In direct contrast, the subunits in Gram positive pili 
are covalently attached to each other producing in effect a single large polymer 
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extending from the bacterial cell surface. Since their discovery, pili in Gram negative 
bacteria have been studied extensively and a great deal of information is known about 
their biogenesis and role in pathogenesis, but detailed studies on Gram positive bacterial 
pili have been comparatively recent.  
 
There are four main groups of Gram negative pili which can be distinguished by their 
morphology and mechanism of biogenesis; (i) pili such as Type I and P-pili assembled 
by the chaperone/usher pathway, (ii) Type IV pili, (iii) curli pili assembled by the 
extracellular nucleation/precipitation pathway, (iv) CS1 pili formed via the ‘alternative 
chaperone-usher pathway’. It is worth noting that these are all quite distinct from pili in 
Gram positive bacteria and will not be discussed further here. For extensive recent 
reviews see (Craig, 2009; Proft and Baker, 2009; Pizarro-Cerda and Cossart, 2006; 
Mattick, 2002; Wu and Fives-Taylor, 2001; Sauer et al., 2000). 
 
1.11 Pili in Gram positive bacteria  
In the years following their discovery, relatively little progress was made in studying 
Gram positive pili. Earlier work was limited to oral commensals such as Actinomyces 
naeslundii or other oral streptococci (Wu and Fives-Taylor, 2001). As mentioned above, 
individual subunits in Gram positive pili are covalently cross linked to each other and 
the assembled pilus is then anchored to the peptidoglycan cross bridge within the lipid 
II precursor. These covalent cross links make Gram positive pili extremely robust and 
the subunits cannot be separated merely by boiling in SDS. The difficulties this presents 
in trying to purify the individual pilus subunits from Gram positive pili is probably why 
early work on these structures was so limited after their initial discovery. Significant 
progress in the field was hampered until genome sequencing data became widely 
available. This was coupled with the realisation that many important human Gram 
positive pathogens produced pili, which may be involved in the establishment of an 
infection and therefore represent novel targets for antimicrobial therapy. Their potential 
as vaccine candidates has been highlighted in a number of studies which show Gram 
positive pili proteins elicit a protective immune response in mice (Buccato et al., 2006; 
Maione et al., 2005; Mora et al., 2005). New information about these intriguing 
structures was published with increasing frequency throughout the course of this Ph.D 
project and provided many insights into their biogenesis and function in Gram positive 
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bacteria. Pili have recently been described in Enterococcus faecium (Hendrickx et al., 
2008), Enterococcus faecalis (Nallapareddy et al., 2006) and Bacillus cereus (Budzik et 
al., 2007) although in this chapter I will only discuss the well characterised pili of 
Corynebacterium diphtheriae and the pathogenic streptococci Streptococcus agalactiae 
(Group B Streptococcus, GBS), S. pneumoniae and S. pyogenes. In each case, these 
structures consist of a major subunit which forms the shaft of the pilus and either one, 
but more usually two minor subunits which play a role in host cell adhesion or 
anchoring the pilus to the cell wall. The genes encoding these subunits are located 
within the same locus on the chromosome adjacent to genes encoding one or more 
specific sortases responsible for assembling the pilus (Mandlik et al., 2008b; Oh et al., 
2008; Scott and Zahner, 2006). Protein subunits to be incorporated, are synthesized as 
precursors with a typical N-terminal signal peptide and are secreted via the GSP. 
Detailed studies on these structures have now been performed in important Gram 
positive pathogens and some of this work is outlined in the following sections. 
 
1.12 Pili in Corynebacterium diphtheriae 
Pili in Gram positive bacteria were first reported in non-pathogenic corynebacteria 
although many years later were discovered in C. diphtheriae. Studies revealed that C. 
diphtheriae expressed three distinct types of pilus, with the genes involved in the 
assembly of each located to a particular cluster in the chromosome, called the spaABC, 
spaDEF and spaHIG (sortase mediated pilus assembly) loci. Each of these clusters 
encode one or two sortases. Work on the SpaABC pilus revealed that SpaA was located 
throughout the structure and formed the shaft, with SpaB decorating it and SpaC located 
at the tip (Ton-That and Schneewind, 2003). The sortase encoded by this gene cluster, 
confusingly called SrtA but not actually the house keeping sortase (which is termed 
SrtF in C. diphtheriae), was shown to play an important role in pili biogenesis as its 
deletion abolished SpaA polymerisation into pili (Ton-That and Schneewind, 2003). 
The discovery of this mechanism meant that a transpeptidation reaction was needed to 
cross link pili subunits and therefore must involve at least one free amino group. 
Sequence alignment of the major pilus subunits from a number of Gram positive 
bacteria identified a so called ‘pilin motif’ of WxxxVxVYPK, containing a conserved 
lysine residue at position 190 of SpaA. This lysine was revealed as crucial to pili 
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biogenesis as substitution for alanine abrogated the polymerisation of SpaA monomers 
(Ton-That and Schneewind, 2003). The incorporation of SpaB into the pilus was 
reported to involve the so called ‘E-box’ motif of SpaA - YxLxETxAPxGY. Mutation 
of the conserved glutamate within this sequence did not affect polymerisation of SpaA 
into pili but did seem to affect SpaB incorporation. The precise role that this region 
plays in pilus assembly was revealed at a later time (see section 1.15). Both the ‘pilin 
motif’ and ‘E-box’ are found in many but not all Gram positive major pilus subunits; 
for example, neither are found in Spy0128 of M1 GAS strain SF370 (see 1.14.2). 
 
C. diphtheriae ΔspaB mutants released pili from the cell surface after the bacteria were 
boiled in hot SDS while this was not possible with the wild-type cells (Ton-That et al., 
2004). This led to detailed work by Ton-That and colleagues who showed that the 
housekeeping sortase plays a distinct role in pilus assembly. Deletion of the srtF gene 
from the chromosome led to the secretion of pili into the culture medium. This coupled 
with the observation that the ΔspaB mutant exhibited the same phenotype suggested that 
SpaB was the final subunit incorporated into the pilus and would therefore be anchored 
to the cell wall by the house keeping sortase (Mandlik et al., 2008a; Swaminathan et al., 
2007). The assembly of SpaABC pili is outlined in Figure 1.4. 
 
The spaDEF and spaHIG gene clusters each encode a major subunit; SpaD and SpaH 
respectively, and two minor subunits; SpaF and SpaG likely positioned at the pilus tip 
and SpaE and SpaI potentially anchoring assembled pili to the cell wall. In contrast to 
the spaABC locus, both harbour genes encoding two sortases. These sortases probably 
play analogous roles to SrtA and SrtF during SpaA pilus formation described above 
(Gaspar and Ton-That, 2006; Swierczynski and Ton-That, 2006). Although C. 
diphtheriae produces three distinct pili, only a role for SpaABC pili has been identified 
so far in pathogenesis. C. diphtheriae adhesion to pharyngeal cells (representing the 
primary site of C. diphtheriae infection) was greatly diminished in bacteria which did 
not express either SpaB or SpaC. Bacterial binding could also be blocked with specific 
sera to these two proteins while beads coated with SpaB or SpaC both adhered to 
cultured cells (Mandlik et al., 2007). Deletion of the SpaA protein abolished pilus 
formation but surprisingly did not reduce bacterial adherence significantly implying that 
in the absence of SpaA, SpaB and/or SpaC can still mediate adhesion to pharyngeal 
cells (Mandlik et al., 2007). This suggests that the two remaining pili types are not  
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Figure 1.4: General model of heterotrimeric pilus assembly in Gram positive 
                    bacteria.       
                         
All subunits here are depicted with an ‘LPXTG’ motif. Depending on the organism in 
question, subtle variations on this sequence and process are observed. In C. diphtheriae, 
the major shaft subunit SpaA and tip protein SpaC both contain the same C-terminal 
sorting signal, LPLTG, while SpaB has an LAFTG sorting signal. Step 1: Prior to 
polymerisation into pili, subunits are translocated across the cytoplasmic membrane by 
the GSP where they are retained in the membrane by their C-terminal stop transfer 
signal. Step 2: Current models of assembly suggest that SpaC is the first subunit to be 
incorporated and its LPLTG motif is cleaved by the pilus associated sortase between the 
threonine and glycine creating an acyl-enzyme intermediate as outlined in section 1.9. 
Step 3: This intermediate is presumably resolved by the free ε-amino group from 
Lys190 of the first SpaA subunit to be incorporated into the pilus. This subunit is then 
cleaved at its own LPLTG motif by the pilus associated sortase and in turn, this ‘new’ 
acyl-enzyme intermediate is resolved by the next SpaA subunit. Step 4: This process is 
repeated many times to produce the polymerised pilus. Step 5: The terminal step in 
pilus assembly most likely involves the incorporation of SpaB (‘Link’ protein) at the 
base where a critical lysine at position 139 resolves the final sortase-SpaA acyl-enzyme 
intermediate (Mandlik et al., 2008a). Step 6: The LAFTG motif of SpaB is then cleaved 
by the housekeeping sortase and anchored to the lipid II precursor in the cell wall 
(Mandlik et al., 2008a). Recent evidence has shown that all of the components involved 
in this process localise in the same region of the cytoplasmic membrane leading to a 
highly specialised centre termed the ‘pilusosome’ (Guttilla et al., 2009). 
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involved in adhesion to this cell type and could potentially facilitate adhesion to other, 
as yet unidentified niches. 
 
1.13 Pili in Streptococcus agalactiae and Streptococcus pneumoniae 
Pili have also been discovered at the surface of important human pathogens from the 
Streptococcus genus. These include S. agalactiae (Group B Streptococcus, GBS) and S. 
pneumoniae, which show similarities but also distinct differences in pilus assembly to 
each other and the previously characterised C. diphtheriae pili. The presence of pili in 
GBS was first identified in 2005 (Lauer et al., 2005) and the locus to which they were 
mapped was termed Pilus Island 1 (PI-1). Two additional pilus loci were subsequently 
identified in GBS and were considered to be variants of the same island, PI-2a and PI-
2b. All three of these loci encode one major and two minor subunits adjacent to two 
class B sortases (Figure 1.5) (Dramsi et al., 2006; Rosini et al., 2006). Work carried out 
on pili in GBS revealed that all strains studied to date express at least one type of pilus 
(Margarit et al., 2009). It has been suggested that the two sortases from each locus show 
a degree of redundancy; while both can polymerise the major subunit into polymeric 
pili, each shows a distinct specificity for incorporating only one of the minor subunits 
into the pilus (Dramsi et al., 2006). In an analogous manner to the SpaABC pili of C. 
diphtheriae, GBS ∆srtA mutants released fully polymerised PI-2a pili containing all 
three subunits into the culture medium (Nobbs et al., 2008). Also, similar to the C. 
diphtheriae ΔspaB mutant, deletion of the gbs150 minor subunit from PI-2a led to 
accumulation of pili in the culture medium. This suggests that PI-2a pili are covalently 
anchored to the cell wall by SrtA via GBS150 (Nobbs et al., 2008). GBS is responsible 
for causing sepsis, pneumonia and meningitis in neonates and attempts to clarify the 
roles of the minor pilus subunits have been made. Recombinant proteins corresponding 
to GBS52 and GBS104 (from PI-1, see Figure 1.5) were shown to bind cultured 
pulmonary epithelial cells although specific antibodies against GBS52 did not block 
binding (Krishnan et al., 2007). The same study also found that Δgbs52 mutants 
displayed dramatically reduced binding and used this as evidence that GBS52 must be 
the pilus adhesin. However, this reduction in binding was probably due to the release of 
pili from the cell surface rather than GBS52 acting as the adhesin. Subsequently, 
GBS104 has been identified as responsible for mediating adhesion to epithelial cells, as  
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Figure 1.5: Pilus loci of GBS and S.pneumoniae. 
 
White arrow: transcriptional regulator. Green arrow: major subunit. Yellow arrow: pilus 
anchor. Red arrow: adhesin. Blue arrow: sortase. Gene numbers correspond to genome 
annotations for GBS strain 2603 V/R (PI-1 and PI-2a) and COH1 (PI-2b). 
 
has GBS67 from PI-2a (Pezzicoli et al., 2008). A similar study on a different GBS 
strain suggested that one subunit, PilA (homologous to GBS67 from PI-2a), was crucial 
for adhesion while the backbone subunit, PilB, mediated internalisation into brain 
endothelial cells (Maisey et al., 2007). In contrast, Pezzicoli et al. (Pezzicoli et al., 
2008) found that deletion of the pilus genes from the chromosome had no effect on the 
cellular internalisation of GBS, but noted they invaded via the paracellular route 
instead.  
 
Some of the structural pilus proteins encoded by GBS share over 50% sequence 
homology with proteins encoded by the rlrA pilus islet of S. pneumoniae. The rlrA 
island is a region of ~11 kb encoding three pilus associated sortase enzymes, srtC-1, 
srtC-2 and srtC-3, an rlrA regulator and three wall associated proteins, rrgA, rrgB and 
rrgC, which have been shown to assemble into polymeric pili (Barocchi et al., 2006). 
Pili encoded by this islet are composed of repeating RrgB monomers forming the shaft 
of the pilus (which also contains both the canonical ‘E-box’ and ‘pilin motif’) (LeMieux 
et al., 2006). Early work attempting to elucidate specific roles and positions in the pilus 
PI-2a 
PI-2b 
        san1519                           san1518                              san1516 
rlrA islet  
PI-1 
 araC        gbs80                   gbs52                                                           gbs104      
rogB                  gbs67                               gbs59                                                gbs150 
 rlrA                  rrgA                                   rrgB                    rrgC           srtC-1       srtC-2       srtC-3 
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for RrgA and RrgC suggested that pili formed coiled-coils at the surface of S. 
pneumoniae (Hilleringmann et al., 2008). Detailed EM studies however confirmed that 
RlrA pili are formed by a single string of RrgB monomers (Hilleringmann et al., 2009) 
arranged in a head-to-tail conformation with a single monomer of RrgA located at the 
tip and a single monomer of RrgC at the base (Hilleringmann et al., 2009). This 
confirmed earlier studies suggesting RrgA was the pilus presented adhesin 
(Hilleringmann et al., 2008; Nelson et al., 2007; LeMieux et al., 2006). Analysis of the 
two minor subunits revealed recombinant proteins to both bound to cultured A549 
pulmonary epithelial cells although RrgA bound with much greater affinity (Nelson et 
al., 2007). This arrangement of subunits presents a similar mode of pilus assembly in S. 
pneumoniae to both C. diphtheriae and GBS. The recently determined RrgA crystal 
structure revealed it to be an elongated four domain protein containing a metal ion-
dependant adhesion site (MIDAS) motif in its top domain (Izore et al., 2010). These 
motifs have been shown to mediate protein binding to collagen (Emsley et al., 2000). 
The RrgA protein has homologues in GBS and M2 GAS pili while the conserved 
MIDAS motif in these proteins suggests horizontal transfer of the pilus island and a 
common target for binding. The discovery of three sortase enzymes encoded in the rlrA 
locus led to the hypothesis that there was a one-to-one sortase to surface protein 
assembly pathway for pili in S. pneumoniae. Although this is an attractive model for 
pilus assembly, recent evidence suggests that this is not strictly the case as the three 
sortases exhibit (although to a minor degree) redundancy. SrtC-1 was found to be the 
major sortase involved in polymerisation of RrgB monomers into pili, although in 
ΔsrtC-1 strains, ‘background’ polymerisation of RrgB was observed while SrtC-3 can 
also form RrgB oligomers in vitro (Manzano et al., 2008). Other studies have suggested 
that while SrtC-1 is responsible for polymerisation of all three subunits into pili, SrtC-3 
is required to anchor the pili to a specific location at the cell surface (Falker et al., 
2008). Another study by LeMieux et al. (LeMieux et al., 2008) reported sortase 
redundancy in the polymerisation of RrgB but suggested that SrtC-1 incorporated RrgC 
and SrtC-3 incorporated RrgA into the pilus, while also dismissing the role of the house 
keeping sortase, as mutants lacking SrtA displayed a wild-type amount of pili at the cell 
surface. The presence of three sortases in this cluster presents a slightly more complex 
mechanism of pilus assembly in S. pneumoniae than C. diphtheriae and GBS although 
the specific role of each sortase remains unclear. Recent crystal structures of these 
sortases have provided insights into their mechanism of action, revealing a flexible ‘lid’ 
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covering the active site, in contrast to SrtA which instead protects its active site within a 
hydrophobic pocket (Manzano et al., 2008). The critical Asp and aromatic residues 
contained within this ‘lid’ structure, are thought to stabilise the active site residues and 
upon recognition of a pilus subunit the ‘lid’ opens and allows entry of the ‘LPXTG’ 
type motif (Manzano et al., 2009; Neiers et al., 2009; Manzano et al., 2008). Searches 
for ‘lid’ residues in other pilus associated sortases has revealed their presence in a 
number of Gram positives including GAS. In addition to the RlrA pilus, a second locus 
has been identified in S. pneumoniae, termed pilus island 2 (PI-2) encoding two 
structural proteins PitB, the major subunit, PitA (whose gene contains an internal stop 
codon and was therefore not found in mature pili), two sortases (one of which is a 
pseudogene) and a signal peptidase related product (Bagnoli et al., 2008). Strains 
containing the polymerised PitB pilus were found to be more adherent to A549 cells 
than strains where the genes encoding the pilus had been deleted from the chromosome 
(Bagnoli et al., 2008). Bagnoli et al. (Bagnoli et al., 2008) tested their entire strain 
collection for the presence of the PI-2 locus and found that only 16.4% of their 305 
collected isolates harboured the region. This finding was analogous to a similar search 
for the rlrA island in a different strain collection of 465 isolates, which revealed that 
only 27% contained the region (Aguiar et al., 2008). This study found that not all 
disease causing strains possessed the rlrA pilus island but did show that strains carrying 
the island were more likely to be resistant to at least one anti-microbial. Interestingly, a 
number of strains found to be negative for the island did contain remnants of genes 
contained within it, suggesting horizontal transfer and the presence of this locus in the 
strain’s ancestors. The expression of pili in S. pneumoniae did not seem to be crucial for 
the causation of disease but did contribute to adherence (Aguiar et al., 2008). 
 
 
1.14 GAS pili 
 
1.14.1 The FCT region of GAS 
The genes involved in pili biogenesis in GAS have been mapped to an area of the 
genome which had previously been designated the FCT region. This was because in 
some strains this region had been found to contain genes encoding a fibronectin binding 
protein, a collagen binding protein and a T antigen (Bessen and Kalia, 2002). The FCT 
region is an 11 to 16 kb locus situated between two highly conserved genes, one 
encoding a putative heat shock protein and the second of yet undescribed function. This 
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region has a considerably lower GC% content than the sequences directly up and 
downstream of it which may be indicative of a pathogenicity island although it lacks 
other commonly associated features and has been discovered in every GAS genome 
sequenced to date (Podbielski, 2007). The exact structure of the FCT region and the 
sequence of genes within it can vary quite extensively between strains and to date nine 
different FCT structures have been described (see Figure 1.6), although FCT-7 and 
FCT-9 contain no adhesin (Falugi et al., 2008; Kratovac et al., 2007). Interestingly, the 
two sortases and minor subunits contained within the FCT-6 region harboured by M2 
GAS share 88-93% sequence homology with the same genes from GBS PI-1. This 
suggests that not only is there recombination of this region between strains of GAS but 
also between species of streptococci. GBS are able to colonise the vaginal mucosa while 
M2 GAS are primarily isolated from patients with puerperal sepsis (Falugi et al., 2008). 
The M-protein has previously been shown to undergo extensive recombination enabling 
GAS to evade the host immune system (Kehoe et al., 1996) and perhaps this region is 
subject to similar selective pressures which hastens its evolution.  
   
All FCT regions contain either a rofA or nra gene and in addition some harbour an 
msmR (multiple sugar metabolism regulator), all of which are regulators of 
transcription. RofA is important in bacterial-host cell interactions and in response to 
increased oxygen levels positively regulates itself and the fibronectin binding protein 
(Kreikemeyer et al., 2002; Fogg and Caparon, 1997; Fogg et al., 1994). The binding of 
ΔrofA mutants to HEp-2 cells was reduced by 40% compared to wild-type bacteria 
(Beckert et al., 2001). Inactivation of nra lead to a decrease in virulence of GAS in a 
mouse model and it was also noted that Nra appeared to have no effect on mga 
transcription (Luo et al., 2008b). Mga is a stand alone response regulator responsible for 
the expression of many key virulence factors involved in host cell attachment and 
immune evasion, including the M-protein and C5a-peptidase (Hondorp and McIver, 
2007; Kreikemeyer et al., 2003). Transcription is strongly activated by Mga during the 
exponential phase of growth (McIver and Scott, 1997) whereas Nra is preferentially 
expressed during early stationary phase. A recent study showed that transcription of 
certain virulence factors is regulated by either Mga or Nra but not by both (Luo et al., 
2008a). This suggests that there is a highly complex but finely tuned network of genes, 
cross regulating the expression of virulence factors in GAS as the organism moves from  
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Figure 1.6: The nine FCT regions of GAS. 
 
RofA is the transcriptional regulator encoded in all regions except FCT-3 and FCT-8, 
which contain Nra. The second regulator of transcription in FCT-3, FCT-4, FCT-7 and 
FCT-8 is of the AraC/XylS type. FCT genes encoded by FCT-3 and FCT-4 share the 
greatest degree of similarity and were found to be the most prevalent type in studies by 
Kratovac et al. (Kratovac et al., 2007) and Falugi et al. (Falugi et al., 2008). In contrast, 
FCT-2 and FCT-6 were found to be rare in the same sample set (Kratovac et al., 2007).  
FCT-7 and FCT-8 are derivatives of FCT-4 (FCT-7 lacks a detectable minor subunit 1 
while FCT-8 is identical to FCT-4 apart from nra replacing rofA). The genes of the M1 
GAS strain SF370 FCT-2 region responsible for pilus assembly are highlighted. This 
figure was compiled from available genome sequence data for FCT-1 to FCT-6 
inclusive and from data presented by Kratovac et al. (Kratovac et al., 2007) and Falugi 
et al. (Falugi et al., 2008) for FCT-7 to FCT-9 inclusive. 
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one stage of growth and infection to the next, potentially conferring on a strain a 
particular tissue tropism. These regulatory events are likely to be strain specific as Nra 
from two strains of GAS, both harbouring an FCT-3 region have differing effects; in an 
M49 GAS strain, Nra negatively regulates pilus expression (Podbielski et al., 1999) 
while in an M53 GAS strain Nra positively regulates pilus gene expression (Luo et al., 
2008b). The gene encoding the MsmR regulator is present in a number of FCT regions 
and belongs to the AraC/XylS type transcriptional regulators. GAS ΔmsmR strains have 
been shown to exhibit reduced binding to immobilised fibronectin and human 
pharyngeal cells which was suggested to be as a result of downregulated expression of 
the major and a single minor pilus subunit in these strains (Nakata et al., 2005). This 
information taken together suggests that MsmR positively regulates the FCT region 
genes and consequently pilus expression. 
 
 A number of FCT regions, including types 2 and 3, harbour a sipA or lepA gene 
(depending on the strain) whose product exhibits homology to previously described 
signal peptidases. Upon closer examination however, common features such as the 
catalytically important lysine and serine residues were not present. A role for these 
proteins in pilus assembly was highlighted when its deletion from the chromosome 
resulted in unpolymerised major pilus subunit monomers at the cell surface (Nakata et 
al., 2009). It has been suggested it functions as a chaperone (Zahner and Scott, 2008), 
although its precise function in pilus biogenesis has yet to be revealed.  
 
1.14.2 Pili in Streptococcus pyogenes  
Pili in GAS were first visualised extending from the cell surface of serotype M1 GAS 
strain SF370 (the strain used in this study) by immuno-gold labelling (Mora et al., 
2005). These pili are encoded by the FCT-2 locus shown in Figure 1.6. The product of 
the spy0128 gene was shown to be the major pilus subunit which forms the shaft and 
unlike many other major pilus subunits, Spy0128 does not contain an ‘E-box’ or ‘pilin 
motif’. The products of minor subunits spy0125 and spy0130 were also associated with 
the pilus but were present in far fewer copies (Mora et al., 2005). The minor subunits 
had been shown to display some homology to previously described fibronectin and 
collagen binding proteins (Kreikemeyer et al., 2005; Rocha and Fischetti, 1999) 
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although more recent evidence suggests that neither fibronectin or collagen act as the 
receptor (Abbot et al., 2007). The FCT region of M1 GAS strain SF370 also encodes a 
sortase that was designated SrtC, (sometimes referred to as a ‘pilin polymerase’) but 
this is actually a type B sortase in the classification system devised by Dramsi (Dramsi 
et al., 2005). A second encoded sortase (designated SrtB), does not contain a signal 
peptide and is therefore not thought to be functional at the cell surface (Barnett et al., 
2004; Barnett and Scott, 2002). Abbot et al. (Abbot et al., 2007) showed that deletion of 
this gene had no detectable effects on the expression of pili or other surface proteins 
examined. In addition, there is a rofA transcriptional regulator, sipA and two transposase 
genes highlighting that this region was probably acquired horizontally (Figure 1.6). 
Mora et al. (Mora et al., 2005) observed that polymerisation of all three structural 
subunits into high molecular weight ‘ladders’ on immunoblots, characteristic of pili, 
was abolished in a Spy0128 deletion mutant. This phenotype was repeated in a SrtC 
deletion mutant while they reported a Spy0130 deletion mutant as displaying 
polymerised pili that appeared to be less frequent at the cell surface. Subsequent work 
performed by Abbot et al. (Abbot et al., 2007) showed that essentially four genes were 
needed from the FCT region for the formation of functional pili at the cell surface. 
Deletion of spy0128 or srtC from the chromosome abrogated pilus assembly 
(confirming the earlier observations of Mora et al.) while deletion of spy0125 or 
spy0130 produced polymerised pili that were not functional. This suggested that 
Spy0125 and/or Spy0130 might act as adhesins but their roles had not been clearly 
defined at the beginning of this project. This work also showed that GAS pili adhered to 
specific tissue types, representative of the common sites of GAS infection, including 
human tonsil, primary keratinocytes and HaCaT’s but not others such as A549 and Hep-
2 cells that are commonly used in GAS adhesion experiments. This was supported by 
Manetti et al. (Manetti et al., 2007) who showed that recombinant proteins of Spy0125 
and Spy0130, both adhered to Detroit human pharyngeal cells. Similar to the Abbot et 
al. study, strains deficient in the major subunit and SrtC were unable to bind to the 
cultured cell line (Manetti et al., 2007). These data taken together suggest a direct role 
for pili in the initial adherence of GAS to human cells and therefore a role in the 
pathogenicity of the organism. Pili in GAS have also been attributed a role in forming 
biofilms in an in vitro model, but the importance and role of biofilms in GAS infection 
is unclear (Manetti et al., 2007). In contrast to the beneficial adhesive properties of pili, 
a salivary agglutinin gp340 was found to bind pili from the M1 GAS strain SF370 
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causing bacterial aggregation, potentially helping with their clearance from the 
oropharynx (Edwards et al., 2008).  
 
1.15 Isopeptide bonds of Spy0128  
During the early stages of this project Kang et al. (Kang et al., 2007) reported the 
crystal structure of the major pilus subunit, Spy0128. This was combined with mass 
spectrometry analysis of intact pili and identified Spy0128 Lys161 as the nucleophile 
responsible for resolving the SrtC-Spy0128 acyl enzyme intermediate and forming a 
covalent link to the Thr residue within the ‘EVPTG’ motif at the C-terminus of the 
preceeding Spy0128 monomer to be incorporated into the growing pilus. In addition, a 
particularly novel observation were two intra-molecular isopeptide bonds, one in each 
domain of the protein, linking the first and last β-strands of the domains (Kang et al., 
2007). These covalent bonds are self generated between the side chains of lysine and 
asparagine residues with the help of a crucial glutamate residue. These types of bonds 
had only been previously reported between polypeptides, rather than within the same 
molecule and being formed by the action of enzymes such as transglutaminases (Lorand 
and Graham, 2003), ubiquitin ligases (Pickart, 2001) and sortases (see section 1.9). 
Viral proteins forming the capsid of the HK97 phage were found to be cross-linked by 
inter-molecular isopeptide bonds that appeared to be self generated by the action of a 
specific glutamate residue, which when mutated to alanine abolished the cross linking 
of capsid monomers (Wikoff et al., 2000; Duda, 1998). Mutation of the critical 
glutamate in Spy0128 also abrogated bond formation (Kang et al., 2007). A plausible 
mechanism for the formation of intra-molecular isopeptide bonds has been proposed 
(Kang et al., 2007). Within the hydrophobic environment of the protein core, the 
glutamate side chain becomes protonated and is able to polarise the C=O of the 
asparagine side chain. This event induces a partial positive charge on the asparagine Cγ, 
which is then subject to nucleophilic attack by the unprotonated lysine ε-amino group, 
generating the bond (Kang et al., 2009a; Kang et al., 2007). Mutagenic studies carried 
out to characterise intra-molecular isopeptide bonds revealed that their most likely role 
was to provide extra stability to the protein in a manner analogous to disulphide bonds 
in eukaryotic proteins. Recombinant Spy0128 harbouring point mutations which 
abrogated intra-molecular bond formation were shown to be much more susceptible to 
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protease degradation and heating when compared to the native protein (Kang and Baker, 
2009).  
 
Following this fascinating discovery crystal structures of pilus subunits from a range of 
Gram positive pathogens were reported to contain intra-molecular isopeptide bonds. 
The major subunit BcpA responsible for forming pili in B. cereus was shown to be a 4 
domain protein with each domain harbouring an intra-molecular isopeptide bond 
(Budzik et al., 2009b; Budzik et al., 2008a). The bonds present in the CNA2 and CNA3 
domains were shown to link the first and last β strands of the domain in a similar way to 
the bonds present in each domain of Spy0128 (Budzik et al., 2009b). The crystal 
structure of the SpaA subunit from C. diphtheriae revealed the protein to contain an 
intra-molecular isopeptide bond in two of its three domains, in addition to a disulphide 
bond within its C-terminal domain (Kang et al., 2009b). While the intra-molecular 
isopeptide bond present within the C-terminal domain of SpaA links the first and last β 
strands of the domain, the bond situated in the middle domain links the first and 
penultimate β strands (Kang et al., 2009b). The SpaA structure also showed for the first 
time that the glutamate residue of the so called ‘E-box’ was in fact the crucial glutamate 
residue needed for intra-molecular isopeptide bond formation (Kang et al., 2009b). As 
this Ph.D project progressed more information about structural pilus proteins became 
available and increasingly showed that although these proteins came from a wide 
variety of organisms they contained similar features such as intra-molecular isopeptide 
bonds. This was further highlighted by recent work done on S. pneumoniae pili, 
showing that all three pilus subunits contained isopeptide bonds. Biochemical 
characterisation of the RrgB and RrgC proteins revealed that they contain three and two 
intra-molecular bonds respectively (El Mortaji et al., 2010) while the X-ray crystal 
structure of RrgA highlighted the presence of two isopeptide bonds (Izore et al., 2010). 
The role of these bonds across the species of bacteria discussed here is probably the 
same, in that they are required for providing extra stability to these surface exposed 
structures that are likely to experience significant mechanical forces upon host cell 
binding.          
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1.16 Project objectives 
The original objectives of this project were to study all three pilus subunits, combining 
structural and molecular microbiology, with the aim of providing insights into their 
structure, role in pilus biogenesis and function. At the beginning of this project, 
Spy0128 had been described as the major pilus subunit that is assembled into the pilus 
shaft while Spy0125 and Spy0130, had been described as minor subunits but their 
specific functions were not known (Mora et al., 2005). Studies on Spy0128 suggested 
that the formation of intra-molecular isopeptide bonds was not critical to pilus function. 
From the outset it was anticipated that work on the individual subunits would progress 
at different rates, depending on the progress made and parallel studies of other 
laboratories. This proved to be the case, with a large proportion of this project focussing 
on Spy0125. Experiments by Manetti et al. (Manetti et al., 2007) suggested that both 
minor subunits might be pilus adhesins. However, work done in this thesis shows that 
only one, Spy0125, is responsible for the attachment of M1 GAS strain SF370 pili to 
host surfaces and is positioned at the pilus tip. Intriguingly, the crystal structure of the 
Spy0125 binding region presented here reveals a potentially novel mechanism of 
attachment for bacteria to host cells.  
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Chapter 2. Materials and methods 
 
2.1 Bacterial strains and plasmids  
The Streptococcus pyogenes and Escherichia coli strains used in this work are described 
in Tables 2.1 and 2.2. The plasmid vectors used are described in Figures 2.1 and 2.2. 
 
2.2 Chemicals, enzymes and reagents  
All chemicals used in this work were purchased from Sigma-Aldrich Company Ltd. 
(Poole, Dorset, UK) or VWR International (West Chester, Pennsylvania, USA) unless 
specified otherwise. 
Finnzymes Phusion High Fidelity polymerase was supplied by New England Biolabs 
Ltd (Hertfordshire, UK) and KOD Hot Start DNA Polymerase by Novagen (Merck 
Chemicals Ltd, Darmstadt, Germany). Restriction endonucleases were purchased from 
Roche Diagnostics Ltd (Lewes, East Sussex, UK) or Fermentas (York, UK). T4 DNA 
ligase was purchased from Roche Diagnostics Ltd.  All enzymes were supplied with 
their appropriate reaction buffers and were used as described in the manufacturer’s 
instructions. 
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Table 2.1. Streptococcus pyogenes strains 
 
M Type Strain Source / Reference Disease 
association 
 
S. pyogenes M1 
 
 
SF370 
 
ATCC 700294 / (Suvorov and 
Ferretti, 1996) 
 
 
Wound infection 
 
 
Table 2.2. Escherichia coli strains 
 
Strain Genotype and other descriptions Source / Reference 
 
DH5α 
 
F-, ø80dlacZΔM15 recA1 endA1 gyrA96 
λ- thi-1 hsdR17 (rK-,mK+) phoA supE44 
relA1 deoR Δ(lacZYA-argF)U169 
 
 
(Hanahan, 1983) 
 
BL21 (DE3) 
 
 
F- ompT hsdSB(rB-, mB-) gal dcm λ(DE3) 
 
Stratagene, 
Amsterdam, Europe 
 
 
BL21 (DE3) 
CodonPlus Type 
RIL 
 
 
F-, ompT hsdS(rB-,mB-) dcm Tet
r gal 
λ(DE3) endA Hte [argU ileY leuW Camr] 
 
 
Stratagene, 
Amsterdam, Europe 
 
B834 (DE3) 
 
 
F- ompT gal hsdSB (rB-mB-) met dcm lon 
λ(DE3) 
 
 
Gift from Structural 
Biology Lab, 
Newcastle University 
 
 
TG1-dev 
 
recA sup hsbΔ5 thi Δ(lac-proAB), 
F’[traD36 proAB+ lacqZΔM15] c/s:: 
repA. 
 
A derivative strain TG1, where the wild-
type repA gene from the cryptic 
Lactococcus lactis plasmid pWV01 
(precursor of pG+host9) has been inserted 
into the chromosome. This enables 
pG+host9 to replicate in E. coli at 37oC. 
 
 
(Law et al., 1995) 
E. Maguin, personal 
communication 
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Figure 2.1: pET-28a(+) expression vector and modifications. 
 
Panel A: The pET-28a(+) plasmid is designed to express cloned gene products as 
translational fusions with an N terminal, or optional C terminal His-tag. The plasmid 
encodes a thrombin cleavage site and T7 configuration. Panel B: The pET-28a(+) 
cloning region is shown and was modified by the removal of bases 203-248 as indicated 
by the red box to create pET-28a(+)-D. Source Novagen, Nottingham, England. Figure 
adapted from www.emdchemicals.com/showBrochure?id=200905.345. 
B 
A 
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Figure 2.2. pG+host9.  
 
The allele replacement vector pG+host9 encodes repA, the temperature sensitive 
replication gene, and ermAM an adenine methylase, which confers resistance to 
macrolide, lincosamine and streptogrammin (MLS) type antibiotics. The multiple 
cloning site is derived from pBluescript SK (Stratagene) and the recognition sequences 
of NotI, BstXI and SacI are overlapping. Figure adapted from Smith, 2004. 
 
 
 
 
 
 
 
repA 
ermAM 
                                                                 BamHI    
                                                                  SacII 
                                                                BstXI 
                                                                 NotI 
                                                               XbaI 
                                                              SpeI    
                                                            SmaI 
                                                        BamHI 
                                                         SmaI 
                                                          PstI 
                                                     EcoRI 
                                                  EcoRV 
                                                  HindIII 
                                                     ClaI 
                                                    SalI 
                                                  XhoI 
                                                 ApaI 
                                                KpnI 
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2.3 Media, culture conditions and strain storage 
All media were made using de-ionised water and sterilised by autoclaving at 121oC, 15 
psi for 30 min. Sterilised molten agar was allowed to cool to <45oC before adding heat 
sensitive supplements after which plates were poured immediately. 
 
S. pyogenes strains were grown in either THY broth (THYB) or on THY blood agar 
plates in a static incubator at 37oC, 5% CO2. THYB consisted of Todd Hewitt broth 
(Difco, Oxford, UK) with 0.5% (w/v) Bacto-yeast extract (Difco). For THY plates, 
1.5% (w/v) Bacto-agar (Difco) was added prior to sterilisation. After cooling THY agar 
to 45oC, 2.5% (v/v) defibrinated horse blood (TCS Biosciences Ltd, Botolph Claydon, 
Bucks, UK) was added immediately prior to pouring the plates. When selecting for the 
Ermr marker encoded by pG+host9, erythromycin was added to a final concentration of 
1 µg/ml. S. pyogenes strains were stored at 4oC for up to 4 weeks on THY blood agar 
plates sealed with Parafilm. For long-term storage glycerol stocks were prepared by 
inoculating 5 ml THYB with a single colony and cultures were grown for a minimum of 
8 h, at which point filter sterilised glycerol was added to a final concentration of 25% 
(v/v). All stocks were stored at -80oC in sterile cryogenic vials (Nalgene, New York, 
USA). 
 
E. coli strains were cultured in Luria-Bertani (LB) broth at 37oC (with shaking at 200 
rpm) in an orbital incubator (Sanyo, Gallenkamp PLC, Leicester, UK). Individual 
colonies were grown on LB agar plates in a static incubator at 37oC for 16-24 h. LB 
consisted of 1% (w/v) Bacto-tryptone (Difco), 0.5% (w/v) sodium chloride, 0.5% (w/v) 
Bacto-yeast extract. LB agar was prepared by the addition of 1.5% (w/v) Bacto-agar 
(Difco) prior to sterilisation. When selecting for pET-28a(+), kanamycin was added to 
media at a final concentration of 50 µg/ml. Selection of the pET30 markers carried by 
the BL21 (DE3) CodonPlus Type RIL host strain was acheived with the addition of 
chloramphenicol to the media at a final concentration of 34 µg/ml. When selecting for 
Ermr markers encoded by pG+host9, LB media was supplemented with 300 µg/ml 
erythromycin. E. coli strains were stored long term as glycerol stocks, prepared 
essentially as described above after being grown for a minimum of 8 h in LB broth at 
37oC with shaking at 200 rpm.  
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Stock solutions of antibiotics were prepared, filter sterilised using 0.2 µm acrodiscs 
(Pall Life Sciences, Newquay, Cornwall, UK) and stored in sterile microfuge tubes at    
-20oC prior to use. Stocks of kanamycin (10 mg/ml) were prepared in water. Stocks of 
chloramphenicol (34 mg/ml) and erythromycin (1 mg/ml and 100 mg/ml) were prepared 
in ethanol to aid dissolving.   
 
2.4 Bacterial growth rates 
For each strain a single well separated colony was inoculated into 10 ml THYB and 
incubated for 16 h at 37oC with 5% CO2. Cultures were diluted 1/25 into fresh THYB 
pre-warmed to 37oC, and then incubated at 37oC with 5% CO2. Over the next 9-12 h, 1 
ml samples were removed from each culture at hourly intervals for OD600 
measurements. 
 
2.5 General DNA procedures 
 
2.5.1 Isolation of plasmid DNA from E. coli  
A single well-separated E. coli colony transformed with the desired plasmid was used to 
inoculate 5 ml of LB broth supplemented with appropriate antibiotics, and the cultures 
were grown for 16 h at 37oC with shaking at 200 rpm. Plasmid DNA was recovered 
from these cultures using the QIAprep Spin Miniprep Kit (Qiagen Ltd, Crawley, West 
Sussex, UK). These kits follow the modified alkaline lysis method developed by 
Birnboim and Doly (Birnboim and Doly, 1979). Cell lysate was neutralised and 
adjusted to high salt binding conditions before centrifugation at 16,000 x g for 10 min to 
pellet insoluble cell debris. The supernatant, containing plasmid DNA was then applied 
to a QIAprep Spin Column to allow binding of plasmid DNA to the column silica gel 
membrane in high concentrations of chaotropic salts. At this stage contaminating 
material was removed with several wash steps using the buffers provided in the kit and 
up to 20 µg of high quality plasmid DNA was eluted from the membrane with 50 µl 10 
mM Tris-Cl, pH 8.5, and the DNA was stored at -20oC. 
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2.5.2 Preparation of GAS chromosomal DNA 
Isolation of GAS chromosomal DNA employed cell suspension solution, lytic enzyme, 
cell lysis solution, protein precipitation solution and DNA hydration solution provided 
by the Archive Pure DNA Yeast and Gram positive kit (5 PRIME, Flowgen Bioscience, 
Nottingham, UK). 
 
For preparation of total chromosomal DNA, a single well isolated GAS colony from a 
fresh THY blood agar plate was used to inoculate 7.5 ml THYB and was grown for 16 h 
at 37oC with 5% CO2 in a static incubator. Cells were harvested by centrifugation at 
3,600 x g for 15 min and resuspended in 500 µl of cell suspension solution with 25 µl 
mutanolysin (10 U/µl), 50 µl lysozyme (100 mg/ml) and 60 U lytic enzyme added. The 
mixture was incubated at 37oC for 3 h to digest cell walls. After incubation, resulting 
protoplasts were pelleted at 16,000 x g and the supernatant was removed. The cell pellet 
was resuspended in 500 µl cell lysis solution with gentle pipetting up and down 
employed to aid cell lysis. Samples were heated to 80oC for 30 min and then allowed to 
cool to room temperature before 7.5 µl RNase A (4 mg/ml) was added. Samples were 
then incubated for a further 60 min at 37oC before being cooled on ice and 500 µl of 
protein precipitation solution was added, followed by vortexing at high speed to aid 
mixing. Samples were chilled on ice for 5 min before precipitated proteins were pelleted 
by centrifugation at 16,000 x g. The supernatant containing the chromosomal DNA was 
collected into a clean microfuge tube with 500 µl of isopropanol added, mixed and 
centrifuged at 16,000 x g to pellet the DNA. The isopropanol was removed and the 
DNA was washed with 500 µl of 70% (v/v) ethanol followed by centrifugation at 
16,000 x g. The ethanol was poured off and samples were allowed to air dry for 15 min 
before 100 µl of DNA hydration solution was added. DNA was rehydrated by 
incubation for 1 hour at 65oC followed by 6 h at room temperature and then stored at 
4oC.         
 
2.5.3 Transformation of E. coli by modified Hanahan method (Heat Shock) 
A slightly modified version of the procedure devised originally by Hanahan (Hanahan, 
1983) was used. Competent cells were prepared by inoculating a single well isolated 
colony from a freshly streaked LB agar plate into 7.5 ml of LB broth, and incubating 
42 
 
this culture for 16 h at 37oC and 200 rpm. Next day, this was used to inoculate 300 ml 
of LB (1/40) which was incubated at 37oC and 200 rpm until the culture density at 
OD600 reached 0.6. Once the desired density had been achieved, cells were chilled on 
ice for 20 min and then harvested by centrifugation at 2,355 x g for 20 min at 4oC using 
a 3-16 K centrifuge (Sigma). Pelleted cells were washed by resuspending in 100 ml of 
ice cold TFB1 [30 mM potassium acetate, 10 mM CaCl2.2H2O, 100 mM KCl, 15% 
(v/v) glycerol, initially dissolved and autoclaved in 900 ml H2O and then made up to 1 l 
by the addition of 100 ml autoclaved 500 mM MnCl2]. Cells were harvested as above 
and resuspended in 7 ml ice cold TFB2 [75 mM CaCl2, 10 mM KCl, 15% (v/v) glycerol 
initially dissolved in 900 ml H2O and then made up to 1 l by the addition of 100 ml of 
autoclaved 100 mM Na-MOPS pH 7.0]. Aliquots of 200 µl were made in pre-cooled 
sterile microfuge tubes and frozen rapidly in an ethanol-dry ice bath. The frozen 
competent cells were stored at -80oC. 
 
For transformation, competent cells were thawed on ice and incubated with plasmids or 
ligation mixtures, immediately upon thawing, for 30 min. Cells were then heat shocked 
at 42oC for 2 min and returned to ice for 3 min to cool before 1 ml of LB broth was 
added to each transformation mixture. These were incubated at 37oC and 200 rpm for 
120 min to allow expression of antibiotic resistance markers. Samples (e.g. 100 µl) of 
culture were spread onto LB agar plates containing appropriate antibiotics and 
incubated for 16 h at 37oC in a static incubator to allow growth of single colonies. 
 
2.5.4 Transformation of E. coli by electroporation  
Electroporation was used to transform E.coli TG1-dev. Freshly competent cells were 
prepared by inoculating 10 ml of LB broth with a single well-isolated colony from a 
freshly streaked LB agar plate and the culture was incubated for 16 h at 37oC and 200 
rpm. The culture was used to inoculate 500 ml of LB broth (1/100) and was incubated at 
37oC and 200 rpm until the OD600 reached 0.5-0.6. Once the desired OD had been 
achieved cells were chilled on ice for 20 min and then harvested by centrifugation at 
2,355 x g for 20 min at 4oC. Cells were resuspended in 500 ml of ice cold, sterile H2O 
and harvested as above. Cells were washed for a second time in 250 ml of ice cold, 
sterile H2O and for a final time in 50 ml of ice cold, 10% (v/v) glycerol (which had been 
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filter sterilised using a 0.22 µM acrodisc, Millipore) and centrifuged as above. Cells 
were resuspended in 1 ml of ice-cold 10% (v/v) glycerol (filter sterilised as above) and 
60 µl aliquots were dispersed in pre-cooled microfuge tubes, which were frozen rapidly 
in an ethanol-dry ice bath and stored at -80oC. 
 
For electrotransformation, competent cells were thawed on ice and incubated with 1-10 
ng of plasmid DNA for 5 min. The mixture was then transferred to a pre-chilled Gene 
Pulser cuvette, 0.2 cm electrode gap (Bio-Rad), which was dried and placed in the 
electroporation chamber. The Gene Pulser II (Bio-Rad) was used to pulse the sample 
under the following electroporator settings: 2.5 kV voltage, 25 µF capacitance and 200 
Ω resistance. The sample was removed from the chamber and 1.5 ml of LB broth was 
immediately added. Cells were incubated at 37oC for 20 min in a static incubator 
followed by 40 min at 37oC with shaking at 130 rpm, after which 100 µl of culture was 
plated out onto LB agar plates containing appropriate antibiotics. The plates were then 
incubated for 16 h at 37oC. 
 
2.5.5 Transformation of GAS  
GAS cells were transformed with plasmid DNA by electroporation using a slightly 
modified version of the method described by Simon and Ferretti (Simon and Ferretti, 
1991). Fresh competent cells were prepared using a single well isolated colony to 
inoculate 10 ml of THYB which was incubated at 37oC with 5% CO2 for 16 h. This 
culture was used to inoculate 200 ml of THYB (1/20) and incubated at 37oC with 5% 
CO2 until the OD600 of the culture reached 0.22. Once the desired cell density had been 
achieved the culture was centrifuged for 15 min at 2,355 x g to pellet the cells. The 
pellet was resuspended in 10 ml of ice-cold filter sterilised 0.5 M sucrose and cells were 
harvested again at 2,355 x g. This wash step was repeated twice more to remove any 
trace salts which may have impaired the electrotransformation. The washed cell pellet 
was finally resuspended in 1 ml of 0.5 M sucrose and 100 µl aliquots were dispersed in 
pre-cooled sterile microfuge tubes that were frozen rapidly in an ethanol-dry ice bath 
before storage at -80oC.  
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For transformation of competent GAS, cells were allowed to thaw before the immediate 
addition 1-10 ng of plasmid DNA and the mixture was transferred to a pre-chilled Gene 
Pulser cuvette, 0.2 cm electrode gap (Bio-Rad). The sample was pulsed using a Gene 
Pulser II (Bio-Rad) under the following electroporator settings: 2.5 kV voltage, 25 µF 
capacitance and 200 Ω resistance. The sample was removed from the chamber and 1 ml 
of THYB was immediately added. The cells were incubated at 28oC for 3 h in a static 
incubator to allow the expression of Ermr markers on the temperature sensitive 
pG+host9 plasmid. Culture was plated in volumes of 100 µl onto THY blood agar 
containing the appropriate antibiotics. Plates were incubated at 28oC for 36-48 h to 
allow growth of single colonies. 
 
2.5.6 Restriction endonuclease digestion and DNA ligation  
Restriction endonucleases and T4 ligase together with appropriate buffers were 
purchased from standard commercial sources (section 2.2). Restriction endonuclease 
digestions and DNA ligations were carried out according to the manufacturer’s protocol 
using appropriate supplied reaction buffers for the enzyme being used. Restriction 
endonuclease digests were performed in 40-50 µl reaction volumes and incubated at 
37oC for 2-3 h. When required resulting digest products were analysed by agarose gel 
electrophoresis (section 2.5.11) and fragments were purified using the Qiagen Gel 
Extraction kit (Qiagen Ltd, section 2.5.12). A reaction volume of 10 µl was used for 
DNA ligations and samples were incubated at 4oC for 16 h.  
 
2.5.7 Synthesis of oligonucleotide primers 
Oligonucleotide primers were synthesised to order by VH Bio (Newcastle upon Tyne, 
UK). Primers were supplied in a lyophilised form and resuspended in 1 ml of double 
processed tissue culture water (Sigma-Aldrich Company Ltd.). Primer concentrations 
were adjusted to 10 pmol/µl, and aliquots were stored at -20oC. The oligonucleotide 
primers used in this study are described in Table 2.3. 
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2.5.8 Polymerase chain reaction (PCR)  
Standard endpoint PCR was performed essentially as described by Mullis (Mullis, 
1990), using Phusion High Fidelity DNA polymerase (section 2.2) and HF buffer 
supplied by the manufacturer. Reaction mixes consisted of 1 X HF buffer, 0.2 mM of 
each dNTP, 20 pico-moles of each primer, 1 U Phusion High Fidelity DNA Polymerase 
and up to 1 µg of template DNA, made up to 50 µl with double processed tissue culture 
water (Sigma). Thermal cycling was performed using a Biometra T3000 Thermocycler 
(Biometra, Goettingen, Germany), and amplification of products was achieved using the 
following conditions: 
 
Initial denaturation             98oC             30 s 
Denaturation                    98oC             10 s 
Primer annealing                 xoC              30 s                      30 cycles 
Primer extension                72oC            30 s / kb 
Final extension                   72oC            10 min 
Holding step                        4oC 
 
Primer annealing temperature ( x ) was estimated using the following equation, %GC x 
0.41 + 69 – (650/total no. of bases) and was usually the lower melting temperature of 
the two primers being used. Annealing temperature could then be optimised if needed 
by changing the Tm of the reaction in 1oC steps. PCR products were visualised by 
agarose gel electrophoresis and the Tm which gave rise to the best yield of product was 
used in future reactions. 
 
2.5.9 Site directed mutagenesis 
 
2.5.9.1 Quickchange PCR 
A modified quickchange PCR protocol (Stratagene) was used in site directed 
mutagenesis experiments to construct point mutations. PCR primers encompassing the 
desired point mutation were used with plasmids purified as described above (section 
2.5.1) as template. 10 ng of template in 1 µl was added to a 24 µl reaction mixture 
containing 1 X buffer for KOD Hot Start DNA polymerase (section 2.2), 1.5 mM 
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MgSO4, 0.2 mM dNTP’s, 0.3 µM each primer, 0.02 U/µl KOD Hot Start DNA 
polymerase, made up to 25 µl with 15.5 µl double processed tissue culture water 
(Sigma). Amplification was carried out using the following conditions: 
 
 
Hot Start                       95oC               2 min 
Denaturation                 95oC                20 s 
Annealing                      xoC                 10 s                             18 cycles 
Extension                      70oC             25 s / kb 
Holding Step                  4oC 
 
 
Digestion of the original template plasmid DNA was then achieved in a new reaction in 
which 10 µl of the above PCR mix was added to a 20 µl reaction mixture containing 16 
µl double processed tissue culture water, 1X Tango reaction buffer and 1 µl Dpn-1 
restriction enzyme (Fermentas). Dpn-1 specifically digests methylated DNA and 
consequently digests the original plasmid template while leaving the un-methylated 
PCR amplified products encompassing the desired point mutation intact. All reactions 
were incubated for 2 h at 37oC before plasmid DNA harbouring point mutations was 
purified using a QIAquick PCR purification kit (section 2.5.10, Qiagen Ltd.). 
 
2.5.9.2 Overlap Extension PCR  
In addition to quickchange PCR (section 2.5.9.1), overlap extension PCR was employed 
to construct point mutations in target genes as summarised in Figure 2.3. The two 
fragments of the target gene harbouring the overlapping sequence needed for the 
annealing stage were produced in separate forward and reverse 50 µl PCR reactions 
(panel A, Figure 2.3). Reaction mixes consisted of 1 X HF buffer (section 2.2), 0.2 mM 
dNTP’s, 20 pico-moles of an outside primer with corresponding inside primer 
containing the mutation and 1 U Phusion High Fidelity DNA polymerase. Up to 1 µg of 
template GAS chromosomal DNA was added to the reaction mix, which was made up 
to 50 µl with double processed tissue culture water. Thermal cycling was performed on 
a Biometra T3000 Thermocycler (Biometra) using the following conditions: 
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Figure 2.3: Overlap extension PCR. 
 
Panel A: Bases to be mutated are shown in red. Primers depicted by arrows containing 
green line (2 and 3) represent overlapping mutagenic primers. An initial PCR reaction is 
set up to include primers labelled 1 and 2, and a second separate PCR reaction is 
performed using primers labelled 3 and 4. Panel B: This creates two fragments with 
overhangs each containing the mutated residues in green. Panel C: These are used in an 
annealing PCR reaction where all reagents are included in the PCR mix except primers 
and this allows complementary bases to be ‘filled’ in by DNA polymerase. Panel D: 
Outside primers used previously (1 and 4) are added and a normal PCR is performed to 
amplify the desired fragment.  
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Initial denaturation             98oC           30 s 
Denaturation                    98oC           10 s 
Primer annealing                xoC             30 s                       30 cycles 
Primer extension                72oC           30 s / kb 
Final extension                   72oC           10 min 
 
 
Amplified fragments (panel B, Figure 2.3) were analysed by agarose gel electrophoresis 
(section 2.5.11) and purified using a QIAquick PCR purification column (section 2.5.10 
Qiagen Ltd.). Fragments to be used in an annealing PCR were diluted 1/10 and 1/50. 
For the annealing PCR, 1 µl of each purified fragment dilution was added to a reaction 
mixture containing 1 X HF buffer, 0.2 mM dNTP’s, 1 U Phusion High Fidelity DNA 
polymerase and made up to 40 µl with double processed tissue culture water. Cycling 
conditions were as described above except an initial 10 cycles were used to anneal the 
fragments and complete the complementary strands of the template (panel C, Figure 
2.3). Upon completion of the annealing PCR, 20 pico-moles of each ‘outside’ primer 
(labelled 1 and 4 in Figure 2.3) were added to the reaction and the PCR was continued 
as above, except with no initial denaturation step, for another 30 cycles to amplify the 
mutagenised target (panel D, Figure 2.3).  
 
2.5.10 Purification of PCR amplified products 
PCR products were purified using the QIAquick PCR purification kit (Qiagen Ltd.). 
This kit was used for the direct purification of double stranded PCR products (0.1-10 
kb) from PCR amplification reactions. The kit was used as per the manufacturer’s 
guidelines. Essentially, the method utilises a silica-gel membrane which absorbs DNA, 
only in high concentrations of chaotropic salts. After washing to remove contaminants, 
DNA was eluted from the membrane in 50 µl (or 30 µl to increase DNA concentration) 
10 mM Tris, pH 8.5, and stored at -20oC. 
 
2.5.11 Agarose gel electrophoresis 
Agarose was purchased from FMC Bioproducts, Rockland, USA. Agarose gels of 0.7% 
(w/v) or 1.0% (w/v), depending on the size of DNA molecules being examined, were 
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cast in TAE buffer (40 mM Tris-acetate, 1.0 mM EDTA, pH 8.0) containing 0.5 µg/ml 
ethidium bromide. Gels were submerged horizontally in TAE running buffer. Prior to 
loading, a third volume of DNA load buffer [40% (w/v) sucrose, 100 mM EDTA, pH 
8.0, 0.01% (w/v) bromophenol blue] was added to DNA samples. Once loaded, gels 
were run at a constant voltage (usually 100 V) until the bromophenol blue tracker dye 
had run sufficiently through the gel. DNA was visualised using exposure to long wave 
ultra violet (UV) light from a transilluminator (Bio-Rad Laboratories Ltd, Hemel 
Hampstead, Herts., UK) and images of gels were recorded. 
 
2.5.12 Purification of DNA fragments from agarose gels 
DNA fragments were subject to agarose gel electrophoresis as described above (section 
2.5.11) until separation was sufficient for excision of bands from the gel (using a sterile 
scalpel blade). Purification of the DNA was carried out using a QIAquick Gel 
Extraction kit (Qiagen Ltd.) as per the manufacturer’s protocol. Briefly, using the 
supplied solubilisation buffer DNA was released from the gel fragment and bound to 
the silica-gel membrane in the presence of high concentrations of chaoptropic salts. 
After washing to remove contaminants, DNA was eluted from the membrane in 50 µl 
(or 30 µl for increased DNA concentration), 10 mM Tris, pH 8.5 and stored at -20oC. 
 
2.5.13 DNA sequencing  
DNA sequencing was performed to order by a commercial company. Between 2-5 µg of 
purified DNA was sent, with an appropriate sequencing primer (section 2.5.7) to 
Eurofins Genetic Services Ltd (Eurofins MWG Operon, Ebersberg, Germany) and 
sequenced using the dideoxy chain termination/cycle sequencing technique on an ABI 
3730XL sequencing machine (Applied Biosystems, California, USA). 
 
2.5.14 Allele replacement mutagenesis in GAS  
The introduction of mutagenised DNA into the GAS chromosome was done using the 
allele replacement technique described by Fontaine et al. (Fontaine et al., 2003). The 
steps involved are summarised in Figure 2.4. The DNA to be integrated into the GAS  
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Figure 2.4: Allele replacement 
 
Diagrammatic representation of allele replacement. Panel A: integration of the 
pG+host9 plasmid by a single cross over recombination event at complimentary 
sequences contained within both the mutant and target gene. Panel B: This leads to 
incorporation of the entire plasmid into the chromosome (c/s). Panel C: a second cross 
over event occurs at complimentary sequences causing excision of the plasmid. Panel 
D: If this event occurs at position 1 the wild-type gene is retained in the c/s but if the 
second cross over event occurs at position 2, the mutant gene is retained in the c/s. 
 
56 
 
chromosome was cloned into the temperature sensitive plasmid pG+host9. Competent 
GAS were transformed with the desired pG+host9 construct by electroporation (section 
2.5.5), selecting for single transformant colonies on THY blood agar plates containing 1 
µg/ml erythromycin at 28oC (the permissive temperature) for 48 h. A single transformed 
colony was used to inoculate 1 ml of THYB containing 1 µg/ml erythromycin and was 
incubated overnight at 28oC. The overnight culture was diluted 1/100 into the same 
media and incubated at 28oC until the OD600 of the culture reached 0.2-0.3, at which 
point the culture was shifted to the restrictive temperature of 37oC, 5% CO2 for 6-9 
generations (approximately 12 h) to inhibit replication of unincorporated plasmid. 
Samples were then plated in decreasing 10-fold dilutions from neat to 10-4 onto blood 
agar plates containing 1 µg/ml erythromycin and incubated at 37oC, 5% CO2 to allow 
growth of cells in which a single cross over (sco) plasmid integration event had 
occurred, resulting in the integration of the entire plasmid into the bacterial 
chromosome.  
 
A single sco colony containing the pG+host9 construct integrated into the chromosome 
was used to inoculate 1 ml THYB with 1 µg/ml erythromycin added and the culture was 
incubated overnight at 37oC, 5% CO2 in a static incubator. The overnight culture was 
diluted 10-5 in drug free THYB and to stimulate the second cross over event the culture 
was incubated at 28oC for no less than 12 h. This enables replication to be initiated from 
the integrated plasmid. The pG+host9 plasmid replicates via the rolling circle 
mechanism and resulting single stranded DNA is believed to facilitate second 
recombination events. To identify Erms cells where plasmid excision had occurred, the 
culture was serially diluted in decreasing 10 fold dilutions to 10-6 in PBS and 100 µl of 
each dilution was plated onto drug free blood agar plates and incubated at 37oC, 5% 
CO2 in a static incubator. Sterile wooden tooth picks were used to replica plate single 
colonies from these plates first onto drug free blood agar and then onto blood agar 
plates containing 1 µg/ml erythromycin. These plates were incubated overnight at 37oC, 
5% CO2 in a static incubator and colonies that grew on the non-selective plates but did 
not grow on the erythromycin plates were likely to have undergone a second 
recombination event deleting the integrated plasmid. Chromosomal DNA preparations 
(section 2.5.2) were prepared for these colonies and screened by PCR to identify those 
57 
 
containing the desired mutation, which was analysed by sequencing to confirm a double 
cross over event had occurred. 
 
2.6 Protein procedures 
 
2.6.1 Separation of proteins by discontinuous sodium dodecyl polyacrylamide gel 
         electrophoresis (SDS-PAGE) 
       
 
SDS-PAGE gels were run essentially as described by Laemmli (Laemmli, 1970) on a 
Mini Protean II system (Bio-Rad, Hemel Hampstead, Hertfordshire, UK). Resolving 
gels of appropriate percentage were prepared by mixing either 5.328 ml (8% v/v), 6.66 
ml (10% v/v), 8 ml (12% v/v) or 10 ml (15% v/v) of 30% (w/v) 
acrylamide/bisacrylamide with 5 ml 1.5 M Tris-HCl pH 8.8, 0.2 ml 10% (w/v) SDS 
made up to 20 ml with water and 170 µl 10% (w/v) ammonium persulphate. 
Polymerisation was achieved with the addition of 10 µl of N,N,N’,N’–
Tetramethylethylenediamine (TEMED) immediately prior to pouring. The resolving gel 
was poured between two glass plates separated by 1 mm until the meniscus reached 2 
cm from the top of the smaller plate. Isopropanol was overlaid on top of the resolving 
gel until it had set to ensure a level surface before being removed by extensive washing 
with double distilled water. A 5% (v/v) stacking gel was prepared with 830 µl of 30% 
(w/v) acrylamide/bisacrylamide, 0.63 ml 1M Tris-HCl pH 6.8, 50 µl 10% (w/v) SDS 
made up to 5 ml with water and 50 µl ammonium persulphate. Polymerisation of the 
stacking gel was achieved with the addition of 5 µl TEMED immediately prior to 
pouring on top of the resolving gel. A Teflon comb was inserted into the liquid stacking 
gel to provide wells. After setting, the gel was placed into the Mini Protean II 
electrophoresis tank and the comb was removed. The gel was completely covered and 
both chambers were filled with running buffer [25 mM Tris-HCl, 250 mM glycine and 
0.1% (w/v) SDS].  
 
Protein samples were prepared for loading by mixing with SDS load buffer, which 
consisted of 50 mM Tris-HCl pH 6.8, 0.1% (w/v) bromophenol blue, 10% (v/v) 
glycerol and 2% (w/v) SDS, before being boiled at 100oC for 5 min to denature 
proteins. Samples were loaded into wells using gel loading tips (Starlab, Milton Keynes, 
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UK) and electrophoresis was performed at a constant voltage (usually 250 V) for 40 
min or until the bromophenol blue tracker dye had reached the bottom of the resolving 
gel. 
 
2.6.2 Coomassie staining of SDS-PAGE gels 
Protein gels were stained with coomassie blue essentially as described by Laemmli 
(Laemmli, 1970). Gels were removed from the glass plates and immersed in staining 
solution which contained 40% (v/v) methanol, 45% (v/v) acetic acid and 0.1% (w/v) 
Coomassie Brilliant Blue R250 and left for 1 hour with gentle shaking. Gels were rinsed 
with double distilled water and destained for several h in a solution containing 30% 
(v/v) methanol, 10% (v/v) acetic acid, with occasional replacement of the destain 
solution. Destained gels were recorded by scanning onto a computer using a Canon 
CanoScan 3200F (Canon Inc., Tokyo, Japan). 
 
2.6.3 Production of recombinant proteins  
BL21 (DE3) and BL21 (DE3) CodonPlus Type RIL host strains were freshly 
transformed with the desired recombinant plasmid and trial inductions were carried out 
on several transformants from each host as soon as possible following transformation. 
Individual transformants were used to inoculate 1.5 ml of LB broth supplemented with 
kanamycin for BL21 (DE3) or kanamycin and chloramphenicol for BL21 (DE3) 
CodonPlus Type RIL as described in section 2.3, and cultures were grown for 16 h at 
37oC with shaking at 200 rpm. These cultures were used to inoculate 10 ml of fresh LB 
medium containing antibiotics (1/20) and cells were grown to OD600 0.6-0.7 at 37
oC 
with shaking at 200 rpm. Protein expression was induced by the addition of Isopropyl β-
D-1-thiogalactopyranoside (IPTG) to final concentration 1 mM and continuing 
incubation at 30oC and 200 rpm. Samples of 1 ml were taken before induction and at 
hourly intervals post-induction from each culture for up to 4 h. Samples were harvested 
by centrifugation at 16,000 x g and resuspended in SDS load buffer. Samples were 
boiled and cell lysate was assessed for protein expression by SDS PAGE (section 2.6.1) 
to identify optimal conditions for large-scale expression. Once identified, optimised 
conditions were applied to induction of protein in 1 litre of culture as outlined above. 
Cells were harvested at 2,355 x g at 4oC for 20 min and stored at -80oC.  
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2.6.4 Selenomethionine derivatisation of proteins  
To prepare protein labelled with selenomethionine, freshly competent B834 (DE3) 
methionine auxotroph cells were transformed with the appropriate plasmid and a single 
well separated colony was used to inoculate 10 ml of LB broth containing the 
appropriate antibiotic. Following incubation at 37oC for 16 h with shaking at 200 rpm, 
this culture was used to inoculate 100 ml of fresh LB broth, 1/100. This culture was 
incubated as above until the culture OD600 reached 0.2. Cells were harvested by 
centrifugation at 2,355 x g for 10 min at 4oC. Media to support growth of B834 (DE3) 
and selenomethionine incorporation (1 l) used 2X M9 media (2 g NH4Cl, 6 g KH2PO4, 
12 g Na2HPO4), 2 ml of 1 M MgSO4, 25 mg of FeSO4, 10 ml of 40% (w/v) glucose, 1 
ml of vitamin mix (1 mg/ml of Niacinamide, Pyroxidine monohydrochloride, 
Riboflavin and Thiamine), 40 mg of each L-amino acid (excluding methionine and 
selenomethionine) and the appropriate antibiotic. The cell pellet obtained above was 
washed in 10 ml of this media and harvested as above to remove traces of LB broth. 
This pellet was resuspended in a minimal volume and added to 1 l of the above media 
followed by addition at this stage of 40 mg L(+)-Selenomethionine (Acros Organics, 
Geel, Belgium). The culture was then incubated at 37oC with shaking at 200 rpm. Cells 
were induced with IPTG (1 mM final concentration) when the culture density reached 
between 0.4-0.6 and incubated for 16 h at 20oC with shaking at 200 rpm. Cells were 
harvested by centrifugation at 2,355 x g and stored at -80oC. 
 
2.6.5 Purification of recombinant proteins  
Purification of all proteins was done using an Äktaprime™ system (GE Healthcare, 
Bucks, UK). All proteins in this study were expressed with an N-terminal hexa-histidine 
tag to aid purification. 
 
2.6.5.1 His-tag affinity chromatography 
Pelleted cells containing recombinant protein were resuspended in 20 ml ‘His-load’ 
buffer (20 mM Tris-Cl, 150 mM NaCl, 10 mM Imidazole, pH 7.5) with 0.025% (v/v) β-
mercaptoethanol and 100 µl Protease Inhibitor Cocktail Set III (Calbiochem, Darmstadt, 
Germany) added. Cells were lysed using a Sonoplus HD2070 sonicator (Bandelin, 
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Berlin, Germany) and the supernatant clarified by centrifugation at 15,000 x g for 40 
min. Clear lysate was loaded onto a pre-equilibrated 5 ml Hi-Trap nickel chelating 
column (pre-equilibrated with nickel, GE healthcare). The column was washed through 
with ‘His-load’ buffer until absorbance at 280 nm returned to baseline to remove any 
non-specifically bound proteins. Bound protein was eluted with an imidazole gradient 
(10-500 mM) using ‘His-elute’ buffer (20 mM Tris-Cl, 150 mM NaCl, 1 M imidazole, 
pH 7.5) over 12 column volumes. Fractions were collected with continuous monitoring 
of absorbance at 280 nm and peak fractions were analysed by SDS-PAGE (section 
2.6.1). 
 
2.6.5.2 Size exclusion gel filtration chromatography  
Peak fractions from affinity chromatography containing the protein of interest were 
pooled and concentrated in an appropriate molecular weight cut off centrifuge cell 
(Sartorius, GmbH, Goettingen, Germany). Concentrated protein was centrifuged at 
15,000 x g at 4oC for 30 min to pellet any insoluble material prior to loading 2 ml 
volumes onto a Hi-Load 16/60 Superdex 75 or Hi-Load 16/60 Superdex 200 gel 
filtration column [GE Healthcare, Bucks, UK, pre-equilibrated with gel filtration buffer 
(20 mM Tris-Cl, 150 mM NaCl, pH 7.5)], depending on the molecular weight of the 
protein. Gel filtration columns were run at 1 ml/min for 2 column volumes with 
continuous monitoring of absorbance at 280 nm. Peak fractions were analysed by SDS-
PAGE (section 2.6.1) and those containing the protein of interest at >95% purity were 
pooled and concentrated to 10 mg/ml in an appropriate molecular weight cut off 
centrifuge cell. Protein concentration was determined by absorbance at 280 nm using 
the protein’s molar extinction coefficient (the amount of light a protein absorbs at a 
given wavelength) as determined by the ProtParam program (Gasteiger et al., 2005) 
located on the Expert Protein Analysis System proteomics server 
(http://www.expasy.ch/). For establishing protein concentration, the total absorbance of 
a sample was divided by the protein of interest’s molar extinction coefficient and 
adjusted accordingly. 
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2.6.5.3 Purification of selenomethionine labelled proteins 
The purification of selenomethionine labelled proteins was as described above but with 
the addition of 15% (v/v) β-mercaptoethanol to both His-chelation buffers in section 
2.6.5 and 5 mM DTT to the gel filtration buffer in 2.6.5.2. This was to ensure that the 
selenomethionine remained reduced during purification.  
 
2.6.7 Thrombin digest  
When necessary, the N-terminal His-tag was cleaved from the expressed proteins using 
thrombin (GE Healthcare, Bucks, UK). To establish appropriate conditions, test digests 
were performed by mixing 1 mg of protein with 10 units of thrombin in 20 mM Tris-Cl, 
150 mM NaCl, pH 7.5 and incubating at 4oC and 20oC. Samples were taken at 0 min, 30 
min, 60 min and then hourly for a further 5 h before a final sample was taken after 16 h. 
The samples collected at both temperatures were analysed by SDS- PAGE (section 
2.6.1) with a decrease of ~2 kDa indicative of tag removal. The optimal temperature and 
digest time (derived from these tests, usually 16 h at 4oC) were applied to a large scale 
experiment where 10 mg of protein was digested with 100 units of thrombin in 20 mM 
Tris, 150 mM NaCl, pH 7.5. After the digest was complete, the sample was applied to a 
1 ml His-chelation column (pre-equilibrated with Ni2+, prepared as above), then washed 
with 3 ml ‘His-load’ buffer (section 2.6.5.1). The flow-through, which contained 
cleaved protein, was then applied to a pre-equilibrated 1 ml benzamidine column (GE 
Healthcare, bucks, UK) to remove protease from the sample, again washing with 3 ml 
‘His-load’ buffer and collecting the flow through. The resulting samples were analysed 
by SDS-PAGE to ensure pure, cleaved protein had been obtained. The sample 
concentration was determined by absorbance at 280 nm and concentrated to 10 mg/ml 
(as before 2.6.5.2). 
 
2.6.8 Extraction of GAS cell wall associated proteins  
A single, well-separated GAS colony was used to inoculate 40 ml THYB and cultures 
were incubated at 37oC with 5% CO2 for 18 h until they had reached an OD600 of 0.6-
0.7. Cell density was checked and adjusted if needed so that all cultures were at the 
same stage of growth. GAS were pelleted by centrifugation at 5,000 x g for 10 min. The 
supernatant, which could be analysed for any proteins released prior to enzymatic 
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digestion of the cell wall, was collected and passed through a 0.22 µM pore size filter to 
remove any remaining bacteria, and the sample was concentrated 40-fold in a 10 kDa 
cut off centrifuge cell and stored at -80oC.  
 
The pelleted bacterial cells were resuspended and washed in 5 ml of ice-cold TE buffer 
(50 mM Tris-Cl pH 8.0, 1mM EDTA) and pelleted as above. The wash step was 
repeated and cells were resuspended in 1 ml TE sucrose buffer (50 mM Tris-Cl pH 8.0, 
1 mM EDTA, 20% (w/v) sucrose, 100 mg/ml lysozyme, 100 U mutanolysin and 400 U 
protease inhibitors) and the mixtures were incubated for 2 h at 37oC to digest cell walls, 
with constant rotation to aid mixing. After incubation resulting protoplasts were pelleted 
by centrifugation at 16,000 x g for 5 min and the supernatant, defined as the cell wall 
extract containing the enzymatically digested cell wall material was harvested into a 
fresh, sterile 1.5 ml microfuge tube and stored at -80oC. The insoluble cell extract 
containing the bacterial protoplasts and cell debris, was resuspended in 1 ml H2O and 
stored at -80oC.  
 
2.7 Production and purification of rabbit antibodies  
 
2.7.1 Production of specific anti-sera  
To produce the inoculum, 700 µl of highly purified recombinant protein at a 
concentration of 0.4 mg/ml was dialysed into PBS (Sigma). Protein was mixed with 
Freund’s adjuvant (1:1) by passaging through a steel tube held between two sterile glass 
syringes until a stable white emulsion, extremely resistant to movement had formed. 
Prior to immunization, 1.4 ml of sterile 2% (v/v) Tween-80 in saline was added and 
mixed to give a milky suspension. For each antigen, a single, female, New Zealand 
White rabbit weighing >3 kg was purchased from Charles River UK Ltd. (Margate, 
Kent, UK). Rabbits were rested for 10-14 days prior to collection of 5 ml pre-immune 
blood into a sterile glass universal tube via a single nick in an ear vein. This sample was 
incubated at 37oC for 30 min to facilitate clotting and then centrifuged at 2,500 x g for 
20 min. Clear serum was removed and stored at -20oC. The above inoculum mix was 
injected subcutaneously into multiple sites on the rabbits back. After 2 weeks the rabbit 
was boosted with an inoculum prepared as described above. A 5 ml blood sample was 
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collected as discussed above, two weeks after boosting and serum was checked for 
production of specific antibodies by immuno-blotting samples of antigen spotted onto 
nitrocellulose membrane. Rabbits were boosted on a maximum of 4 occasions at two-
weekly intervals. Five days after the last boost, rabbits under terminal anaesthesia were 
bled by cardiac puncture and serum was collected and stored as above.  
 
2.7.2 Purification of antibodies  
A 2.5 ml Protein A affinity column (Sigma) was used to isolate the IgG class of 
antibodies. The column was prepared by washing with 5 ml of loading buffer (1 M 
potassium phosphate, pH 9.0). Prior to loading, 1 volume of antiserum was mixed with 
3 volumes of loading buffer. Any unbound sample was collected for re-processing 
before the column was washed with 12 ml of loading buffer. Bound IgG antibodies 
were eluted with 0.1 M citric acid, pH 3.0 and 1.25 ml fractions were collected in sterile 
microfuge tubes containing 250 µl of 1.5 M Tris-Cl, pH 8.5 to neutralize the acid. 
Fractions determined to contain protein at 280 nm were pooled and dialysed into PBS, 
pH 7.0 and stored at -20oC.  
 
2.8 Blotting procedures 
 
2.8.1 Western blotting  
Enzymatically extracted cell wall proteins (section 2.6.8) were run on precast Tris-Cl   
4-15% (v/v) gradient gels (Bio-rad). Separated proteins were electroblotted onto 
nitrocellulose membrane in transfer buffer [200 mM glycine, 25 mM Tris base, 20% 
(v/v) methanol] for 90 min at 35 mAmps using a Bio-Rad Mini Trans-blot cell. After 
blotting, all free protein sites on the nitrocellulose membrane were ‘blocked’ by 
submerging the filter in 10 mM Tris-Cl, 150 mM NaCl, 2 mM EDTA, 5% (w/v) bovine 
serum albumin, 0.05% (v/v) Triton X-100, pH 7.5 and incubating at 4oC for 16 h. 
‘Blocking’ buffer was removed and the membrane was subjected to 3 successive 7 min 
washes in wash buffer 1 [10 mM Tris-Cl, 2 mM EDTA, 150 mM NaCl, 0.1% (w/v) 
BSA, 0.01% (v/v) Triton X-100, pH 7.5]. Primary antibodies were then added to the 
membrane, made up to an appropriate dilution in wash buffer 1, and the membrane was 
incubated at room temperature for 1 hour with gentle shaking. Any unbound primary 
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antibodies were washed from the membrane with 3 successive 7 min washes in wash 
buffer 1, prior to the addition of an appropriate peroxidise conjugated anti-primary 
antibody at an appropriate dilution in wash buffer 1. The membrane was incubated for 1 
hour at room temperature with gentle shaking before any unbound secondary antibody 
was washed off by 3 successive 7 min washes in wash buffer 2 [10 mM Tris-Cl, 2 mM 
EDTA, 1 M NaCl, 0.1% (w/v) bovine serum albumin, 0.01% (v/v) Triton X-100, pH 
7.5] followed by rinsing in 10 mM Tris-Cl pH 7.5. The peroxidise conjugated antibody 
was then visualised by submerging the membrane in developing solution. This was 
comprised of solution A (30 mg 4-chloro-1-naphthol dissolved in 10 ml ice cold 
methanol, made up 15 min prior to use) mixed with solution B (30 ml ice cold 10 mM 
Tris-Cl to which 30 µl H2O2 was added immediately prior to use) immediately before 
addition to the membrane. This was incubated at room temperature with gentle shaking. 
The staining reaction was stopped after 5-30 min by washing the membrane in copious 
amounts of water. 
 
2.8.2 Electroblotting of proteins for N-terminal sequencing  
Immediately prior to use, polyvinylidene difluoride (PVDF) membrane was submerged 
in 100% (v/v) methanol for 5 min before being transferred to 10 mM CAPS pH 11, 50% 
(v/v) methanol, 0.02 mg/ml DTT and finally soaked in 10 mM CAPS pH 11, 0.02 
mg/ml DTT to prepare membrane for use. Proteins to be investigated by N-terminal 
sequencing were run on an SDS-PAGE gel which was rinsed in ultra pure water 
containing 0.02 mg/ml DTT and then soaked in 10 mM CAPS pH 11, 0.02 mg/ml DTT 
for 10 min with one buffer change after 5 min. Proteins were blotted onto the prepared 
PVDF membrane at a constant current of 150 mA for 60 min in blotting buffer [10 mM 
CAPS pH 11, 10% (v/v) methanol]. After blotting the PVDF membrane was rinsed with 
ultra pure water containing 0.02 mg/ml DTT and stained using 2 mg/ml Coomassie 
Brilliant Blue R250 in 5:4:1 methanol:water:acetic acid. The membrane was then 
destained in the same solvent as above until protein bands appeared, at which point the 
membrane was removed and rinsed in ultra pure water containing 0.02 mg/ml DTT 
before air drying. 
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2.9 Mass spectrometry procedures 
 
2.9.1 Fourier Transform-Ion Cyclotron Resonance mass spectrometry (FT-ICR  
         MS) 
 
Protein concentration was determined by absorbance at 280 nm (as above, 2.6.5.2) 
followed by dilution to 1 mg/ml in standard gel filtration buffer (20 mM Tris-Cl, 150 
mM NaCl, pH 7.5). Protein samples were analysed by Pinnacle Laboratory (Newcastle 
University) using an LTQ-FT Ultra Hybrid Mass Spectrometer (Thermo Scientific, 
Waltham, MA, USA). Data was collected at a resolution of 400,000 (at m/z = 400). 
Purified protein, at 10 pmoles/µl in acetonitrile/0.1% (v/v) formic acid (25%/75%), was 
sprayed directly into the mass spectrometer using an ‘Ion Max’ ion source 
(ThermoElectron, Bremen, Germany) at 10 µl/min. The QualBrowser program 
(ThermoElectron, Bremen, Germany) was used to deconvolute mass spectrum plots to 
determine the average molecular mass of the protein assuming ‘averagine’ (0.2678% 
sulphur) composition. 
 
2.9.2 N-Terminal amino acid sequencing  
Proteins of interest were blotted onto PVDF membrane (as described 2.8.2) and 
submitted for N-terminal protein sequencing at Pinnacle Laboratory (Newcastle 
University) using the Edman degradation technique on a Beckman Coulter LF 3000 
Protein Sequencer (Beckman Coulter, Fullerton, CA, USA). 
 
2.10 Solution biophysical characterisation techniques 
 
2.10.1 Circular dichroism spectroscopy  
Circular dichroism (CD) spectroscopy refers to the differential absorption of the two 
circularly polarised components of plane polarised light (Kelly et al., 2005). One rotates 
clockwise, the other anti-clockwise and when these interact with a protein, its electronic 
structure gives rise to characteristic features in specific regions of the CD spectra. For 
use in CD experiments, the concentration of each stock protein solution was determined 
by absorbance at 280 nm followed by dilution to 0.5 mg/ml immediately before the 
spectra was examined. Spectra were recorded in 20 mM sodium phosphate, pH 7.5 
(unless other wise stated). Circular dichroism spectra were collected between 180 nm 
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and 250 nm using a JASCO-810 spectropolarimeter (Jasco, Tokyo, Japan) fitted with a 
Peltier temperature controller, at 25oC using a 0.2 mm-pathlength cuvette. Five repeat 
scans were used to generate the final spectra with appropriate protein-free buffer scan 
subtracted. The data was plotted without smoothing in Microsoft Excel (Microsoft, 
USA). 
 
2.10.2 Analytical ultracentrifugation (AUC)  
The sedimentation velocity technique was used in this study to apply a centrifugal force 
to samples. This leads to the formation of a concentration boundary as protein 
molecules are depleted at the meniscus, which moves to the bottom of the cell as a 
function of time (Lebowitz et al., 2002). Sedimentation velocity (SV) experiments were 
carried out by the Analytical Ultracentrifugation facility (Newcastle University) using a 
Beckman Coulter ProteomeLab XL-I analytical ultracentrifuge. An experimental 
temperature of 4oC was used, with samples mounted in an 8-hole AnTi50 rotor with 
double sector aluminium-epon centrepieces. The centrifuge was operated at a rotation 
speed of 48,000 rpm. Protein concentrations ranged from 0.15-2 mg/ml, using 7 sample 
dilutions, in a total volume of 400 µl in standard gel filtration buffer. 
 
2.10.3 Small angle X-ray scattering (SAXS) 
SAXS was used to provide information on the size and shape of proteins in solution 
(Neylon, 2008; Petoukhov and Svergun, 2007). SAXS is carried out on samples in 
solution containing protein molecules that are randomly orientated throughout the 
sample. The most common use for SAXS data is to reconstruct the overall 3-
dimensional shape of the molecule by ab initio shape restoration, which provides a low 
resolution molecular envelope describing the overall shape of the molecule (Koch et al., 
2003). AUC is highly complementary to SAXS by providing information about the 
monodispersity, elongation and aggregation of the sample in solution independent of the 
SAXS data (Neylon, 2008; Hura et al., 2009). Solution X-ray scattering experiments 
were carried out by Dr. Alexandra Soloyova on beamline 2.1 at the Synchrotron 
Radiation Source (SRS, Daresbury, UK, at a wavelength of 1.54 Å) or using the X33 
camera at the European Molecular Biology Laboratory Hamburg outstation on the 
storage ring DORIS III of the German Electron Synchrotron (DESY, at a wavelength of 
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1.5 Å). Protein concentrations used were 5 and 10 mg/ml in gel filtration buffer and 
measurements were recorded at 4oC. The data for the first and last frames were 
compared to check for protein aggregation and radiation damage.   
 
2.11 X-ray crystallography 
 
2.11.1 Initial crystallisation trials  
Initial protein crystallisation experiments were setup in a 96-well sitting drop format 
(panel A, Figure 2.5) using the JCSG and Classics sparse matrix screens (as supplied by 
Qiagen Ltd.). The main well of the crystallisation plate was filled with 100 µl of 
precipitant solution and a Mosquito nanolitre pipetting robot (TTP LabTech, Royston, 
UK) was used to setup sitting drops containing 0.5 µl of 10 mg/ml protein mixed with 
0.5 µl of precipitant solution in the sub well. After sealing (with adhesive tape), plates 
were stored at 20oC and checked daily for the growth of protein crystals. In conditions 
where protein crystals were observed, fresh reagents were used to scale up the 
crystallisation condition to produce diffraction quality crystals. The sparse matrix 
condition was varied by altering the pH of the buffer and the concentration of 
salts/precipitants. Each condition was made up separately in a microfuge tube and 
centrifuged at 18oC for 10 min at 13,000 x g. Protein samples were centrifuged at 
13,000 x g for 30 min at 4oC before use to pellet any precipitate. The hanging drop 
vapour diffusion technique (panel B, Figure 2.5) was used to set up drops on plastic 
cover slips containing 2 µl of 10 mg/ml protein and 2 µl of precipitant solution which 
were sealed over the well with grease. 
 
2.11.2 Data collection  
Litholoops (Molecular Dimensions Ltd., UK) were used to transfer crystals into 
paratone-N oil, which was used as the cryoprotectant in this study, and to subsequently 
freeze crystals in liquid nitrogen. All X-ray diffraction data were collected using the 
standard oscillation method on cryo-cooled crystals at synchrotron beamlines, including 
IO3 of the Diamond Light Source (DLS, Oxford, UK) and BM14 of the European 
Synchrotron Radiation Facility (ESRF, Grenoble, France). 
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Figure 2.5. Sitting and hanging drop vapour diffusion techniques. 
 
 
 
 
2.11.3 Data processing and reduction  
X-ray diffraction images for each dataset were processed using iMOSFLM (Leslie, 
2006). This program attempts to automatically determine crystal parameters such as the 
unit cell dimensions, crystal orientation, point group and can estimate a value for the 
mosaicity. This process predicts where in reciprocal space conditions satisfying Bragg’s 
Law occur and hence a diffraction spot [Miller index (hkl)] is expected. These estimates 
are then refined to elucidate more accurate parameters enabling the images to be 
integrated (with further refinement of crystal parameters to best predict hkl positions).  
An experimental measurement of each diffraction spot intensity is obtained (Ihkl), along 
with their standard uncertanties (Leslie, 2006).  
 
Following integration, the data was reduced and scaled using SCALA (Evans, 2006). 
This program puts all observations on a common scale using the redundancy of multiple 
measurements of symmetry related reflections (Evans, 2006). An internal control of the 
quality of crystallographic data is given by R factors (reliability factors). Analysis of the 
data after scaling used Rmerge, which gives a measure of overall data quality. These 
statistics can highlight regions of a dataset which agree poorly with the rest of the data 
(and maybe discarded) and can also reveal whether the crystal has suffered radiation 
damage during data collection. 
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SCALA was used as supplied within the Collaborative Computational Project no. 4 
suite, 1994. 
 
2.11.4 Obtaining phase information  
To produce an interpretable electron density map and ultimately solve a crystal structure 
two things are needed: amplitudes, which are measured during the diffraction 
experiment, and phases, which are lost during data collection. The phase problem is a 
fundamental issue in crystallography and although it is possible to solve small molecule 
structures by direct methods with extremely high resolution data, this is generally not 
applicable to most protein structures. 
 
There are three ‘umbrella’ methodologies used to solve the phase problem in protein 
crystallography and all of these methods for calculating phases assume some prior 
knowledge of the electron density or structure (Taylor, 2003). Molecular replacement 
can be used when there is a homology model of the protein of interest available with 
typically, at least 25% sequence identity. Initial phases can be generated by positioning 
the known model correctly in the new unit cell. When there is not a pre-existing model 
known to be homologous to the protein of interest, so called ‘experimental phasing’ 
techniques are employed. 
 
2.11.4.1 Isomorphous replacement  
Isomorphous replacement usually involves soaking a native protein crystal in a heavy 
metal salt solution which can migrate through solvent channels within the crystal and 
bind to specific sites on the protein. This leads to measurable changes in the intensities 
collected during a diffraction experiment. As long as the heavy atom derivative crystal 
remains ‘isomorphous’ (same unit cell dimensions and orientation of the protein in the 
unit cell, ‘replacement’ refers to the fact that the heavy atom is probably replacing a 
water or other solvent molecule in the native crystal) the positions of the heavy atoms 
can be solved by Patterson or direct methods and initial phase estimates can be derived 
for the heavy atoms. These can then be ‘bootstrapped’ onto all of the atoms in the 
protein to produce an initial electron density map for the entire crystal. The use of only 
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one heavy atom derivative creates a twofold phase ambiguity which frequently has to be 
broken with the use of a second (or more) heavy atom compound (that binds to different 
sites on the protein), and this technique is known as Multiple Isomorphous Replacement 
(MIR). The phase ambiguity can also be resolved with the use of anomalous scatter 
(section 2.11.4.2) in conjunction with isomorphous differences in the Single 
Isomorphous Replacement with Anomalous Scatter (SIRAS) technique. Screening for 
derivatised crystals can be a time consuming and largely trial and error process. Native 
PAGE can be used to search for gel shifts caused by interaction of the protein with a 
heavy metal compound in solution (Boggon and Shapiro, 2000), suggesting a potential 
interaction between the heavy atom compound and protein within the crystal. 
 
2.11.4.1.1 Screening heavy metal salt solutions by native PAGE  
Protein derivatisation by heavy metal salt compounds in solution was carried out 
essentially as described by Boggon and Shapiro (Boggon and Shapiro, 2000). Mixtures 
that contained 2 µl of 2 mg/ml protein and 2 µl of 5 mM heavy metal salt solution were 
incubated on ice for 10 min. Samples of 1 µl mixed with 6 µl of loading dye (1 M Tris-
Cl pH 8.5, 20% (v/v) glycerol and 1% (w/v) bromophenol blue) were loaded onto an 
8% (v/v) native PAGE gel that was prepared by mixing 1.33 ml of 30% (w/v) 
acrylamide/bisacrylamide, 1.66 ml H2O, 1 ml of 1 M Tris-Cl pH 8.5 and 50 µl of 10% 
(w/v) ammonium persulphate, polymerised with the addition of 5 µl TEMED 
immediately prior to pouring. Electrophoresis was performed at a constant voltage of 
200 V for 90 min.  
 
2.11.4.1.2 Soaking crystals in heavy atom salt solutions  
Crystals were soaked in varying concentrations of heavy atom compounds dissolved in 
a stabilising solution, which was composed of the crystal mother liquor with a 1-2% 
increase in major precipitant concentration. Soaks were performed in sitting drop cross 
bridges (Molecular Dimensions Ltd., UK), placed in a 24 well plate with 300 µl of 
stabilising solution added to wells to keep soaks hydrated. The well was then sealed 
with a plastic coverslip. 
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2.11.4.2 Anomalous diffraction  
When X-ray energy (aligned with wavelength) is close to the absorption edge of an 
atom (e.g. the K edge of selenium), some of the radiation is re-emitted with altered 
phase. This causes a breakdown in Friedel’s law (which states that Ihkl = I-h-k-l), and 
these anomalous differences can be used in a similar way to isomorphous differences, in 
a derivative dataset, to determine the positions of the anomalous scatterers and extract 
phase information (Taylor, 2003). Anomalous differences are much smaller than 
isomorphous differences and the total anomalous diffraction only generates small 
differences in intensities (Dodson, 2003). However, due to advances in tunable 
synchrotron beams, CCD detectors and data collection and phasing algorithms 
(especially when used in conjunction with cryo-cooled crystals), these differences can 
be accurately measured to a fraction of a percent of the total scattered intensity (Dauter, 
2006).  
 
When X-ray energy is close to the absorption edge of an atom an electron from an inner 
shell is promoted to a higher shell; when it decays back to its original shell, energy is 
released as fluorescence. This information can be used to optimise a data collection 
strategy to maximise the anomalous signal from the crystals by using a fluorescence 
scan around the relevant absorption edge. This requires a tunable synchrotron beamline, 
and can result in optimal absorptive (f”) and dispersive (f’) values. 
 
A textbook excitation spectrum is shown in Figure 2.6 and the program CHOOCH (G. 
Evans, included as part of the CCP4 suite) is often used to automatically determine the 
f’ and f” values from the X-ray fluorescence data. It is important to examine the 
fluorescence spectrum for each derivative crystal directly as experimentally determined 
values for f’ and f” can vary between crystals and also from the theoretical values. 
 
Two major techniques for deriving phase information using anomalous diffraction are 
used. The first is single-wavelength anomalous diffraction (SAD), which involves 
collecting highly redundant data at the high energy side of the absorptive edge (at the 
peak wavelength, f”). This results in a phase ambiguity in a similar way to single  
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Figure 2.6: Example excitation spectrum at the K edge of selenium. 
Peak absorption spectrum (f”) is shown alongside the dispersive spectrum (f’). Using a 
tunable beamline at a synchrotron a fluorescence scan is performed to determine 
maximised values for f” and f’ and the three wavelengths chosen to perform a MAD 
experiment are highlighted (peak, inflection and remote). Figure is adapted from Taylor, 
2003. 
 
 
isomorphous replacement, but this can be resolved with powerful phasing and density 
modification algorithms (Dodson, 2003). Multi-wavelength anomalous diffraction 
(MAD) also exploits anomalous diffraction as a phasing tool. During collection of a 
MAD dataset, data is typically collected at three wavelengths to maximise the 
anomalous differences (f”) and measure the minimum dispersive differences (f’). The 
third wavelength known as the ‘remote dataset’ is collected to provide a measure of the 
f’ value away from the edge (highlighted as remote in Figure 2.6). The absorptive and 
dispersive peaks can be separated by as little as 2 eV which makes it critical to 
determine these values experimentally. Anomalous and dispersive differences can be 
used to locate the heavy atom positions in the unit cell, and these positions can be used 
to initiate phase calculations. 
 
 
f ’ 
f ” 
Peak 
Inflection 
Remote 
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2.11.5 Structure solution (calculating the first interpretable electron density map) 
The technological advances in data collection in recent years have been matched by 
advances in algorithms able to derive maximal information from such data. Many of 
these algorithms have been incorporated into structure-solution packages that can take 
X-ray diffraction data, attempt to derive initial phases directly, follow this with density 
modification (to improve the phases) and ultimately build a protein model into the 
initial electron density map.  
 
The AutoSol wizard of PHENIX (Adams et al., 2002) can attempt to solve protein 
structures directly from MAD datasets. The AutoSol wizard utilises HYSS (Grosse-
Kunstleve and Adams, 2003) to locate heavy atom sites and their substructure positions 
are subsequently used by SOLVE (Terwilliger and Berendzen, 1999) to determine the 
phases. Density modification (Terwilliger, 2000) is performed on the best scoring 
electron density maps from SOLVE (Terwilliger and Berendzen, 1999) by RESOLVE 
(Terwilliger, 2003) which also attempts autobuilding when supplied with a primary 
protein sequence. Finally, refinement with phenix.refine produces an initial model. 
 
2.11.6 Refinement/model building and validation 
The initial model created by either the automatic building programs or by manual chain 
tracing in a molecular graphics program will likely obtain a correct fold but will also 
contain many incorrect features. These include poorly positioned loops between 
secondary structure elements and other regions where the electron density poorly 
defines the model; this is because the experimentally derived structure factors 
[│Fobs│phi(calc)] will be in poor agreement with the calculated structure factors used in 
the initial model [│Fcalc│phi(calc)]. Crystallographic refinement aims to find a set of 
atomic positions for the protein model that give │Fcalc│ values that are as close as 
possible to the │Fobs│ values. This is achieved by the adjustment of the atomic 
positions within the model. REFMAC5 (Murshudov et al., 1997) was used for 
refinement in this Ph.D project and uses the amplitude based maximum likelihood 
method of refinement. The crystallographic R factor is a measure of how well your 
model matches your data although this is susceptible to manipulation and is therefore 
not a totally reliable guide to accuracy of the model (Tickle et al., 1998). In order to 
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combat this, the Free R factor (Rfree) was introduced by Brunger (Brunger, 1992) and is 
the same as the conventional R factor but contains between 5-10% of random reflections 
from the dataset which are excluded from the structure refinement. This has the 
advantage of measuring the degree to which │Fcalc│ predicts │Fobs│, without bias from 
the model, and therefore tells you whether the model has been made better or worse 
from a paticular manipulation. It is a much more reliable test in assessing the quality of 
the model. Rfree will always be higher than the R factor and both will drop during the 
course of a successful refinement. For the majority of refined protein structures the Rfree 
value for the final model will be between 20-30%. Final models were produced with 
iterative cycles of refinement in REFMAC5 and manual rebuilding in COOT (Emsley 
and Cowtan, 2004). Structures were validated using the validation tools in COOT and 
finally using the MOLPROBITY server (Davis et al., 2007). All crystallography images 
displayed in this thesis were produced using PyMOL (The PyMOL Molecular Graphics 
System, Version 0.99rc6, Schrödinger, LLC.). 
 
2.12 Human tissue culture 
Unless specified, media and supplements were purchased from Sigma-Aldrich (UK). 
 
HaCaT cells were a gift from C. Todd (Dermatology Sciences, Newcastle University). 
Cells were handled in a class 2 Microbiological Safety Cabinet (MSC), taking routine 
precautions to minimise the risk of contamination. All experiments were carried out 
under containment level II conditions. HaCaT cells are derived from human 
keratinocytes and have been reported to exhibit most of the characteristics of the cells 
from which they were derived (Boukamp et al., 1988). In previous experiments done by 
colleagues in the laboratory a number of human tissues and immortalized cell lines had 
been examined for the binding of M1 GAS strain SF370. It was found that adhesion 
assays with tonsil explants, primary keratinocytes and HaCaT cells all gave essentially 
the same results. For this reason, HaCaTs were selected as the model cell line used in 
this study, as they give relevant physiological results and are easy to maintain in the 
laboratory. 
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2.12.1 Passaging HaCaT cells  
HaCaT cells were cultured in Dulbecco’s Modified Eagle’s Medium, supplemented 
with 10% (v/v) fetal calf serum, 110 µg/ml sodium pyruvate, 100 U/ml penicillin and 
100 µg/ml streptomycin (complete HaCaT media). The cells were incubated at 37oC in 
an atmosphere of 5% CO2 and grown to confluency in a T25 cm
2 flask. At this point 
cells were washed 3 times in 10 ml of phosphate buffered saline (PBS). Residual PBS 
from the final wash was removed prior to detachment of cells from the bottom of the 
flask, achieved with 1 ml 0.05% (w/v) Trypsin/0.02% (w/v) EDTA incubated at 37% 
with 5% CO2 until gaps were seen appearing between cells (usually 10 min). As soon as 
gaps became apparent, 9 ml of complete HaCaT media was added and a sterile needle 
and syringe was used to flush attached cells from the bottom of the flask. Cell numbers 
were assessed by counting cells present in 0.5 ml cell suspension in 20 ml isotone on a 
Beckman Coulter Z1 dual particle counter (Beckman Coulter, CA, USA). Cells were 
diluted to 0.5 x 106 cells in 10 ml of complete media, added to a new sterile T25 cm2 
flask, and incubated at 37oC with 5% CO2 until confluency was reached and cells could 
be passaged again. 
 
2.12.2 Infection of HaCaT cells - adhesion assay  
For adhesion assays 1 x 105 HaCaT cells were seeded onto 13 mm-diameter glass 
coverslips in 12 well tissue culture plates and incubated at 37oC with 5% CO2 until 
confluent. Cells were washed three times in PBS and 1 ml complete HaCaT media, 
minus antibiotics (assay media) was added to each well, and incubation was continued 
for 3 h at 37oC with 5% CO2 prior to infection. In parallel, overnight GAS cultures were 
used to inoculate 10 ml fresh THY media (1/20) and incubated at 37oC with 5% CO2 
until cultures reached mid log phase of growth (OD600-0.5). For infection, 1 ml of GAS 
culture was pelleted at 16,000 x g, washed twice in double processed tissue culture 
water, and resuspended in 1 ml of assay media. 
 
Immediately prior to infection, assay medium was removed from each well of the 
HaCaT tissue culture plate. Cells were washed once with PBS before 0.5 ml of GAS 
suspension was added and the plate was then incubated at 37oC with 5% CO2 for 20 
min. Unbound GAS were removed by washing each well three times with PBS before 
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cells were fixed with 2% (w/v) paraformaldehyde on ice for 15 min. Each well was 
washed three times with PBS to remove residual fixative before staining. 
 
Fixed cells were permeabilised with the addition of 0.1% (v/v) Trition-X 100 to each 
well and the plate was incubated at room temperature for 15 min with gentle shaking. 
Triton solution was removed by washing each well three times with PBS and cells were 
then ‘blocked’ for 60 min with 10% (v/v) non-immune rabbit serum in PBS at room 
temperature. Blocking solution was replaced with 0.5 ml GAS-FITC antibody (5 µg/ml, 
Acris Antibodies, Herford, Germany) and phalloidin-TRITC (50 µg/ml) in 10% (v/v) 
rabbit serum in PBS, and incubation was continued in the dark, at room temperature for 
60 min with gentle shaking. This staining solution was removed and wells were washed 
three times with PBS before coverslips were allowed to air dry. On glass slides, dry 
coverslips were placed face down onto a drop of vectashield, to preserve fluorescence 
(Vector Laboratories, Peterborough, UK), and covered with foil to minimise exposure 
to light.  
 
GAS adhesion to HaCaT cells was visualised under a Leica laser scanning confocal 
microscope (Leica Microsystems (UK) Ltd., Bucks, UK) using a FITC/TRITC 
glowover and UV 20x 1.4 NA lens, with zoom and pinhole set to 1. Four repeat scans 
were used to produce a final image with all PMT values recorded for each experiment.  
 
2.12.3 Quantifying GAS adhesion 
The quantification of GAS binding to HaCaT cells was achieved using Qwin software 
(Leica, Bucks, UK) by calculating pixel intensity of top-cell (x-y) sections. Pixel 
intensity for the total bacterial component was divided by the calculated pixel intensity 
for a single bacterium to give the total number of adherent bacteria. Each experiment 
was repeated on at least three separate occasions, always including the parent wild-type 
strain as a positive control (100% adhesion). The significance of apparent differences 
between the wild-type and mutant strains were calculated using the Students t-test, as 
described in Abbot et al., 2007. 
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Chapter 3. Characterisation of Spy0130 and Spy0128 
 
3.1 Introduction  
 
At the beginning of this project it was known that pili produced by M1 GAS strain 
SF370 were composed of one major subunit (Spy0128) that forms the shaft, and two 
minor subunits (Spy0125 and Spy0130) of unknown function. During the first year of 
this project Manetti et al. (Manetti et al., 2007) reported that both minor subunits may 
be acting as pilus adhesins. However, studies by workers in the Kehoe laboratory 
revealed this was not the case. Briefly, these studies showed that (a) only anti-
recombinant (r)Spy0125 sera (and not anti-rSpy0128 or anti-rSpy0130) inhibited 
adhesion of wild-type M1 GAS strain SF370 to human keratinocytes or tonsil 
epithelium, which suggests that Spy0128 and Spy0130 do not contribute directly to 
adhesion; (b) in a Δspy0125 mutant Spy0128 was assembled into pili that were found 
mostly in the cell wall (analogous to wild-type) but these pili were non-adhesive; (c) 
polymerisation of Spy0128 into pili required the action of Spy0129 (the pilin 
polymerase), and occurred in a ΔsrtA mutant but these pili were found mostly in culture 
supernatants indicating that SrtA was responsible for pilus attachment to the cell wall; 
(d) in a Δspy0130 mutant, Spy0128 was assembled into pili but these pili were found 
mostly in culture supernatants (similar to the ΔsrtA mutant) and also appeared longer 
than their wild-type counterparts suggesting a role for Spy0130 in anchoring the pilus to 
the cell wall and regulating its length. These data considered together suggest that 
Spy0130 acts as a ‘linker’ protein incorporated as the final subunit at the base of the 
pilus and covalently attached to the lipid II precursor in the cell wall by the 
housekeeping sortase SrtA (Smith et al., 2010). It is now clear that each of the three 
subunits play distinct but equally essential roles in forming intact, functional pili. 
 
Much of the work presented in this thesis focused on Spy0125 and this is described in 
detail in chapters 4 and 5. The work in this chapter describes studies on Spy0130 and 
Spy0128, although these studies were limited for the reasons outlined below.   
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3.2 Recombinant protein expression and purification 
 
At the beginning of the work described in this chapter, recombinant plasmids consisting 
of the E. coli pET-28a(+) expression vector containing cloned spy0130 or spy0128 
sequences had been constructed by Dr Wendy Smith and were available in the 
laboratory. These plasmids, pWS010 and pWS009, had been designed to express the 
fully processed versions of Spy0130 and Spy0128. This involved omitting sequence for 
the N-terminal signal peptide, as determined by the SignalP 3.0 server (Emanuelsson et 
al., 2007), and the sequence downstream of the cell wall sorting signal after the glycine 
of the LPST(G) motif for Spy0130 and the valine of the EVPTG(V) motif for Spy0128 
as it was predicted that these sequences would be absent from the mature form of the 
protein on the GAS cell surface. The final spy0130 and spy0128 sequences cloned into 
pET-28a(+) are shown in panel A of Figures 3.1 and 3.2 with their corresponding amino 
acid sequences shown in panel B. After examining a range of different strains and 
induction conditions it was decided to use E. coli BL21 (DE3) CodonPlus type RIL for 
the expression of both proteins, induced at an OD600 of 0.6 with 1 mM IPTG for 3 h. 
 
Optimised growth conditions determined during small scale expression tests were 
applied to large scale inductions of both recombinant proteins. Cells were harvested and 
lysed by sonication before cell lysate was applied to a His-tag column. Eluted fractions 
which corresponded to the protein peak on the elution profile at 280 nm were analysed 
by SDS-PAGE and fractions which were deemed to contain a significant amount of 
protein were pooled and concentrated. However, this material was observed to contain 
contaminating host proteins (Figure 3.3). Therefore, concentrated fractions were 
purified further on a Hi-Load 16/60 Superdex 75 gel filtration column. Panels A and B, 
Figure 3.4 show recombinant (r)Spy0130 and rSpy0128 gel filtration elution profiles at 
280 nm, revealing a single sharp peak for both. Fractions corresponding to this peak 
were analysed by SDS-PAGE and are shown in Figure 3.4 panels C (rSpy0130) and D 
(rSpy0128), as highly pure samples. Fractions corresponding to lanes 4-7 for rSpy0130 
(panel C, Figure 3.4) and lanes 3-8 for rSpy0128 (panel D, Figure 3.4) were pooled and 
concentrated to 10 mg/ml. This was determined by absorbance at 280 nm using the 
molar extinction coefficient of 11920 M-1 cm-1 for Spy0130 and 26360 M-1 cm-1 for 
Spy0128 as determined from the amino acid sequences by the ProtParam tool  
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A 
 
     T7 Promoter                       lac operator                                  
                                              
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACT 
 
                rbs                                                  His – tag                                 Thrombin site 
 
TTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGC 
 
 
GGCAGCCATATGGAGAACCTCACTGCAAGCATTAATATTGAAGTTATTAATCAAGTTGATGTTGCTACCA
ACAAACAATCCTCTGACATAGATGAAACGTTTATGTTTGTAATTGAAGCGTTAGATAAAGAAAGTCCTTT
ACCTAATTCGGTAACTACTTCTGTTAAGGGAAATGGGAAAACATCATTTGAACAGTTGACTTTTTCAGAA
GTTGGACAATATCATTATAAAATTCATCAACTGTTAGGTAAGAATAGTCAATATCATTATGATGAAACAG
TATATGAAGTTGTTATTTACGTATTGTATAATGAGCAAAGTGGTGCTTTAGAAACTAACCTAGTTTCTAA
CAAACTTGGAGAAACCGAAAAATCGGAGCTTATTTTTAAACAAGAATATAGTGAAAAAACACCGGAACCT
CATCAACCAGATACAACTGAGAAGGAAAAACCTCAGAAAAAACGTAATGGTATTTTGCCATCAACTGGTT
AACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA 
 
B 
 
GSHMENLTASINIEVINQVDVATNKQSSDIDETFMFVIEALDKESPLPNSVTTSVKGNGKTSFEQLTFSE
VGQYHYKIHQLLGKNSQYHYDETVYEVVIYVLYNEQSGALETNLVSNKLGETEKSELIFKQEYSEKTPEP
HQPDTTEKEKPQKKRNGILPSTG 
 
 
 
Figure 3.1: Recombinant plasmid pWS010. 
 
Panel A: The spy0130 DNA sequences cloned in pWS010 are shown in blue with 
primer encoded stop codon at the end of the sequence underlined. Vector sequences are 
shown in black, with important features underlined in bold type and indicated above the 
sequence. NdeI (forward primer) and XhoI (reverse primer) restriction endonuclease 
sites used to clone into the vector are shown in red type adjacent to the cloned DNA. 
The spy0130 DNA fragment was cloned in-frame with the vector encoded His-tag 
creating a fusion protein. Panel B: The rSpy0130 amino acid sequence. The Spy0130 
sequences are shown in blue, with vector encoded residues remaining at the N-terminus 
after thrombin cleavage removing the His-tag shown in black. 
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A 
 
      T7 Promoter                       lac operator                                  
                                              
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACT 
 
                rbs                                                  His-tag                                   Thrombin site 
 
TTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGC 
 
 
GGCAGCCATATGGAGACTGTTGTAAACGGAGCCAAACTAACAGTTACAAAAAACCTTGATTTAGTTAATA
GCAATGCATTAATTCCAAATACAGATTTTACATTTAAAATCGAACCTGATACTACTGTCAACGAAGACGG
AAATAAGTTTAAAGGTGTAGCTTTGAACACACCGATGACTAAAGTCACTTACACCAATTCAGATAAAGGT
GGATCAAATACGAAAACTGCAGAATTTGATTTTTCAGAAGTTACTTTTGAAAAACCAGGTGTTTATTATT
ACAAAGTAACTGAGGAGAAGATAGATAAAGTTCCTGGTGTTTCTTATGATACAACATCTTACACTGTTCA
AGTTCATGTCTTGTGGAATGAAGAGCAACAAAAACCAGTAGCTACTTATATTGTTGGTTATAAAGAAGGT
AGTAAGGTGCCAATTCAGTTCAAAAATAGCTTAGATTCTACTACATTAACGGTGAAGAAAAAAGTTTCAG
GTACCGGTGGAGATCGCTCTAAAGATTTTAATTTTGGTCTGACTTTAAAAGCAAATCAGTATTATAAGGC
GTCAGAAAAAGTCATGATTGAGAAGACAACTAAAGGTGGTCAAGCTCCTGTTCAAACAGAGGCTAGTATA
GATCAACTCTATCATTTTACCTTGAAAGATGGTGAATCAATCAAAGTCACAAATCTTCCAGTAGGTGTGG
ATTATGTTGTCACTGAAGACGATTACAAATCAGAAAAATATACAACCAACGTGGAAGTTAGTCCTCAAGA
TGGAGCTGTAAAAAATATCGCAGGTAATTCAACTGAACAAGAGACATCTACTGATAAAGATATGACCATT
ACTTTTACAAATAAAAAAGACTTTGAAGTGCCAACAGGAGTATAACTCGAGCACCACCACCACCACCACT
GAGATCCGGCTGCTAA 
 
B 
 
GSHMETVVNGAKLTVTKNLDLVNSNALIPNTDFTFKIEPDTTVNEDGNKFKGVALNTPMTKVTYTNSDKG
GSNTKTAEFDFSEVTFEKPGVYYYKVTEEKIDKVPGVSYDTTSYTVQVHVLWNEEQQKPVATYIVGYKEG
SKVPIQFKNSLDSTTLTVKKKVSGTGGDRSKDFNFGLTLKANQYYKASEKVMIEKTTKGGQAPVQTEASI
DQLYHFTLKDGESIKVTNLPVGVDYVVTEDDYKSEKYTTNVEVSPQDGAVKNIAGNSTEQETSTDKDMTI
TFTNKKDFEVPTGV 
 
 
Figure 3.2: Recombinant plasmid pWS009. 
 
Panel A: The spy0128 DNA sequences cloned in pWS009 are shown in blue with 
primer encoded stop codon at the end of the sequence underlined. Vector sequences are 
shown in black, with important features underlined in bold type and indicated above the 
sequence. NdeI (forward primer) and XhoI (reverse primer) restriction endonuclease 
sites used to clone into the vector are shown in red type adjacent to the cloned DNA. 
The spy0128 DNA fragment was cloned in-frame with the vector encoded His-tag 
creating a fusion protein. Panel B: The rSpy0128 amino acid sequence. The Spy0128 
sequences are shown in blue, with vector encoded residues remaining at the N-terminus 
after thrombin cleavage removing the His-tag shown in black. 
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Figure 3.3: Expression and purification of rSpy0128 by affinity chromatography.
 
Coomassie-blue stained SDS-PAGE gel showing rSpy0128. Lane 1: molecular size 
standards. Lane 2: sample of induced cell lysate. Lane 3: sample of unbound material 
from His-tag column. Lanes 4-15: fractions collected during rSpy0128 elution. 
Fractions corresponding to the absorbance peak of the elution profile, lanes 9-14, were 
pooled. Fractions eluted during rSpy0130 affinity chromatography were also observed 
to contain contaminating host proteins (data not shown). 
 
 
 
 
 
Figure 3.4: Elution profiles for rSpy0130 and rSpy0128 S75 gel filtration and     
                   analysis of peak fractions on SDS-PAGE.  
Panel A: rSpy0130 gel filtration elution profile at 280 nm. Panel B: rSpy0128 gel 
filtration elution profile at 280 nm. Panel C: coomassie blue stained SDS-PAGE gel 
analysing rSpy0130 peak fractions. Panel D: coomassie blue stained SDS-PAGE gel 
analysing rSpy0128 peak fractions. For both C and D; Lane 1: molecular size standards. 
Lanes 2-10: samples of fractions corresponding to the major peak from the elution 
profile.        
97 kDa 
67 kDa 
45 kDa 
30 kDa 
1    2   3   4  5   6   7   8  9  10 11 12 13 14 15 
rSpy0128 
    1      2    3      4      5     6     7      8      9     10 
45 kDa 
30 kDa 
20.1 kDa 
33.4 kDa 
14.4 kDa 
20.1 kDa 
30 kDa 
19.9 kDa 
    1     2     3     4    5     6     7      8      9    10 C D 
A B 
  
82 
 
(Gasteiger et al., 2005) on the ExPASy server (www.expasy.ch). When needed, the N-
terminal His-tag was removed by digestion with thrombin. After removal of cleaved 
His-tag (on a His-chelation column) and thrombin (on a benzamidine column) as 
described in chapter 2, section 2.6.7, rSpy0130 and rSpy0128 were pooled, dialysed 
into gel filtration buffer and concentrated.  
 
3.3 Biophysical characterisation of rSpy0130 and rSpy0128 in solution 
 
Purified rSpy0130 and rSpy0128 from section 3.2 (with the N-terminal His-tag 
removed) were used in biophysical characterisation experiments. A number of 
biophysical techniques were used to probe the physical structure of rSpy0130 and 
rSpy0128: (i) The secondary structure for both was examined using circular dichroism 
spectroscopy (CD) (Bulheller et al., 2007; Kelly et al., 2005); (ii) The heterogeneity and 
oligomeric state of the proteins in solution were investigated by analytical 
ultracentrifugation (AUC) using the sedimentation velocity technique (Lebowitz et al., 
2002); and (iii) Small angle X-ray scattering (SAXS) was used to provide information 
on the size and shape of the molecules in solution (Neylon, 2008; Petoukhov and 
Svergun, 2007). As mentioned in the materials and methods, AUC provides information 
which is highly complementary to SAXS, such as data regarding the monodispersity, 
elongation and aggregation of the molecule in solution (Hura et al., 2009; Neylon, 
2008).    
 
Both AUC and SAXS experiments were carried out in collaboration with Dr. Alexandra 
Solovyova who provides these techniques as a service for our institute. 
 
3.3.1 Secondary structure of rSpy0130  
 
CD was used to probe the rSpy0130 secondary structure. For CD experiments rSpy0130 
was diluted to 0.5 mg/ml. Five repeat scans were used to produce the final spectra 
which were corrected for background “noise” from the sample buffer by subtracting the 
protein free spectra. The far UV spectra for rSpy0130 is shown as the red graph in 
Figure 3.5 and reveals it to contain very little identifiable secondary structure. However, 
features characteristic of internal disorder such as a negative shoulder near 222 nm or 
minimum at 203 nm are not observed (Receveur-Brechot et al., 2006). 
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Figure 3.5: Far UV spectra for rSpy0130 and rSpy0128.
 
rSpy0130 (red line) exhibits little identifiable secondary structure. rSpy0128 (blue line) 
displays a classical βI-type sheet spectrum.  
 
 
 
Although the spectrum is unusual, a lack of these features combined with the data from 
the sedimentation velocity and SAXS experiments (see below) suggests that rSpy0130 
is not completely unfolded in solution but may exhibit a much elongated structure. 
 
3.3.2 Secondary structure of rSpy0128
 
rSpy0128 samples were diluted to 0.5 mg/ml for use in CD experiments and the spectra 
was corrected as described above. The far UV spectrum for rSpy0128 is shown as the 
blue graph in Figure 3.5 and displays a classical βI-type sheet spectrum, with a single 
minimum at 215 nm and a maximum at 202 nm (Solovyova et al., 2010).  
 
3.3.3 Analytical ultracentrifugation of rSpy0130  
 
Concentrations of rSpy0130 used ranged from 0.32-2.04 mg/ml in gel filtration buffer. 
The continuous c(s) distribution model shown in panel A of Figure 3.6 reveals a single 
dominant species observed as a single peak at 1.76 S, indicating that rSpy0130 is 
monodisperse and monomeric in the sample. The calculated sedimentation coefficient 
for a typically hydrated sphere of equivalent molecular mass to rSpy0130 of 2.32 S is 
significantly larger than that determined experimentally. This suggests a significant 
elongation of rSpy0130 in solution. This is supported by a much increased f/f0
shape of  
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Figure 3.6: Size distribution c(s) for rSpy0130 and rSpy0128. 
 
Panel A: A single dominant peak is observed for rSpy0130 at 1.76 S using the general 
c(s) size distribution model. The concentrations of protein examined were: 0.32 mg/ml 
(black line), 0.61 mg/ml (red line), 0.91 mg/ml (green line), 1.23 mg/ml (magenta line), 
1.57 mg/ml (cyan line), 2.04 mg/ml (blue line). Panel B: A single dominant peak is 
observed for rSpy0128 at 2.63 S using the general c(s) size distribution model. The 
concentrations of protein examined were: 0.15 mg/ml (black line), 0.26 mg/ml (red 
line), 0.43 mg/ml (green line), 0.72 mg/ml (magenta line), 1.01 mg/ml (cyan line), 1.34 
mg/ml (blue line) and 1.65 mg/ml (yellow line).  
 
 
 
Table 3.1: rSpy0128 and rSpy0130 sedimentation velocity results. 
 
 
               Calculated parameters       SV experimental data 
 
 Mass (kDa) s (S) RMSDa f/f0
shape S20,w Mass (kDa) 
Spy0128 33.9 2.54 0.0109 1.23 2.63 ± 0.019 34.48 ± 1.35 
Spy0130 19.9 2.32 0.0121 1.45 1.76 ± 0.003 20.47 ± 0.47 
 
a The root mean square deviation (RMSD) of the fit of the data for the highest sample 
concentration is shown. 
 
 
 
 
1.45 when compared to f/f0 = 1 for a sphere (Table 3.1). From the sedimentation 
velocity data it is possible to calculate an accurate mass for the protein present in the 
sample. The experimentally determined mass of 20.47 kDa reveals that rSpy0130 is 
monomeric in solution when compared to the calculated mass of 19.9 kDa for the 
rSpy0130 construct (Solovyova et al., 2010). 
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3.3.4 Analytical ultracentrifugation of rSpy0128 
 
Concentrations of rSpy0128 used in sedimentation velocity experiments ranged from 
0.15-1.65 mg/ml in gel filtration buffer. A sharp, single peak for rSpy0128 is revealed 
by the continuous c(s) distribution model in panel B of Figure 3.6. The derived value of 
1.23 for f/f0
shape is significantly larger than 1 (f/f0 = 1 for a sphere) which implies 
elongation of the protein (Table 3.1). An experimentally derived mass of 34.5 kDa was 
obtained for rSpy0128 from the sedimentation velocity data. This is consistent with the 
expected mass of the expressed Spy0128 construct of 33.9 kDa and reveals that 
rSpy0128 is monodisperse and monomeric in solution (Solovyova et al., 2010). 
 
3.3.5 rSpy0130 solution structure modelled ab initio 
 
Solution X-ray scattering experiments were carried out on rSpy0130 that had been 
confirmed by AUC as monomeric and monodisperse in solution at 5 mg/ml and 10 
mg/ml in gel filtration buffer. The SAXS data for rSpy0130 was collected on beamline 
X33 at the EMBL Hamburg outstation and the low resolution solution structure was 
determined by Dr Alexandra Solovyova by averaging 20 ab initio restored models, 
constructed as dummy atom models (DAM) using DAMMIN (Svergun, 1999), with a 
maximum resolution of 25 Å. The DAM for rSpy0130 is shown in panel A Figure 3.7 
and was constructed with approximate dimensions of 105 Å x 25 Å x 14 Å, revealing an 
extremely elongated architecture but suggestive that rSpy0130 is not completely 
unfolded and displays some globular structure (Solovyova et al., 2010). 
 
3.3.6 rSpy0128 solution structure modelled ab initio 
 
The SAXS data for rSpy0128 was collected on beamline 2.1 at the SRS (Daresbury, 
UK). A DAM was constructed for rSpy0128 as described above and is shown in panel 
B Figure 3.7. An envelope of 66 Å x 37 Å x 24 Å was determined for rSpy0128 and its 
DAM is suggestive of a two domain structure. 
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Figure 3.7: SAXS DAMs for rSpy0130 and rSpy0128 in three orientations.  
 
Structures are not to scale. Panel A: rSpy0130. Approximate dimensions: 105 Å x 25 Å 
x 14 Å. Panel B: rSpy0128. Approximate dimensions: 66 Å x 37 Å x 24 Å. 
 
 
 
3.4 Crystallisation of rSpy0130 and X-ray analysis of SeMet labelled rSpy0128 
 
During the course of this project, attempts to crystallise rSpy0130 proved unsuccessful, 
potentially for a variety of reasons and these are outlined in the discussion to this 
chapter. In parallel and in collaboration with Dr Paul Race, who had collected a native 
rSpy0128 dataset (limited to ~3 Å), this project focussed on producing rSpy0128 
selenomethionine (SeMet) crystals. SeMet labelled rSpy0128 was produced essentially 
as described in chapter 2, section 2.6.4. The rSpy0128 SeMet protein (10 mg/ml) was 
used to set up initial crystallisation trials using commercially available sparse matrix 
screens as described in materials and methods (section 2.11.1). Initial crystals were 
observed in ~70% of all conditions throughout the screens and almost exclusively in 
conditions harbouring PEG as a precipitant. The most promising crystals grew in 20% 
(w/v) PEG 6000 and 100 mM tri-sodium citrate pH 5.0. Crystal growth was optimised 
by screening the concentration of the precipitant against the pH of the buffer using the 
hanging drop vapour diffusion technique. Crystal growth was observed overnight with 
maximal dimensions achieved within one week. Large well formed crystals were 
obtained in 13-14% (w/v) PEG 6000 and 300 mM tri-sodium citrate pH 4.25. 
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Figure 3.8: Examples of optimised rSpy0128 SeMet crystals. 
 
 
 
Examples of these crystals are shown in Figure 3.8. Prior to data collection crystals 
were harvested in Litholoops, transferred to a cryo-protectant solution of paratone-N 
and flash frozen in liquid nitrogen. Although these crystals were extremely large and 
highly bi-refringent, their diffraction of X-rays was highly anisotropic and limited in 
resolution to ~3 Å. Multiple MAD datasets were collected on rSpy0128 SeMet crystals 
at the ESRF, Grenoble, France. All were low-resolution (3.5 Å at best), showed 
evidence of twinning and the structure could not be solved from these crystals. As 
attempts were being made to solve these problems, we learnt that the structure of 
Spy0128 had just been solved by a group in New Zealand (subsequently published by 
Kang et al. 2007), and therefore this aspect of the project was not pursued. 
 
 
3.5 Construction of spy0128 inter and intra molecular isopeptide bond mutants in  
      the M1 GAS strain SF370 chromosome 
 
Analysis of the rSpy0128 crystal reported by Kang et al. (Kang et al., 2007), revealed it 
to be an elongated, two domain protein with individual subunits aligned end on end. 
This, in combination with mass spectrometry of intact pili identified Lys161 as joining 
to the Thr of the EVPTG motif (forming the inter-molecular bond) on adjacent subunits. 
In addition, Spy0128 was found to contain two intra-molecular isopeptide bonds with 
one in each domain; between Lys36 and Asn168 in the N-terminal domain and between 
Lys179 and Asn303 in the C-terminal domain. As explained in chapter 1, section 1.15, 
formation of these bonds is dependant on an appropriately positioned Glu residue 
1 mm 0.4 mm 
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(Glu117 in the N-terminal domain and Glu258 in the C-terminal domain) (Kang et al., 
2007). More recently, the importance of the above Glu residues was confirmed with the 
observation that mutation to alanine abrogates bond formation (Kang and Baker, 2009). 
These bonds had been confirmed in vitro to convey proteolytic and thermal stability 
upon Spy0128 (Kang and Baker, 2009) but their biological function and role in vivo had 
not been explored. Since this project focused on adhesion, following publication of the 
Spy0128 structure it was decided to examine the effects of intra-molecular bond 
disruption on GAS adhesion to HaCaT cells. The residues that were targeted for 
mutagenesis to alanine were; Lys36 and Glu117 from the first intra-molecular 
isopeptide bond, Lys179 and Glu258 from the second, and the inter-molecular linker, 
Lys161. 
 
The mutant alleles were first constructed in the temperature sensitive plasmid pG+host9. 
The two outer primers (shown as 1 and 2 in Figure 3.9) were used to amplify the entire 
wild-type spy0128 including DNA flanking each side of the gene, which would be 
utilised later during allele replacement mutagenesis (see below). These primers were 
designed with an EcoRI restriction endonuclease site in the forward primer and an XhoI 
site in the reverse primer, to facilitate cloning into the pG+host9 vector which had been 
cut with the same enzymes. Figure 3.9 shows a schematic diagram of this process. The 
structure of the resulting plasmid was confirmed by DNA sequencing and it was 
renamed pJP01. To create each point mutation in spy0128, pJP01 was used as template 
in five separate quickchange PCR mutagenesis reactions (chapter 2, section 2.5.9.1). 
Each reaction contained a pair of mutagenic primers (Table 2.3) which were designed 
with up to 18 bases either side of the altered bases to aid annealing to the template DNA 
and reduce the effects of the base mismatches. The structure of pJP01, highlighting the 
spy0128 codons targeted for mutagenesis is shown in Figure 3.10 and each construct is 
described in Table 3.2. The structures of each of these recombinant plasmids were 
confirmed by DNA sequencing.  
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Figure 3.9: Schematic diagram showing construction of the recombinant 
                   plasmid pJP01.                         
 
Panel A: The primer set 1 + 2 were used to amplify wild-type spy0128 including 
flanking regions of DNA directly adjacent to the gene. Panel B: The amplified fragment 
was cleaved with the restriction endonucleases EcoRI and XhoI. Panel C: This fragment 
was then ligated into the pG+host9 vector, cleaved with the same enzymes to create the 
pJP01 construct.  
 
 
 
Previously in the laboratory, an M1 GAS strain SF370 spy0128 deletion mutant 
(Δspy0128) had been created, deleting the entire spy0128 coding region from the 
chromosome (Abbot et al., 2007). Here, Δspy0128 was used as the target for allele 
replacement mutagenesis experiments (Figure 2.4) which introduced the wild-type 
allele carried on plasmid pJP01 and mutant alleles carried on plasmids pJP02, pJP03, 
pJP04, pJP05 and pJP06 into the M1 GAS strain SF370 chromosome, as summarised in 
Figure 3.11. 
 
A 
spy0128 
EcoRI XhoI 
pG
+
host9 
Erm
R 
EcoR I Xho I 
 Erm
R
 
EcoR I Xho I 
spy0128 
B 
C 
spy0128 
EcoRI      1 
 2       XhoI 
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AATAGCCCTTATTCTTATTGGCGGCTATCTACTTTTTCACTTTGTTTTTGGATTTATGATTATCAAAAG 
AAACGATATGGCTCCTAGTGTAAAAGCAGGAGATGCTATTTTATTTTATCGCTTATCTCAGACTTATAAA
GTAGAAGAAGCAGTTGTTTATGAGGACTCTAAAACATCTATAACGAAAGTCGGTCGGATTATTGCTCAAG
CAGGTGATGAAGTGGACCTGACAGAACAAGGTGAATTAAAAATTAATGGCCATATTCAAAATGAAGGACT
AACTTTTATAAAATCAAGAGAAGCTAATTATCCGTATCGAATTGCTGATAATAGTTATTTGATACTCAAT
GATTACTATAGCCAAGAGAGTGAGAATTACCTACAAGATGCAATTGCTAAAGATGCTATAAAAGGCACGA
TTAATACACTTATTCGATTAAGAAACCATTAAGCTAAAGGCTTATTTAAAAAAGGAGAGAAACAATGAAA
TTACGTCACTTACTATTAACGGGAGCAGCCCTAACTAGTTTTGCTGCTACAACAGTTCACGGGGAGACTG
TTGTAAACGGAGCCAAACTAACAGTTACAAAAAACCTTGATTTAGTTAATAGCAATGCATTAATTCCAAA
TACAGATTTTACATTTAAAATCGAACCTGATACTACTGTCAACGAAGACGGAAATAAGTTTAAAGGTGTA
GCTTTGAACACACCGATGACTAAAGTCACTTACACCAATTCAGATAAAGGTGGATCAAATACGAAAACTG
CAGAATTTGATTTTTCAGAAGTTACTTTTGAAAAACCAGGTGTTTATTATTACAAAGTAACTGAGGAGAA
GATAGATAAAGTTCCTGGTGTTTCTTATGATACAACATCTTACACTGTTCAAGTTCATGTCTTGTGGAAT
GAAGAGCAACAAAAACCAGTAGCTACTTATATTGTTGGTTATAAAGAAGGTAGTAAGGTGCCAATTCAGT
TCAAAAATAGCTTAGATTCTACTACATTAACGGTGAAGAAAAAAGTTTCAGGTACCGGTGGAGATCGCTC
TAAAGATTTTAATTTTGGTCTGACTTTAAAAGCAAATCAGTATTATAAGGCGTCAGAAAAAGTCATGATT
GAGAAGACAACTAAAGGTGGTCAAGCTCCTGTTCAAACAGAGGCTAGTATAGATCAACTCTATCATTTTA
CCTTGAAAGATGGTGAATCAATCAAAGTCACAAATCTTCCAGTAGGTGTGGATTATGTTGTCACTGAAGA
CGATTACAAATCAGAAAAATATACAACCAACGTGGAAGTTAGTCCTCAAGATGGAGCTGTAAAAAATATC
GCAGGTAATTCAACTGAACAAGAGACATCTACTGATAAAGATATGACCATTACTTTTACAAATAAAAAAG
ACTTTGAAGTGCCAACAGGAGTAGCAATGACTGTGGCACCATATATTGCTTTAGGAATTGTAGCAGTTGG
TGGAGCTCTTTACTTTGTTAAAAAGAAAAATGCTTAAATTATTATTATGATAGTAAGACTGATTAAGCTC
CTTGACAAGTTGATAAACGTCATTGTTCTTTGTTTCTTCTTTCTTTGTTTATTGATTGCGGCACTTGGAA
TCTACGATGCTTTAACAGTTTATCAAGGAGCTAATGCTACTAACTATCAACAATATAAGAAAAAGGGTGT
TCAGTTTGACGATTTATTAGCTATTAATTCTGATGTTATGGCATGGCTGACTGTTAAAGGAACGCATATT
GATTATCCAATTGTACAGGGAGAGAATAATTTAGAATATATCAACAAATCAGTAGAAGGAGAGTACTCCT
TATCAGGAAGTGTTTTTCTAGATTATCGTAATAAAGTAACTTTTGAAGATAAATACTCATTAATCTATGC
ACATCATATGGCTGGAAATGTTATGTTTGGCGAATTACCTAACTTTAGGAAAAAATCATTTTTTAATAAA                              
CACAAAGAATTTAGTATTGAAAC                                                            
 
Figure 3.10: DNA sequence for wild-type spy0128 used to construct the 
                   recombinant plasmid pJP01 including bases targeted for     
                   mutagenesis. 
 
Coding sequences for spy0128 are shown in blue with start and stop codons highlighted 
in bold. Also highlighted within the spy0128 coding sequence are codons targeted for 
mutagenesis to alanine. Bases coding for isopeptide bond residues are highlighted as 
follows; Lys36 in dark blue, Glu117 in yellow, Lys161 in grey, Lys179 in black and 
Glu258 in sky blue. Adjacent regions of flanking DNA used to replace spy0128 back 
into the chromosome are shown in black. Primers used to amplify the gene and clone 
into pG+host9 are shown in red. Sequencing primers used to confirm the chromosome 
structure after allele replacement are shown in green.    
 
             
Table 3.2: Description of recombinant plasmids used in allele replacement 
                  to produce Spy0128 isopeptide bond mutants in the M1 GAS strain   
                  SF370 chromosome. 
 
Plasmid name Description of contents within pG+host9  
pJP01 Contains wild-type spy0128 allele 
pJP02 Contains spy0128 allele harbouring K36A point mutation 
pJP03 Contains spy0128 allele harbouring E117A point mutation 
pJP04 Contains spy0128 allele harbouring K161A point mutation 
pJP05 Contains spy0128 allele harbouring K179A point mutation 
pJP06 Contains spy0128 allele harbouring K258A point mutation 
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Figure 3.11 Schematic diagram showing construction of the spy0128 K36A   
                    mutant in the M1 GAS strain SF370 chromosome. 
 
Panel A: Previously, a Δspy0128 strain had been constructed in the laboratory. Panel B: 
the pG+host9 construct containing the spy0128 K36A mutant allele was transformed 
into the Δspy0128 strain and using allele replacement the spy0128 gene containing the 
K36A mutation was replaced in the chromosome.   
 
 
As a control, the wild-type spy0128 allele (carried on pJP01) was put back into the 
chromosome of the Δspy0128 strain. Each of the plasmids in Table 3.2 were introduced 
into an Δspy0128 strain by electrotransformation. Allele replacement was used to insert 
the wild-type and mutagenised spy0128 alleles into the chromosome as described in 
chapter 2, section 2.5.14 and shown in the schematic diagram, Figure 3.11. As 
explained in chapter 2, after the second recombination event involved in the allele 
replacement procedure, the target DNA is either replaced in the chromosome by the 
desired allele or the original structure is restored, depending upon which sequences have 
recombined during excision of the plasmid (chapter 2, Figure 2.3, panel D). To 
distinguish between the two possible scenarios for each mutant, the chromosomal DNA 
of 10-12 erythromycin sensitive colonies for each potential mutant was recovered and 
used as template in a PCR reaction using the sequencing primers highlighted in black in 
Figure 3.11. The products were examined by agarose gel electrophoresis. The two 
possible outcomes are readily identifiable, as seen in the example shown in Figure 3.12.  
spy0128 K36A 
 
pJP02 
∆spy0128 
A 
B 
spy0128 K36A 
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Figure 3.12: Example of PCR screening of Erms colonies containing mutagenised   
                      spy0128 alleles. 
 
The result shown is for allele replacement with pJP02 (K36A allele). All other mutants 
were screened the same way, with similar results. Lane 1: DNA size standards. Lane 2: 
positive control using wild-type M1 GAS strain SF370 chromosome as template. Lanes 
3-12: PCR products from different Erms colonies.  
 
 
 
The larger products (~1.9 kb) identify clones where the spy0128 allele has been 
integrated back into the chromosome of the Δspy0128 mutant, whereas the smaller 
products (~0.9 kb) are clones where the Δspy0128 mutation was restored after the 
second cross over event. For each mutant, the PCR products of interest were purified 
and DNA sequenced to confirm the structure of the entire region, including the 
boundaries between sequences that had been manipulated in vitro and un-manipulated 
flanking regions. Growth rates were examined for all strains on three separate occasions 
with the same results, which identified no significant differences in growth rates 
between strains (data not shown). 
 
3.6 Analysis of inter and intra molecular isopeptide bond mutants 
 
To investigate the effects of isopeptide bond disruption on pili binding to host cells, 
adhesion to HaCaT cells was examined as outlined in chapter 2, section 2.12.2. Each 
experiment was repeated on three separate occasions with essentially the same results. 
An example of a confocal image for each control and mutant is seen in panel A, Figure 
3.13. Control strains behaved as expected, with wild-type M1 GAS strain SF370 
binding to HaCaT cells, while very few adhering bacteria (probably only remaining 
because washing steps were too gentle) were observed for the Δspy0128 strain, 
consistent with previous observations (showing no binding) (Abbot et al., 2007). Panel 
A, Figure 3.13 also shows that the control strain (Δspy0128+spy0128), where wild-type  
3 kb 
2 kb 
1.5 kb 
1 kb 
0.5 kb 
1      2      3      4      5     6     7      8      9    10    11    12 
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Figure 3.13: Adhesion of wild-type M1 and spy0128 mutant strains of GAS to  
                     HaCaT cells. 
 
Panel A: Example confocal images for wild-type GAS and Spy0128 isopeptide bond 
mutants adhesion to HaCaT cells at 20x magnification with strain shown indicated. 
HaCaT cells are labelled red and bacteria green. Panel B: Quantification of 
corresponding GAS strains from panel A. Relative adhesion is shown with wild-type 
binding considered 100% and error bars indicating variation from three independent 
experiments. Significant statistical differences compared to wild-type binding were only 
observed with the Δspy0128 (P <0.0001) and spy0128 K161A (P <0.0001) mutant 
strains. 
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spy0128 has been put back into the Δspy0128 chromosome, is essentially the same as 
the wild-type. This was done in parallel to the spy0128 mutants to show that wild-type 
pili function can be restored using allele replacement. Consequently, any effects 
observed in the mutant strains can be attributed to the point mutation they contain and 
not because of problems caused inserting spy0128 back into the chromosome. As 
predicted, the inter-molecular bond mutant, spy0128 K161A, displayed essentially the 
same results as Δspy0128 where very few adherent bacteria were observed. A noticeable 
feature in all four intra-molecular isopeptide bond mutants is the bacteria appear to be 
‘clumped’ together, rather than dispersed across the monolayer in short chains as seen 
with the wild-type. This was most pronounced in the two glutamate mutants but is 
observed in all cases.  
 
 To assess the contribution of isopeptide bonds in Spy0128 on the ability of M1 GAS 
strain SF370 to bind to HaCaT cells, the levels of binding for each mutant was 
quantified as described in chapter 2, section 2.12.3, and is shown in panel B, Figure 
3.13. Relative adhesion is shown with wild-type binding considered 100%. The 
Δspy0128 (P <0.0001) and spy0128 K161A (P <0.0001) mutant strains both exhibit P-
values which indicate significant differences when compared to the wild-type. It is quite 
clear from this figure that when the formation of these bonds is abrogated, the bacteria 
are still able to bind HaCaT cells as effectively as the wild-type. The largest difference 
in binding was observed between spy0128 E117A and the wild-type but this was not 
significant (P <0.2868). 
 
3.7 Effects of Spy0128 isopeptide bonds on pili polymerisation 
 
In conjunction with the adhesion assays described above, western blots were utilised to 
examine the effects that isopeptide bond disruption might have on polymerisation of pili 
in these strains. Pili present in cell wall and supernatant fractions of parent and mutant 
strains (prepared as described in chapter 2, section 2.6.8) were run on a 4-15% gradient 
SDS-PAGE gel, before being immuno-blotted with anti-rSpy0128 antibody (Figure 
3.14). The subunits of Gram positive pili are covalently linked and when M1 GAS 
strain SF370 pili are blotted with anti-rSpy0128 antibody they appear as characteristic 
high molecular weight polymer (HMW) ‘ladders’ on the blot. This characteristic 
‘laddering’ pattern exhibited by pili present in the cell wall extract of wild-type M1 
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GAS strain SF370 is seen in lane 2 (W), Figure 3.14. The HMW laddering pattern 
exhibited by the Δspy0128+spy0128 strain was identical to wild-type (data not shown).  
This data considered in conjunction with the results from the adhesion assay shows that 
wild-type function has been restored in the Δspy0128+spy0128 strain. It is also common 
to see pili material in the supernatant fraction (S, lane 2, Figure 3.14) as intact pili are 
released during normal cell wall turnover. Not shown in this figure is the Δspy0128 
mutant as it is not detected by anti-rSpy0128 sera. The expected result can be seen for 
the spy0128 K161A mutant in lane 3, Figure 3.14. Only Spy0128 monomer is observed 
in the cell wall fraction, as the K161A mutation has abrogated pili formation at the cell 
surface. It is quite clear from this figure that banding patterns exhibited by the two 
lysine point mutations in lanes 4 and 6 (K36A and K179A) are highly similar to those 
of the wild-type M1 GAS strain SF370, with most of the ‘laddering’ pattern observed in 
the cell wall extract with fewer pili present in the culture supernatants. The ‘laddering’ 
patterns observed for the two glutamate point mutations (E117A and E258A) shown in 
lanes 5 and 7 of Figure 3.14 show fewer HMW polymers in the cell wall fraction. 
Released into the culture supernatant, especially in the spy0128 E258A strain, are much 
lower molecular weight polymers, which do not compare to wild-type at all. However, 
the ability of these two strains to produce functional pili is not affected when considered 
in conjunction with the binding data above. Much of the work in this project focussed 
on Spy0125 and so the reasons for this phenotype were not investigated further. 
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Figure 3.14: Western blot analysis of cell wall extract and supernatant from  
                      wild-type M1 GAS and Spy0128 isopeptide bond mutants using  
                      anti-rSpy0128 sera. 
 
Lane 1: molecular size standards. W: enzymatically digested cell wall extract. S: 
culture supernatants. Lane 2: wild-type M1 GAS strain SF370. Lane 3: spy0128 
K161A. Lane 4: spy0128 K36A. Lane 5: spy0128 E117A. Lane 6: spy0128 K179A. 
Lane 7: spy0128 E258A. Also indicated is Spy0128 monomer at ~36 kDa. Only un-
polymerised Spy0128 monomer is found in the cell wall fraction of the spy0128 K161A 
mutant. Wild-type like ‘laddering’ patterns (lane 2) are observed for both lysine intra-
molecular isopeptide bond mutants in lanes 4 and 6. ‘Laddering’ patterns for the two 
glutamate point mutations in lanes 5 and 7 reveal pili are much fewer in the cell wall 
component and much shorter in the supernatant when compared to the wild-type.  
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3.8 Discussion 
 
Part of the work in this chapter describes the biophysical characterisation of rSpy0130 
in solution. The Spy0130 recombinant protein was revealed as an extremely elongated 
molecule but not completely unfolded. Although the circular dichroism data suggested 
little evidence of secondary structure, features characteristic of an unfolded protein such 
as a negative shoulder near 222 nm or minimum at 203 nm were not observed. The data 
from the AUC and SAXS experiments also showed rSpy0130 to be elongated. Attempts 
during the project to crystallise rSpy0130 were unsuccessful and we recently learnt that 
another group had also attempted to crystallise rSpy0130 without success (E.N. Baker, 
personal communication). However, the Baker group were able to solve the crystal 
structure of a Spy0130 homologue (called FctB) from a different strain of GAS (Linke 
et al., 2010). Although FctB and Spy0130 share only 33% sequence homology, the 
dimensions of this recently published (while this thesis was being written) crystal 
structure are similar to those of the Spy0130 SAXS structure described here suggesting 
a similar overall shape (Linke et al., 2010). Spy0130 has a proline rich tail region and 
elongated shape which may allow it to tolerate higher tensile forces due to its flexibility 
(Solovyova et al., 2010). These characteristics probably explain why attempts to 
crystallise rSpy0130 were unsuccessful, as a flexible architecture would prevent 
intimate packing of molecules during crystal formation.  
 
As mentioned in the introduction to this chapter, Spy0130 was confirmed as the wall 
‘linker’. It was predicted that as for linkages between other pilus subunits, the C-
terminal end of Spy0128 is linked to the side chain of a specific surface exposed lysine 
residue of Spy0130. Following the unsuccessful crystallisation of rSpy0130, during the 
latter part of this project attempts were made to identify conserved lysines by aligning 
all sequenced homologues of Spy0130. Six conserved lysine residues were identified as 
potential targets. Site directed mutagenesis and allele replacement techniques were used 
to successfully construct all Lys-to-Ala mutants in the M1 GAS strain SF370 
chromosome and preliminary experiments to identify the lysine were initiated. 
However, around this time we learnt about the FctB structure, and also that this group 
had identified the critical lysine (K146) in Spy0130 of M1 GAS strain SF370 by mass 
spectrometry (Linke et al., 2010). Because of the failure to crystallise rSpy0130, greater 
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emphasis was put into characterising Spy0125 (see chapters 4 and 5) and further 
structural studies on Spy0130 were not pursued. 
 
The remainder of this chapter describes the structure of rSpy0128 in solution and 
provides an assessment of the roles played by the inter and intra molecular isopeptide 
bonds of Spy0128 on the function of pili. The data presented in this chapter concerning 
the characterisation of rSpy0128 in solution, are entirely consistent with the 
subsequently published crystal structure of Spy0128 (see below). This highlights the 
value and place for these low resolution techniques when reliable high resolution 
crystallographic data are not available. The circular dichroism spectroscopy data 
reported in this chapter suggested rSpy0128 was composed solely of β-sheet and this 
matched the high resolution crystal structure of Spy0128 that is composed of two 
discrete all β domains (Kang et al., 2007). Analytical ultracentrifugation experiments 
determined a sedimentation coefficient of 2.63 S for rSpy0128. This figure is in total 
agreement with the calculated sedimentation coefficient value for rSpy0128 based on its 
high resolution crystal structure using HYDROPRO (Garcia De La Torre et al., 2000) 
of 2.54 S (Solovyova et al., 2010). The SAXS dummy atom model for rSpy0128 is 
superimposed with its high resolution crystal structure using SUBCOMB (Kozin and 
Svergun, 2001) in Figure 3.15. The two have an extremely good fit, confirming that the 
rSpy0128 crystal structure is a good representation of the protein in solution.  
 
Attempts in this project to determine the high resolution crystal structure of Spy0128 
encountered problems and were abandoned when we learnt that a group in New Zealand 
had solved the structure (Kang et al., 2007) using a construct expressing a slightly 
different version of rSpy0128 protein to that produced in this project. The rSpy0128 
produced in this project encompassed Glu24-Val313 (of the ‘EVPTGV’ sortase 
recognition motif), and was designed deliberately to exclude the secretion signal peptide 
and sequence downstream of the CWS motif that would not be present in the protein at 
the cell surface. 
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Figure 3.15: rSpy0128 DAM superimposed with the rSpy0128 crystal structure.  
 
 
 
In contrast, the rSpy0128 used to solve the structure was comprised of Ala18-Glu308, 
including part of the secretion signal peptide. It could be argued that the latter was a less 
well designed product, but it turned out that the extra residues from the signal peptide 
present in this construct formed a critical crystal contact giving rise to more intimate 
packing, which in turn, leads to better diffraction. This interaction meant that this group 
were able to generate crystals that diffracted to 2.2 Å, whereas the best diffraction 
observed from crystals generated in this work was ~3 Å. The author’s remark in their 
publication that another construct was generated comprising Ala18-Thr311 but did not 
produce crystals of sufficient quality to rival the Ala18-Glu308 construct. This is 
probably because the sortase recognition motif is likely to be unstructured and therefore, 
when not present, tighter packing of molecules within the crystal is possible (Kang et 
al., 2007).  
 
The intra-molecular isopeptide bonds discovered within Spy0128 have been shown to 
confer stability on the protein in vitro by making them more resistant to attacks by 
proteases and giving them a higher thermal stability (Kang and Baker, 2009). However, 
the influence these bonds have on the function of pili in vivo, had not been investigated. 
This study attempted to address this by substituting the residues involved in intra-
molecular isopeptide bond formation with alanine in the M1 GAS strain SF370 
chromosome. A ∆spy0128 strain of GAS was used as the host in allele replacement. In 
parallel, wild-type spy0128 was replaced back into the chromosome of this host to 
confirm the wild-type phenotype could be restored by this allele replacement approach. 
All aspects of the resulting strain were similar to wild-type: it bound to wild-type levels 
in adhesion assays and displayed identical laddering patterns on blots of cell wall and 
culture supernatant fractions. These data indicated that wild-type function and 
phenotype had been restored by allele replacement.  
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Lys161 of Spy0128 was confirmed in vitro by mass spectrometry as the residue 
involved in forming the inter-molecular link between Spy0128 molecules in the pilus 
(Kang et al., 2007). Substitution of Lys161 for Ala in the chromosome supported this 
observation, as it abrogated pilus formation and function. This mutant exhibits a similar 
phenotype to the ∆spy0128 strain in adhesion assays showing little or no binding when 
compared to wild-type. Additionally, as predicted, immuno-blots only detected the 
Spy0128 monomer and not polymerised pili. In contrast, immuno-blots of cell wall 
preparations from the Lys-Ala intra-molecular isopeptide bond mutants with anti-
Spy0128 sera, reveal only small effects on the laddering patterns observed, although 
they appeared slightly less intense than the wild-type. For both bonds, the Glu-Ala 
substitutions seemed to have a much more pronounced effect on pili. It appears that the 
Glu mutants produce less HMW polymers at the cell wall and those observed in the 
culture supernatants are much shorter, with no bands seen above 250 kDa. These effects 
occur in both Glu mutants but look to be more pronounced in the Glu258Ala 
substitution (as shown in Figure 3.14). Perhaps the phenotypes observed for these 
mutants are caused by disrupting local hydrogen bonding networks sufficiently to 
reduce efficient pilus polymerisation, whilst the effects caused by the loss of the lysine 
residues are not as great. This is consistent with the findings of Kang et al. (Kang and 
Baker, 2009) who reported that Asn168Ala and Glu117Ala substitutions contained 
within rSpy0128 protein did not affect the overall structure of the protein (solved by X-
ray crystallography) but did cause local disturbances to the protein core. These effects 
were more pronounced for the Glu117Ala mutation than the Asn168Ala. As 
crystallisation ‘fixes’ a protein it in a particular state, this local disturbance could be 
amplified enough in vivo to move Lys161 sufficiently for it to impede efficient 
attachment to the next Spy0128 monomer to be incorporated into the pilus. Also, the 
Glu258Ala mutation could cause enough disruption on the C-terminal domain of 
Spy0128 to compromise the ability of SrtC (which must recognise this domain) to 
effectively polymerise Spy0128 monomers into pili. Surprisingly, when the ability of 
these mutants to bind HaCaT cells was examined they all adhered to wild-type levels. 
The major difference observed between the binding of the mutants and wild-type M1 
GAS strain SF370 was that the mutants appeared to bind in ‘clumps’ rather than spread 
evenly over the monolayer (see below). 
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Intra-molecular isopeptide bonds have also been found in the crystal structures of other 
major Gram positive pilus proteins including SpaA from Corynebacterium diphtheriae 
(Kang et al., 2009b) and BcpA from Bacillus cereus (Budzik et al., 2008a). Work on 
BcpA shows that the protein harbours four intra-molecular amide bonds. When residues 
involved in the formation of two of these bonds (in the CNA2 and XNA domains) are 
mutated to alanine to abrogate bond formation, results very similar to those obtained in 
this chapter for Spy0128 are seen. Mutation of Lys174 and Lys273 of these bonds 
appears to have no effect on pilus phenotype compared to wild-type, as assessed by 
immuno-blotting and immuno-labelling with gold particles. However, mutation of 
Glu223 and Asp312 (the catalytic residues required for amide bond formation), results 
in the much reduced length of pili (Budzik et al., 2009b).  
 
The tensile forces experienced by GAS pili upon and after binding have only recently 
been investigated. Atomic force microscopy (AFM) was used to test the forces that the 
wild-type Spy0128 protein and isopeptide bond mutant protein could withstand before 
unfolding to assess their contribution to stability (Alegre-Cebollada et al., 2010). While 
wild-type protein appeared to be almost inextensible, mutations in either of the 
isopeptide bonds greatly reduced the forces needed to unfold the protein, although these 
forces were still relatively high (Alegre-Cebollada et al., 2010). If such unwinding led 
to bacterial aggregation, this observation could explain the ‘clumping’ on the HaCaT 
monolayer. However, whether forces experienced by intact pili upon binding in vivo 
would be enough to cause unfolding of mutant Spy0128 in the pilus needs further 
investigation.  
 
AFM has been used in conjunction with optical tweezers to probe the effects tensile 
forces have on the P pili of E. coli (Jass et al., 2004). As P pili are stretched, the major 
subunits which are arranged in a helical structure, unwind causing elongation of the pili. 
It was suggested that this reveals a ‘built in’ mechanism to resist shear tensile forces 
experienced by bacteria attached to epithelial surfaces in the human body (Jass et al., 
2004). It could be speculated that intra-molecular bonds within major subunits of Gram 
positive bacteria could be playing a similar role.  
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Chapter 4. Characterisation of Spy0125 
 
4.1 Introduction 
 
As discussed in chapter 1, the FCT region of M1 GAS strain SF370 contains five genes 
involved in forming cell surface pili. One of these, a specific sortase enzyme (encoded 
by spy0129, originally designated sortase C or SrtC) acts at the outer surface of the 
bacterial membrane as a transpeptidase, responsible for forming the covalent linkages 
between pilus subunits following their secretion across the cytoplasmic membrane via 
the general secretion pathway. This action led to SrtC being termed the ‘pilus 
polymerase’. A second gene (spy0127) was originally described as encoding a putative 
signal peptidase based on sequence homologies with other proteins. However, when 
examined more closely it was discovered that Spy0127 lacked signal peptidase activity 
and was suggested to play a role as a chaperone to the pilus subunits although this has 
yet to be confirmed (Zahner and Scott, 2008). The three remaining genes (spy0125, 
spy0128 and spy0130) encode subunits which are incorporated into the pilus structure. 
As already mentioned in chapter 1, at the beginning of this project, Spy0128 had been 
described as the major pilus subunit that is assembled into the pilus shaft while the other 
two, Spy0125 and Spy0130, had been described as minor subunits but their specific 
roles were not known (Mora et al., 2005). All three pilus subunits were to be 
characterised with the objective of probing their physical structure and role in pilus 
function and biogenesis. Depending on the progress made with each subunit and parallel 
work by other laboratories it was anticipated that these studies would progress at 
different rates. This proved to be the case, with a large proportion of this project 
focussing on Spy0125.  
 
During the first year of this project, it was reported by Manetti et al. (Manetti et al., 
2007) that recombinant proteins representing the minor subunits (rSpy0125 and 
rSpy0130) but not the major subunit (rSpy0128) bound to a human pharyngeal cell line. 
This suggested that both minor subunits could be acting as adhesins and therefore could 
be positioned at the pilus tip. If this were the case, it would be expected that deletion of 
one of these genes from the GAS chromosome would only result in a partial loss of 
adhesion. Studies from our laboratory by Abbot et al. (Abbot et al., 2007) revealed that 
this was not the case and that a single deletion of either spy0125 or spy0130 resulted in 
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total loss of adhesion to both human tonsil and cultured keratinocytes. This suggested 
that both minor subunits play equally essential roles in pilus biogenesis. Later work on 
Spy0130 revealed it to play a specific role in anchoring the pilus to the cell wall as a 
‘linker’ molecule located at the base of the pilus (see chapter 3). The experiments 
described in this chapter established that Spy0125 is localised to the tip of the pilus and 
acts as the pilus presented adhesin.     
 
4.2 Recombinant Spy0125 expression and purification 
 
At the beginning of the work described in this chapter, a recombinant plasmid 
consisting of the E. coli pET-28a(+) expression vector containing cloned spy0125 
sequences had been constructed by Dr Wendy Smith and was available in the 
laboratory. This plasmid (pWS011) was designed to express recombinant (r)Spy0125 
protein lacking the N-terminal signal peptide and the sequences downstream of the C-
terminal CWSS after the valine of the VVPTG(V) motif, as these sequences would be 
absent from the mature form of the protein on the GAS cell surface. The spy0125 
sequence cloned into pET-28a(+) is shown in panel A, Figure 4.1. In this project, prior 
to large scale rSpy0125 expression, preliminary small scale cultures were setup to 
identify optimal growth and induction conditions. During these preliminary experiments 
it was first noted that induced rSpy0125 runs a little slowly on SDS-PAGE, giving an 
apparent molecular mass of ~94 kDa, whereas the sequence indicates 78.5 kDa. This 
retarded mobility on SDS-PAGE was subsequently observed consistently throughout 
this project. Reduced protein mobility on SDS-PAGE is not uncommon and the 
particular reasons for the reduced mobility of rSpy0125 on SDS-PAGE gels were not 
explored in this project. It is interesting to note that the RlrA pilus adhesin, RrgA, of S. 
pneumoniae also runs higher than expected on SDS-PAGE (LeMieux et al., 2008). 
 
Having examined a variety of strains and induction conditions, it was decided to use E. 
coli BL21 (DE3) CodonPlus type RIL for rSpy0125 expression and that cells were to be 
induced at a culture density OD600 of 0.6 with 1 mM IPTG for 3 h, as this combination 
produced the greatest quantities of recombinant protein. Growth conditions determined 
during small scale expression tests were applied to large scale production of rSpy0125. 
Following induction, cells were harvested and lysed by sonication. The lysate was then 
subjected to affinity chromatography on a His-tag column and 
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       T7 Promoter                       lac operator                                  
                                              
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACT 
 
                rbs                                                  His-tag                                   Thrombin site 
 
TTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGC 
 
GGCAGCCATATGAAGACTGTTTTTGGTTTAGTAGAATCCTCGACGCCAAACGCAATAAATCCAGATTCAAGTTCGGAA
TACAGATGGTATGGATATGAATCTTATGTAAGAGGGCATCCATATTATAAACAGTTTAGAGTAGCACACGATTTAAGG
GTTAACTTAGAAGGAAGTAGAAGTTATCAAGTTTATTGCTTTAATTTAAAGAAAGCATTTCCTCTCGGATCAGATAGT
AGTGTTAAAAAGTGGTATAAAAAACATGATGGAATCTCTACAAAATTTGAAGATTATGCGATGAGCCCTAGAATTACG
GGAGATGAGCTAAATCAGAAGTTACGAGCTGTTATGTATAATGGACATCCACAAAATGCCAATGGTATTATGGAAGGC
TTGGAACCCTTGAATGCTATCAGAGTTACACAAGAGGCGGTATGGTACTATTCTGATAATGCTCCTATTTCTAATCCA
GATGAAAGTTTTAAAAGGGAGTCAGAAAGTAACTTGGTTAGTACTTCTCAATTATCTTTGATGCGTCAAGCTTTGAAG
CAACTGATTGATCCGAATTTGGCAACTAAAATGCCAAAACAAGTTCCGGATGATTTTCAGCTAAGTATTTTTGAGTCT
GAGGACAAGGGAGATAAATATAATAAAGGATACCAAAATCTTTTGAGTGGTGGTTTAGTTCCTACTAAACCACCAACT
CCAGGAGACCCACCAATGCCTCCAAATCAACCTCAAACGACTTCAGTACTTATTAGAAAGTATGCTATAGGTGATTAC
TCTAAATTGCTTGAAGGTGCAACATTACAGTTGACAGGGGATAACGTGAATAGTTTTCAAGCGAGAGTGTTTAGCAGT
AATGATATTGGAGAAAGAATTGAACTATCAGATGGAACTTATACTTTAACTGAATTGAATTCTCCAGCTGGTTATAGT
ATCGCAGAGCCAATCACTTTTAAGGTTGAAGCTGGCAAAGTGTATACTATTATTGATGGAAAACAGATTGAAAATCCC
AATAAAGAGATAGTAGAGCCTTACTCAGTAGAAGCATATAATGATTTTGAAGAATTTAGCGTTTTAACTACACAAAAC
TATGCAAAATTTTATTATGCAAAAAATAAAAATGGAAGTTCACAGGTTGTCTATTGCTTTAATGCAGATCTAAAATCT
CCACCAGACTCTGAAGATGGTGGGAAAACAATGACTCCAGACTTTACAACAGGAGAAGTAAAATACACTCATATTGCA
GGTCGTGACCTCTTTAAATATACTGTGAAACCAAGAGATACCGATCCTGACACTTTCTTAAAACATATCAAAAAAGTA
ATTGAGAAGGGTTACAGGGAAAAAGGACAAGCTATTGAGTATAGTGGTCTAACTGAGACACAATTGCGTGCGGCTACT
CAGTTAGCAATATATTATTTCACTGATAGTGCTGAATTAGATAAGGATAAACTAAAAGACTATCATGGTTTTGGAGAC
ATGAATGATAGTACTTTAGCAGTTGCTAAAATCCTTGTAGAATACGCTCAAGATAGTAATCCTCCACAGCTAACTGAC
CTTGATTTCTTTATTCCGAATAACAATAAATATCAATCCCTTATTGGAACTCAGTGGCATCCAGAAGATTTAGTTGAT
ATTATTCGTATGGAAGATAAAAAAGAAGTTATACCTGTAACTCATAATTTAACATTGAGAAAAACGGTGACTGGTTTA
GCTGGTGACAGAACTAAAGATTTCCATTTTGAAATTGAATTAAAAAATAATAAGCAAGAATTGCTTTCTCAAACTGTT
AAAACAGATAAAACAAACCTCGAATTTAAAGATGGTAAAGCAACCATTAATTTAAAACATGGGGAAAGTTTAACACTT
CAAGGTTTACCAGAAGGTTATTCTTACCTTGTCAAAGAAACAGATTCTGAAGGCTATAAGGTTAAAGTTAATAGCCAA
GAAGTAGCAAATGCTACAGTTTCAAAAACAGGAATAACAAGTGATGAGACACTTGCTTTTGAAAATAATAAAGAGCCT
GTTGTTCCTACAGGAGTTTAACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAA 
 
B 
 
GSHMKTVFGLVESSTPNAINPDSSSEYRWYGYESYVRGHPYYKQFRVAHDLRVNLEGSRSYQVYCFNLKKAFPLGSDS
SVKKWYKKHDGISTKFEDYAMSPRITGDELNQKLRAVMYNGHPQNANGIMEGLEPLNAIRVTQEAVWYYSDNAPISNP
DESFKRESESNLVSTSQLSLMRQALKQLIDPNLATKMPKQVPDDFQLSIFESEDKGDKYNKGYQNLLSGGLVPTKPPT
PGDPPMPPNQPQTTSVLIRKYAIGDYSKLLEGATLQLTGDNVNSFQARVFSSNDIGERIELSDGTYTLTELNSPAGYS
IAEPITFKVEAGKVYTIIDGKQIENPNKEIVEPYSVEAYNDFEEFSVLTTQNYAKFYYAKNKNGSSQVVYCFNADLKS
PPDSEDGGKTMTPDFTTGEVKYTHIAGRDLFKYTVKPRDTDPDTFLKHIKKVIEKGYREKGQAIEYSGLTETQLRAAT
QLAIYYFTDSAELDKDKLKDYHGFGDMNDSTLAVAKILVEYAQDSNPPQLTDLDFFIPNNNKYQSLIGTQWHPEDLVD
IIRMEDKKEVIPVTHNLTLRKTVTGLAGDRTKDFHFEIELKNNKQELLSQTVKTDKTNLEFKDGKATINLKHGESLTL
QGLPEGYSYLVKETDSEGYKVKVNSQEVANATVSKTGITSDETLAFENNKEPVVPTGV 
 
Figure 4.1: Structure of recombinant plasmid pWS011. 
 
Panel A: The spy0125 DNA sequences cloned in pWS011 are shown in blue with 
primer encoded stop codon at the end of the sequence underlined. Vector sequences are 
shown in black, with important features underlined in bold type and indicated above the 
sequence. NdeI (forward primer) and XhoI (reverse primer) restriction endonuclease 
sites used to clone into the vector are shown in red type adjacent to the cloned DNA. 
The spy0125 DNA fragment was cloned in-frame with the vector encoded His-tag 
creating a fusion protein. Panel B: The rSpy0125 amino acid sequence. The Spy0125 
sequences are shown in blue, with vector encoded residues remaining at the N-terminus 
after thrombin cleavage removing the His-tag shown in black. 
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Figure 4.2: Expression and purification of rSpy0125 by affinity chromatography. 
 
Coomassie-blue stained SDS-PAGE gel showing rSpy0125. Lane 1: molecular size 
standards. Lane 2: sample of induced cell lysate. Lane 3: sample of unbound material 
from His-tag column. Lanes 4-15: fractions collected during rSpy0125 elution. 
Fractions corresponding to the absorbance peak of the elution profile, lanes 9-14, were 
pooled. 
 
 
eluted fractions that contained large quantities of protein were pooled and concentrated 
(Figure 4.2). As seen in Figure 4.2 however, these fractions were still contaminated with 
host cell proteins. Therefore, the pooled and concentrated rSpy0125 was purified further 
using a Hi-Load 16/60 Superdex 200 gel filtration column. Figure 4.3 panel A shows 
the rSpy0125 gel filtration elution profile at 280 nm revealing a single predominant 
peak. Fractions corresponding to this peak were analysed by SDS-PAGE and are shown 
in Figure 4.3, panel B with rSpy0125 revealed as a single band of highly pure protein, 
running slightly high at ~94 kDa as noted above. Sample fractions in lanes 5-8 in Figure 
4.3 panel B were pooled and concentrated to 10 mg/ml (determined by absorbance at 
280 nm using the molar extinction coefficient for Spy0125 of 78745 M-1 cm-1) and 
stored at 4oC. When needed, the N-terminal His-tag was cleaved off by thrombin 
digestion, followed by removal of the separated His-tag (on a His-chelation column) 
and thrombin (on a benzamidine column), as described in the materials and methods, 
section 2.6.7. The resulting rSpy0125 was pooled, dialysed into gel filtration buffer and 
concentrated. The rSpy0125 amino acid sequence including vector encoded sequences 
remaining at the N-terminus after removal of the His-tag is shown in panel B, Figure 
4.1. 
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Figure 4.3: Purification of rSpy0125 by gel filtration. 
 
Panel A: rSpy0125 gel filtration elution profile at 280 nm. Panel B: coomassie blue 
stained SDS-PAGE gel analysing peak fractions.  Lane 1: molecular size standards. 
Lanes 2-10: samples of fractions corresponding to the peak from the elution profile. 
Fractions corresponding to lanes 5-8 were pooled and concentrated. 
 
 
4.3 Biophysical characterisation of rSpy0125 in solution 
 
Purified rSpy0125 from section 4.2 (with the N-terminal His-tag removed) was used in 
biophysical characterisation experiments. Circular dichroism spectroscopy (CD), 
analytical ultracentrifugation (AUC) and small angle X-ray scattering (SAXS) were 
used to probe the physical structure of rSpy0125 in solution.  
 
Both AUC and SAXS experiments were carried out in collaboration with Dr. Alexandra 
Solovyova who provides these techniques as a service for our institute. 
 
B 
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Figure 4.4: Far UV spectrum of rSpy0125. 
rSpy0125 displays a non-classical β-II spectrum with a small α-helical component. 
 
4.3.1 Secondary structure of rSpy0125
 
The secondary structure of rSpy0125 was examined using CD. For use in CD 
experiments stock rSpy0125 was diluted to 0.5 mg/ml. A final spectrum was determined 
by averaging 5 repeat scans and subtracting the appropriate protein-free buffer 
spectrum. Figure 4.4 shows the far UV spectrum for rSpy0125, which displays a non-
classical β-II spectrum and contains mostly β-sheet with a small proportion of α-helix 
(Solovyova et al., 2010).  
 
4.3.2 Analytical ultracentrifugation of rSpy0125 
 
Concentrations of rSpy0125 in gel filtration buffer (20 mM Tris-Cl, 150 mM NaCl) 
ranging from 0.15-0.87 mg/ml were used in sedimentation velocity experiments. Using 
the continuous c(s) distribution model, as shown in Figure 4.5, a single dominant 
species is observed as a single peak at 4.30 S, suggesting that rSpy0125 is monodisperse 
in the sample. The sedimentation coefficient for rSpy0125 that was determined 
experimentally, 4.30 S, is significantly lower than would be calculated from a typically 
hydrated sphere of equivalent molecular mass, 5.65 S, which indicates a significant 
elongation of rSpy0125 (Solovyova et al., 2010).  
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Figure 4.5: Size distribution c(s) for rSpy0125. 
 
A single dominant peak is observed at 4.30 S using the general c(s) size distribution 
model. The concentrations of protein examined were: 0.15 mg/ml (black line), 0.31 
mg/ml (red line), 0.51 mg/ml (green line), 0.65 mg/ml (cyan line), 0.68 mg/ml (yellow 
line), 0.76 mg/ml (blue line), 0.87 mg/ml (magenta line).
 
 
 
Table 4.1: rSpy0125 sedimentation velocity results. 
 
 
               Calculated parameters       SV experimental data 
 
 Mass (kDa) s (S) RMSDa f/f0
shape S20,w Mass (kDa) 
 
Spy0125 76.7 5.65 0.0161 1.41 4.30 ± 0.035 81.81 ± 1.6 
 
a The root mean square deviation (RMSD) of the fit of the data for the highest sample 
concentration is shown. 
 
 
 
 
In addition, the derived value of f/f0
shape, 1.41, was much higher than 1 (f/f0 = 1 for a 
sphere) which also implies elongation of the protein (Table 4.1). Using the 
sedimentation velocity data, an experimentally derived mass of 81.8 kDa was obtained 
and confirms that rSpy0125 is monomeric in solution when compared to the calculated 
mass of the expressed Spy0125 construct, 76.7 kDa (Solovyova 2010 et al., 2010). 
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Figure 4.6: SAXS DAM for rSpy0125 in three orientations. 
 
The approximate dimensions for the rSpy0125 monomer were 136 Å x 51 Å x 55 Å. 
 
 
4.3.3 rSpy0125 solution structure modelled ab initio 
 
For use in SAXS experiments stock rSpy0125 sample that had been confirmed as 
monodisperse and monomeric in solution by AUC was used at 5 mg/ml and 10 mg/ml 
in gel filtration buffer. The SAXS data for rSpy0125 was collected on beamline 2.1 at 
the Synchrotron Radiation Source (Daresbury, UK). The low resolution solution 
structure was determined by Dr Alexandra Solovyova by averaging 20 ab initio restored 
models, using DAMMIN (Svergun, 1999) in the form of dummy atom models (DAM) 
with a resolution of 25 Å. The constructed DAM for rSpy0125 shown in Figure 4.6 and 
the approximate dimensions of the protein envelope were: 136 Å x 51 Å x 55 Å 
(Solovyova et al., 2010). No information about atomic positions within the protein 
molecule can be obtained from SAXS data so it is very difficult to try to predict where 
potentially interesting features of the protein such as the ‘VVPTG’ motif and any 
binding interfaces might actually be located. The DAM for rSpy0125 contains 
significant branching which is indicative of a multi-domain structure for this protein. 
 
4.4 Characterisation of rSpy0125 breakdown products 
 
It was noted that after purification, rSpy0125 (stored at 4oC) was observed to 
breakdown over less than a week into two major fragments along with a number of less 
prominent species (Figure 4.7). In order to explore this in more detail, samples of fresh 
rSpy0125 (10 mg/ml) were stored at ambient room temperature, 20oC, 4oC, -20oC and    
-80oC. At regular time intervals over a period of 7 weeks, samples of rSpy0125 stored at 
each temperature were analysed by SDS-PAGE. As seen in Figure 4.7, it is quite clear  
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Figure 4.7: rSpy0125 degradation over time. 
 
Coomassie blue stained SDS-PAGE gel of rSpy0125 breakdown after storage at various 
temperatures for 7 weeks. Lane 1: molecular size standards. Lane 2: ambient room 
temperature. Lane 3: 20oC. Lane 4: 4oC. Lane 5: -20oC. Lane 6: -80oC. Arrows show 
full length rSpy0125 (Black) and the two major breakdown products (Red). 
 
 
 
at 7 weeks post purification that rSpy0125 stored at ambient room temperature and 
20oC has completely degraded to two major fragments of ~25 kDa and ~50 kDa. A 
similar result is observed for rSpy0125 stored at 4oC although some intact protein 
remains, whereas rSpy0125 stored at -20oC and -80oC is largely intact with only a hint 
of breakdown after 7 weeks. It was decided that the two major breakdown fragments 
observed at ~25 kDa and ~50 kDa were likely to be quite stable because these bands on 
SDS-PAGE only increased in intensity over time with very little further breakdown. 
Potentially, these fragments could make up two stable domains of the intact rSpy0125 
(~25 kDa + ~50 kDa = ~76.7 kDa) although this does not rule out the possibility that 
the fragment at ~50 kDa could be degrading into 2 equally sized fragments of ~25 kDa. 
In order to identify which regions of the intact protein the two peptide fragments 
represent, the rSpy0125 sample stored at 4oC (lane 4, Figure 4.7) was applied to an S75 
gel filtration column to separate the three fragments in solution. Upon isolation, the two 
breakdown fragments were characterised by mass spectrometry. Both fragments were 
subject to FT-ICR MS which provides an extremely accurate mass. In the sample eluted 
at ~25 kDa two distinct masses were identified (data not shown). For analysis, both 
peptide masses were rounded up to 2 decimal places and entered into the FindPept tool 
(Gattiker et al., 2002) on the ExPASy server (Gasteiger et al., 2005) along with the 
Spy0125 sequence. Due to the extremely accurate measurements obtained by the FT-
 1    2     3    4     5    6 
30 kDa 
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45 kDa 
66 kDa 
97 kDa 
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ICR MS this program was able to assign peptide sequence from Spy0125 which had the 
closest calculated equivalent mass as that achieved experimentally. The first mass of 
25674.68 Da, was assigned to the peptide Val54-Gly279, which has a calculated mass 
of 25674.676 Da and is only 0.004 Da different to the experimentally determined mass. 
The second mass (25844.94 Da) found within the lower band on SDS-PAGE was 
assigned to the peptide Gly52-Gly279 which has a calculated mass of 25844.887 Da 
and is only 0.052 Da different to the experimentally determined mass. The difference 
between the two experimentally determined masses of 170.26 Da can be attributed to 
the Gly-Leu (mass 170.2 Da) that is not present on the N-terminus of the peptide with 
the lower mass.  
 
The sample eluted at ~50 kDa was attributed a mass of 49769.14 Da. This mass alone 
however would not be enough information to be able to identify the exact peptide which 
composed the larger degradation product. This is due to the level of accuracy achieved 
by FT-ICR MS at this mass but more importantly, this fragment was likely to be an 
internal portion of Spy0125. In order to address this issue and attribute a definitive 
peptide, the larger breakdown fragment was blotted onto PVDF membrane as described 
in the materials and methods, section 2.8.2, and submitted for N-terminal amino acid 
sequencing. During Edman chemistry, amino acids are sequentially removed from the 
N-terminus and identified by reversed phase high pressure liquid chromatography 
depending on when they are eluted over time compared to a set of amino acid standards. 
The area under the amino acid peak is also quantitative which can help identification of 
the cleaved residue in a mixed sample. Six cycles of Edman chemistry were possible 
that identified Asn – Gln – Pro – Gln – Thr – Thr as the first 6 amino acids of this 
degradation product. These residues could be identified precisely from the Spy0125 
sequence, and correspond to Asn286-Thr291 (data not shown). This information 
coupled with the intact mass of the fragment enabled the peptide Asn286-Val725 to be 
assigned to the larger fragment. The calculated mass (49354.1 Da) of this fragment 
however was someway short of the intact mass of 49769.14 Da determined by the FT-
ICR MS (see discussion). When all the information collected for both degradation 
products is considered together, the most likely scenario for the breakdown of rSpy0125 
in solution is that the protein is cleaving in a proline rich region that separates the two 
fragments (Figure 4.8). The presence of a proline rich region could indicate that two  
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Figure 4.8: Recombinant proteins and chromosomal deletions produced in this   
                   chapter.  
 
Panel A: Full length Spy0125 with its N-terminal signal peptide highlighted in red and 
VVPTGV motif indicated at the C-terminus. Also highlighted is the proline rich region 
identified as separating the two rSpy0125 breakdown fragments. Panel B: Recombinant 
Spy0125 proteins and where they correspond to full length Spy0125. Lys48 indicates 
the N-terminus of the mature, secreted protein. Panel C: Regions of DNA deleted in 
spy0125 with the first and last residues of each deletion indicated (see section 4.6).  
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domains of rSpy0125 have been isolated and to facilitate further studies, both were 
recloned into pET-28a(+)-D. 
 
 
4.5 Cloning, expression and purification of rSpy0125 ‘breakdown’ fragments 
 
The first construct spanned Lys48 (the first residue after the predicted signal peptide is 
removed)-Gly269 (leaving out part of the proline rich region) and was termed the N-
terminal region (Spy0125-NTR), while the second spanned Asn286-Thr723 (the ‘T’ of 
the ‘VVPTG’ motif) to ensure the fully processed version was constructed and was 
termed the C-terminal region (Spy0125-CTR). The structure of the recombinant 
fragments and where they correspond to full length Spy0125 is shown in Figure 4.8. 
Primers were constructed to encompass the regions described above and contained 
BamHI (forward primers) and XhoI (reverse primers) restriction endonuclease sites 
ready for cloning into the pET-28a(+)-D modified expression vector multiple cloning 
site. Reverse primers also contained a termination codon after the final cloned 
sequences to stop read through into vector encoded sequences. The final spy0125-NTR 
(pJP07) and spy0125-CTR (pJP08) sequences cloned into pET-28a(+)-D are shown in 
Figures 4.9 and 4.10 and were confirmed by DNA sequencing.  
 
The expression and purification of rSpy0125-NTR and rSpy0125-CTR was essentially 
as described in section 4.2 for intact rSpy0125. The plamsids pJP07 and pJP08 were 
transformed into E.coli BL21 (DE3) and E. coli BL21 (DE3) CodonPlus type RIL 
strains and small scale expression tests were carried out to identify the optimal 
induction conditions. As before with intact rSpy0125, the E. coli BL21 (DE3) 
CodonPlus type RIL expression strain in combination with induction at a culture density 
OD600 of 0.6 with 1 mM IPTG for 3 h was observed to give the greatest expression of 
both proteins. Optimised growth conditions were implemented during large scale 
production of both proteins and after harvesting, cells were lysed by sonication and 
soluble His-tagged protein was recovered by Ni2+ affinity chromatography. Peak 
fractions were analysed by SDS-PAGE and those containing large quantities of protein 
were pooled and concentrated prior to loading on a Hi-Load 16/60 Superdex 75 
(rSpy0125-NTR) or 200 (rSpy0125-CTR) gel filtration column to remove impurities 
carried over from the His-tag purification. 
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A 
 
    T7 Promoter                           lac operator                                  
                                              
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACT 
 
                rbs                                                  His – tag                                 Thrombin site 
 
TTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGC 
 
 
GGATCCAAGACTGTTTTTGGTTTAGTAGAATCCTCGACGCCAAACGCAATAAATCCAGATTCAAGTTCGG
AATACAGATGGTATGGATATGAATCTTATGTAAGAGGGCATCCATATTATAAACAGTTTAGAGTAGCACA
CGATTTAAGGGTTAACTTAGAAGGAAGTAGAAGTTATCAAGTTTATTGCTTTAATTTAAAGAAAGCATTT
CCTCTCGGATCAGATAGTAGTGTTAAAAAGTGGTATAAAAAACATGATGGAATCTCTACAAAATTTGAAG
ATTATGCGATGAGCCCTAGAATTACGGGAGATGAGCTAAATCAGAAGTTACGAGCTGTTATGTATAATGG
ACATCCACAAAATGCCAATGGTATTATGGAAGGCTTGGAACCCTTGAATGCTATCAGAGTTACACAAGAG
GCGGTATGGTACTATTCTGATAATGCTCCTATTTCTAATCCAGATGAAAGTTTTAAAAGGGAGTCAGAAA
GTAACTTGGTTAGTACTTCTCAATTATCTTTGATGCGTCAAGCTTTGAAGCAACTGATTGATCCGAATTT
GGCAACTAAAATGCCAAAACAAGTTCCGGATGATTTTCAGCTAAGTATTTTTGAGTCTGAGGACAAGGGA
GATAAATATAATAAAGGATACCAAAATCTTTTGAGTGGTGGTTAACTCGAGCACCACCACCACCACCACT
GAGATCCGGCTGCTAA 
 
B 
 
GSKTVFGLVESSTPNAINPDSSSEYRWYGYESYVRGHPYYKQFRVAHDLRVNLEGSRSYQVYCFNLKKAF
PLGSDSSVKKWYKKHDGISTKFEDYAISPRITGDELNQKLRAVMYNGHPQNANGIMEGLEPLNAIRVTQE
AVWYYSDNAPISNPDESFKRESESNLVSTSQLSLMRQALKQLIDPNLATKMPKQVPDDFQLSIFESEDKG
DKYNKGYQNLLSGG 
 
 
Figure 4.9: Recombinant plasmid pJP07. 
 
Panel A: Cloned sequences for spy0125-NTR are shown in blue, with the primer 
encoded stop codon at the end of the sequence underlined. The BamHI and XhoI 
restriction endonuclease sites are shown in bold red type adjacent to the cloned DNA. 
Vector encoded sequences are shown in black with important features underlined and 
indicated above the sequence. The vector encoded start and stop codons are also 
underlined. Panel B: The rSpy0125-NTR amino acid sequence. The rSpy0125-NTR 
sequences are shown in blue with vector encoded residues remaining at the N-terminus 
after thrombin cleavage removing the His-tag shown in black. 
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A 
   
      T7 Promoter                         lac operator                                  
                                              
TAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACT 
 
                rbs                                                  His-tag                                 Thrombin site 
 
TTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGC 
 
 
GGATCCAATCAACCTCAAACGACTTCAGTACTTATTAGAAAGTATGCTATAGGTGATTACTCTAAATTGC
TTGAAGGTGCAACATTACAGTTGACAGGGGATAACGTGAATAGTTTTCAAGCGAGAGTGTTTAGCAGTAA
TGATATTGGAGAAAGAATTGAACTATCAGATGGAACTTATACTTTAACTGAATTGAATTCTCCAGCTGGT
TATAGTATCGCAGAGCCAATCACTTTTAAGGTTGAAGCTGGCAAAGTGTATACTATTATTGATGGAAAAC
AGATTGAAAATCCCAATAAAGAGATAGTAGAGCCTTACTCAGTAGAAGCATATAATGATTTTGAAGAATT
TAGCGTTTTAACTACACAAAACTATGCAAAATTTTATTATGCAAAAAATAAAAATGGAAGTTCACAGGTT
GTCTATTGCTTTAATGCAGATCTAAAATCTCCACCAGACTCTGAAGATGGTGGGAAAACAATGACTCCAG
ACTTTACAACAGGAGAAGTAAAATACACTCATATTGCAGGTCGTGACCTCTTTAAATATACTGTGAAACC
AAGAGATACCGATCCTGACACTTTCTTAAAACATATCAAAAAAGTAATTGAGAAGGGTTACAGGGAAAAA
GGACAAGCTATTGAGTATAGTGGTCTAACTGAGACACAATTGCGTGCGGCTACTCAGTTAGCAATATATT
ATTTCACTGATAGTGCTGAATTAGATAAGGATAAACTAAAAGACTATCATGGTTTTGGAGACATGAATGA
TAGTACTTTAGCAGTTGCTAAAATCCTTGTAGAATACGCTCAAGATAGTAATCCTCCACAGCTAACTGAC
CTTGATTTCTTTATTCCGAATAACAATAAATATCAATCTCTTATTGGAACTCAGTGGCATCCAGAAGATT
TAGTTGATATTATTCGTATGGAAGATAAAAAAGAAGTTATACCTGTAACTCATAATTTAACATTGAGAAA
AACGGTGACTGGTTTAGCTGGTGACAGAACTAAAGATTTCCATTTTGAAATTGAATTAAAAAATAATAAG
CAAGAATTGCTTTCTCAAACTGTTAAAACAGATAAAACAAACCTCGAATTTAAAGATGGTAAAGCAACCA
TTAATTTAAAACATGGGGAAAGTTTAACACTTCAAGGTTTACCAGAAGGTTATTCTTACCTTGTCAAAGA
AACAGATTCTGAAGGCTATAAGGTTAAAGTTAATAGCCAAGAAGTAGCAAATGCTACAGTTTCAAAAACA
GGAATAACAAGTGATGAGACACTTGCTTTTGAAAATAATAAAGAGCCTGTTGTTCCTACATAACTCGAGC
ACCACCACCACCACCACTGAGATCCGGCTGCTAA 
 
B 
 
GSNQPQTTSVLIRKYAIGDYSKLLEGATLQLTGDNVNSFQARVFSSNDIGERIELSDGTYTLTELNSPAG
YSIAEPITFKVEAGKVYTIIDGKQIENPNKEIVEPYSVEAYNDFEEFSVLTTQNYAKFYYAKNKNGSSQV
VYCFNADLKSPPDSEDGGKTMTPDFTTGEVKYTHIAGRDLFKYTVKPRDTDPDTFLKHIKKVIEKGYREK
GQAIEYSGLTETQLRAATQLAIYYFTDSAELDKDKLKDYHGFGDMNDSTLAVAKILVEYAQDSNPPQLTD
LDFFIPNNNKYQSLIGTQWHPEDLVDIIRMEDKKEVIPVTHNLTLRKTVTGLAGDRTKDFHFEIELKNNK
QELLSQTVKTDKTNLEFKDGKATINLKHGESLTLQGLPEGYSYLVKETDSEGYKVKVNSQEVANATVSKT
GITSDETLAFENNKEPVVPT 
 
 
Figure 4.10: Recombinant plasmid pJP08. 
 
Panel A: Cloned sequences for spy0125-CTR are shown in blue, with the primer 
encoded stop codon at the end of the sequence underlined. The BamHI and XhoI 
restriction endonuclease sites are shown in bold red type adjacent to the cloned DNA. 
Vector encoded sequences are shown in black with important features underlined and 
indicated above the sequence. The vector encoded start and stop codons are also 
underlined. Panel B: rSpy0125-CTR amino acid sequence is shown in blue with 
remaining vector encoded residues at the N-terminus after thrombin cleavage of His-tag 
shown in black. 
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The elution profiles for both proteins are shown in Figure 4.11 accompanied by samples 
of the peak fractions assessed by SDS-PAGE. Panels A and B of Figure 4.11 reveal that 
rSpy0125-NTR purifies in a monomer-dimer equilibrium and fractions which contained 
monomer (lanes 5-10 Panel B, Figure 4.11) were of sufficient purity to be pooled and 
concentrated to 10 mg/ml, determined by absorbance at 280 nm using the molar 
extinction coefficient for Spy0125-NTR of 38850 M-1 cm-1. rSpy0125-CTR purifies as a 
single predominant peak as indicated in Figure 4.11 panel C and is assessed by SDS-
PAGE to be homogenous and of high purity (panel D, Figure 4.11). Peak fractions 
represented in lanes 3-8 were pooled and concentrated to 10 mg/ml, determined by 
absorbance at 280 nm using the molar extinction coefficient for Spy0125-CTR of 39770 
M-1 cm -1. When needed, the N-terminal His-tag was removed by digestion with 
thrombin. After removal of cleaved His-tag (on a His-chelation column) and thrombin 
(on a benzamidine column) as described in chapter 2, section 2.6.7, rSpy0125-NTR and 
CTR was pooled, dialysed into gel filtration buffer and concentrated. 
 
The secondary structure of rSpy0125-NTR and CTR were examined by CD as 
described above for rSpy0125 and Figure 4.12 shows example far UV spectra for both 
proteins. Panel A shows rSpy0125-NTR to be well folded and contain a significant α-
helical component. The example spectra for rSpy0125-CTR in panel B shows this 
protein is also well folded and is predominantly composed of β-strand with a small α-
helical component. 
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Figure 4.11: Elution profiles and peak fraction analysis of rSpy0125-NTR  
                     and CTR purification. 
 
Panel A: rSpy0125-NTR elution profile at 280 nm. Panel B: Coomassie blue stained 
gel of corresponding peak fractions from rSpy0125-NTR gel filtration (lanes 2-10). 
Panel C: rSpy0125-CTR elution profile at 280 nm. Panel D: Coomassie blue stained 
gel of corresponding major peak fractions from rSpy0125-CTR gel filtration (lanes 2-9). 
Lane 1 in panels C and D: molecular size standards.  
 
 
 
 
 
 
 
Figure 4.12: Far UV spectra for rSpy0125-NTR and CTR. 
 
Panel A: rSpy0125-NTR spectrum displays a large α-helical component. Panel B: 
rSpy0125-CTR spectrum reveals a largely β-strand protein with a small α-helical 
component. 
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4.6 Construction of Δspy0125-NTR and Δspy0125-ID mutants 
 
In close collaboration, colleagues in the laboratory used the three recombinant proteins 
produced in this chapter to generate specific anti-sera to each (as described in materials 
and methods, section 2.7), and the remaining intact subunits (Spy0128 and Spy0130). In 
experiments carried out by Dr Wendy Smith and Dr Emily Abbot, discussed here for 
clarity, it was revealed that only anti-sera specific to Spy0125 blocked the adhesion of 
wild-type M1 GAS strain SF370 to human tonsil to a significant extent. Further 
experiments were carried out with anti-sera raised against the two Spy0125 fragments 
identified in section 4.4 which found that only anti-sera specific to the CTR of Spy0125 
blocked adhesion of wild-type bacteria. Intriguingly, sequence alignments of all 
Spy0125 homologues reveals that both the M5 and M18 GAS Spy0125 equivalents are 
completely missing the NTR as described above (see discussion). The signal peptides 
are present but the amino acid sequence starts in almost direct alignment with the start 
of the Spy0125-CTR as identified above in section 4.4. Other than missing this region, 
there is a high level of sequence homology between the three proteins which suggests 
either that the NTR is not involved in binding to the target receptor at all or that the M5 
and M18 GAS strains utilise other means for initial attachment to host cells.  In order to 
examine this, it was decided to create two deletion mutants within spy0125 on the M1 
GAS strain SF370 chromosome. The first would delete the entire coding region for the 
Spy0125-NTR described above while the second would be an internal deletion (ID) 
lacking central sequences.  
 
The mutant alleles were designed and constructed with a colleague in the laboratory 
(Dr. Wendy Smith), who produced the recombinant plasmids pWS031 and pWS032 
carrying the Δspy0125-NTR and Δspy0125-ID deletions, essentially as outlined in 
Figure 4.13. PCR primers were designed to delete DNA encoding Leu53-Pro285 
inclusive, for the Spy0125-NTR deletion (Δspy0125-NTR) and Asn286-Pro559 
inclusive, for the Spy0125-ID deletion (Δspy0125-ID), whilst being careful not to 
disrupt the reading frame (panel C, Figure 4.8). In designing primers to construct the 
Δspy0125-NTR, care was taken to maintain the bases encoding the predicted signal 
peptide and the following five amino acids, to minimise any potential secretion and 
processing errors. The exact sequences deleted from spy0125 are shown in Figure 4.14  
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Figure 4.13: Schematic showing construction of recombinant pG+host9 plasmid   
                      used in allele replacement to produce targeted deletions in the M1  
                      GAS strain SF370 chromosome. 
 
Panel A: The two sets of primers 1 + 2 and 3 + 4 were used to amplify regions of 
flanking DNA to the target to be deleted. Panel B: The amplified fragments were 
digested with SalI, whose sites were contained within primers 2 and 3, and ligated to 
form the full length mutant allele. The purified product of this ligation was used as 
template in a further PCR reaction before being purified again and cleaved by PstI and 
XhoI whose sites were contained within primers 1 and 4. Panel C: The cleaved full 
length fragment was subsequently ligated into the pG+host9 vector which had been 
digested with the same two enzymes to construct the recombinant plasmid.  
 
 
 
 
 
(∆spy0125-NTR) and Figure 4.15 (∆spy0125-ID) along with flanking regions and the 
locations of all primers used to create the mutant alleles. Following confirmation by 
DNA sequencing, these plasmids were then used by me to introduce the mutations into 
the M1 GAS strain SF370 chromosome by allele replacement mutagenesis. 
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TTGGTAAAAAGTCGAAACCTTTTGAAATAGCTTTAAAGCAATATTTTCTCAAAAAATCATTTTCAAAAAC
ACTAATTTGGTGAAAAACTTAGTACGAATATATTTCTTTGACTTCAATAGAATGATATGATGTCACATTG
AGAGGAGAGAAAATGAAAAAAACAAGGTTTCCAAATAAGCTTAATACTCTTAATACTCAAAGGGTATTAA
GTAAAAACTCAAAACGATTTACTGTCACTTTAGTGGGAGTCTTTTTAATGATCTTCGCTTTGGTAACTTC
CATGGTTGGTGCTAAGACTGTTTTTGGTTTAGTAGAATCCTCGACGCCAAACGCAATAAATCCAGATTCA
AGTTCGGAATACAGATGGTATGGATATGAATCTTATGTAAGAGGGCATCCATATTATAAACAGTTTAGAG
TAGCACACGATTTAAGGGTTAACTTAGAAGGAAGTAGAAGTTATCAAGTTTATTGCTTTAATTTAAAGAA
AGCATTTCCTCTCGGATCAGATAGTAGTGTTAAAAAGTGGTATAAAAAACATGATGGAATCTCTACAAAA
TTTGAAGATTATGCGATGAGCCCTAGAATTACGGGAGATGAGCTAAATCAGAAGTTACGAGCTGTTATGT
ATAATGGACATCCACAAAATGCCAATGGTATTATGGAAGGCTTGGAACCCTTGAATGCTATCAGAGTTAC
ACAAGAGGCGGTATGGTACTATTCTGATAATGCTCCTATTTCTAATCCAGATGAAAGTTTTAAAAGGGAG
TCAGAAAGTAACTTGGTTAGTACTTCTCAATTATCTTTGATGCGTCAAGCTTTGAAGCAACTGATTGATC
CGAATTTGGCAACTAAAATGCCAAAACAAGTTCCGGATGATTTTCAGCTAAGTATTTTTGAGTCTGAGGA
CAAGGGAGATAAATATAATAAAGGATACCAAAATCTTTTGAGTGGTGGTTTAGTTCCTACTAAACCACCA
ACTCCAGGAGACCCACCAATGCCTCCAAATCAACCTCAAACGACTTCAGTACTTATTAGAAAGTATGCTA
TAGGTGATTACTCTAAATTGCTTGAAGGTGCAACATTACAGTTGACAGGGGATAACGTGAATAGTTTTCA
AGCGAGAGTGTTTAGCAGTAATGATATTGGAGAAAGAATTGAACTATCAGATGGAACTTATACTTTAACT
GAATTGAATTCTCCAGCTGGTTATAGTATCGCAGAGCCAATCACTTTTAAGGTTGAAGCTGGCAAAGTGT
ATACTATTATTGATGGAAAACAGATTGAAAATCCCAATAAAGAGATAGTAGAGCCTTACTCAGTAGAAGC
ATATAATGATTTTGAAGAATTTAGCGTTTTAACTACACAAAACTATGCAAAATTTTATTATGCAAAAAAT
AAAAATGGAAGTTCACAGGTTGTCTATTGCTTTAATGCAGATCTAAAATCTCCACCAGACTCTGAAGATG
GTGGGAAAACAATGACTCCAGACTTTACAACAGGAGAAGTAAAATACACTCATATTGCAGGTCGTGACCT
CTTTAAATATACTGTGAAACCAAGAGATACCGATCCTGACACTTTCTTAAAACATATCAAAAAAGTAATT
GAGAAGGGTTACAGGGAAAAAGGACAAGCTATTGAGTATAGTGGTCTAACTGAGACACAATTGCGTGCGG
CTACTCAGTTAGCAATATATTATTTCACTGATAGTGCTGAATTAGATAAGGATAAACTAAAAGACTATCA
TGGTTTTGGAGACATGAATGATAGTACTTTAGCAGTTGCTAAAATCCTTGTAGAATACGCTCAAGATAGT
AATCCTCCACAGCTAACTGACCTTGATTTCTTTATTCCGAATAACAATAAATATCAATCCCTTATTGGAA
CTCAGTGGCATCCAGAAGATTTAGTTGATATTATTCGTATGGAAGATAAAAAAGAAGTTATACCTGTAAC
TCATAATTTAACATTGAGAAAAACGGTGACTGGTTTAGCTGGTGACAGAACTAAAGATTTCCATTTTGAA
ATTGAATTAAAAAATAATAAGCAAGAATTGCTTTCTCAAACTGTTAAAACAGATAAAACAAACCTCGAAT
TTAAAGATGGTAAAGCAACCATTAATTTAAAACATGGGGAAAGTTTAACACTTCAAGGTTTACCAGAAGG
TTATTCTTACCTTGTCAAAGAAACAGATTCTGAAGGCTATAAGGTTAAAGTTAATAGCCAAGAAGTAGCA
AATGCTACAGTTTCAAAAACAGGAATAACAAGTGATGAGACACTTGCTTTTGAAAATAATAAAGAGCCTG
TTGTTCCTACAGGAGTTGATCAAAAGATCAATGGCTATCTAGCTTTGATAGTTATCGCTGGTATCAGTTT
GGGGATCTGGGGAATTCACACGATAAGGATAAGAAAACATGACTAG 
                                                                                                                                   
 
Figure 4.14: Region of DNA sequence deleted illustrating the construction of    
                     Δspy0125-NTR. 
 
The entire spy0125 coding region is shown with start and stop codons highlighted in 
bold. DNA flanking regions retained in the chromosome are shown in black. Primers 
used to construct the deletion are shown in red with their direction indicated by arrows 
under the sequence. The Ala codon highlighted and in bold type (GCT) codes for the 
predicted final alanine residue of the signal peptide. It was decided to keep five extra 
residues after the signal peptide to ensure proper processing of the new protein. Primer 
sequences were retained in the chromosome. DNA sequence deleted from spy0125 is 
shown in blue.  
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ATGAAAAAAACAAGGTTTCCAAATAAGCTTAATACTCTTAATACTCAAAGGGTATTAAGTAAAAACTCAA
AACGATTTACTGTCACTTTAGTGGGAGTCTTTTTAATGATCTTCGCTTTGGTAACTTCCATGGTTGGTGC
TAAGACTGTTTTTGGTTTAGTAGAATCCTCGACGCCAAACGCAATAAATCCAGATTCAAGTTCGGAATAC
AGATGGTATGGATATGAATCTTATGTAAGAGGGCATCCATATTATAAACAGTTTAGAGTAGCACACGATT
TAAGGGTTAACTTAGAAGGAAGTAGAAGTTATCAAGTTTATTGCTTTAATTTAAAGAAAGCATTTCCTCT
CGGATCAGATAGTAGTGTTAAAAAGTGGTATAAAAAACATGATGGAATCTCTACAAAATTTGAAGATTAT
GCGATGAGCCCTAGAATTACGGGAGATGAGCTAAATCAGAAGTTACGAGCTGTTATGTATAATGGACATC
CACAAAATGCCAATGGTATTATGGAAGGCTTGGAACCCTTGAATGCTATCAGAGTTACACAAGAGGCGGT
ATGGTACTATTCTGATAATGCTCCTATTTCTAATCCAGATGAAAGTTTTAAAAGGGAGTCAGAAAGTAAC
TTGGTTAGTACTTCTCAATTATCTTTGATGCGTCAAGCTTTGAAGCAACTGATTGATCCGAATTTGGCAA
CTAAAATGCCAAAACAAGTTCCGGATGATTTTCAGCTAAGTATTTTTGAGTCTGAGGACAAGGGAGATAA
ATATAATAAAGGATACCAAAATCTTTTGAGTGGTGGTTTAGTTCCTACTAAACCACCAACTCCAGGAGAC
CCACCAATGCCTCCAAATCAACCTCAAACGACTTCAGTACTTATTAGAAAGTATGCTATAGGTGATTACT
CTAAATTGCTTGAAGGTGCAACATTACAGTTGACAGGGGATAACGTGAATAGTTTTCAAGCGAGAGTGTT
TAGCAGTAATGATATTGGAGAAAGAATTGAACTATCAGATGGAACTTATACTTTAACTGAATTGAATTCT
CCAGCTGGTTATAGTATCGCAGAGCCAATCACTTTTAAGGTTGAAGCTGGCAAAGTGTATACTATTATTG
ATGGAAAACAGATTGAAAATCCCAATAAAGAGATAGTAGAGCCTTACTCAGTAGAAGCATATAATGATTT
TGAAGAATTTAGCGTTTTAACTACACAAAACTATGCAAAATTTTATTATGCAAAAAATAAAAATGGAAGT
TCACAGGTTGTCTATTGCTTTAATGCAGATCTAAAATCTCCACCAGACTCTGAAGATGGTGGGAAAACAA
TGACTCCAGACTTTACAACAGGAGAAGTAAAATACACTCATATTGCAGGTCGTGACCTCTTTAAATATAC
TGTGAAACCAAGAGATACCGATCCTGACACTTTCTTAAAACATATCAAAAAAGTAATTGAGAAGGGTTAC
AGGGAAAAAGGACAAGCTATTGAGTATAGTGGTCTAACTGAGACACAATTGCGTGCGGCTACTCAGTTAG
CAATATATTATTTCACTGATAGTGCTGAATTAGATAAGGATAAACTAAAAGACTATCATGGTTTTGGAGA
CATGAATGATAGTACTTTAGCAGTTGCTAAAATCCTTGTAGAATACGCTCAAGATAGTAATCCTCCACAG
CTAACTGACCTTGATTTCTTTATTCCGAATAACAATAAATATCAATCCCTTATTGGAACTCAGTGGCATC
CAGAAGATTTAGTTGATATTATTCGTATGGAAGATAAAAAAGAAGTTATACCTGTAACTCATAATTTAAC
ATTGAGAAAAACGGTGACTGGTTTAGCTGGTGACAGAACTAAAGATTTCCATTTTGAAATTGAATTAAAA
AATAATAAGCAAGAATTGCTTTCTCAAACTGTTAAAACAGATAAAACAAACCTCGAATTTAAAGATGGTA
AAGCAACCATTAATTTAAAACATGGGGAAAGTTTAACACTTCAAGGTTTACCAGAAGGTTATTCTTACCT
TGTCAAAGAAACAGATTCTGAAGGCTATAAGGTTAAAGTTAATAGCCAAGAAGTAGCAAATGCTACAGTT
TCAAAAACAGGAATAACAAGTGATGAGACACTTGCTTTTGAAAATAATAAAGAGCCTGTTGTTCCTACAG
GAGTTGATCAAAAGATCAATGGCTATCTAGCTTTGATAGTTATCGCTGGTATCAGTTTGGGGATCTGGGG
AATTCACACGATAAGGATAAGAAAACATGACTAG 
 
 
Figure 4.15: Region of DNA sequence deleted illustrating the construction of    
                     Δspy0125-ID. 
 
The entire spy0125 coding region is shown with start and stop codons highlighted in 
bold. DNA flanking regions retained in the chromosome are shown in black. Primers 
used to construct the deletion are shown in red with their direction indicated by arrows 
under the sequence. Primer sequences were retained in the chromosome. DNA sequence 
deleted from spy0125 is shown in blue.  
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Figure 4.16: Screening of Erms Δspy0125-NTR colonies by PCR. 
 
Erythromycin sensitive colonies of wild-type M1 GAS strain SF370 which had been 
subject to allele replacement using the pWS031 plasmid were screened by PCR and 
their products analysed on 1% agarose gel. Lane 1: DNA size standards. Lane 2: 
negative control containing no template DNA. Lanes 3-12: PCR products from different 
screened colonies. The larger DNA product at 2.948 kb represents the restored wild-
type allele whereas in lanes 3, 5, 11 and 12 the smaller DNA product of 2.249 kb 
indicates that allele replacement has deleted the NTR of spy0125. Similar results were 
obtained for the ∆spy0125-ID. 
 
 
 
Plasmids pWS031 and pWS032 were introduced into wild-type M1 GAS strain SF370 
by electrotransformation and allele replacement was used to delete the defined DNA 
sequences outlined above, as described in chapter 2, section 2.5.14. After the second 
cross over event either the desired DNA is deleted or the wild-type allele can be 
restored depending on which sequences have recombined during excision of the plasmid 
(see chapter 2, Figure 2.4). To distinguish between the two different outcomes, the 
chromosomal DNA of 10 erythromycin sensitive colonies was recovered and used as 
template in PCR reactions using primers outside the sequences that had originally been 
cloned to produce pWS031 and pWS032. The resulting products were examined by 
agarose gel electrophoresis. The two different outcomes are readily identifiable in 
Figure 4.16 for ∆spy0125-NTR. The larger products running at 2.948 kb are where the 
wild-type allele had been restored while the smaller products running at 2.249 kb are 
where the spy0125-NTR had been deleted. Similar results were obtained while screening 
for potential ∆spy0125-ID mutants. The PCR products of interest were purified and 
confirmed by DNA sequencing. The final DNA sequence remaining in the chromosome 
after allele replacement for ∆spy0125-NTR is shown in Figure 4.17 and for ∆spy0125-
ID in Figure 4.18. 
 
1.5 kb 
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TTGGTAAAAAGTCGAAACCTTTTGAAATAGCTTTAAAGCAATATTTTCTCAAAAAATCATTTTCAAAAAC
ACTAATTTGGTGAAAAACTTAGTACGAATATATTTCTTTGACTTCAATAGAATGATATGATGTCACATTG
AGAGGAGAGAAAATGAAAAAAACAAGGTTTCCAAATAAGCTTAATACTCTTAATACTCAAAGGGTATTAA
GTAAAAACTCAAAACGATTTACTGTCACTTTAGTGGGAGTCTTTTTAATGATCTTCGCTTTGGTAACTTC
CATGGTTGGTGCTAAGACTGTTTTTGGTGTCGACAATCAACCTCAAACGACTTCAGTACTTATTAGAAAG
TATGCTATAGGTGATTACTCTAAATTGCTTGAAGGTGCAACATTACAGTTGACAGGGGATAACGTGAATA
GTTTTCAAGCGAGAGTGTTTAGCAGTAATGATATTGGAGAAAGAATTGAACTATCAGATGGAACTTATAC
TTTAACTGAATTGAATTCTCCAGCTGGTTATAGTATCGCAGAGCCAATCACTTTTAAGGTTGAAGCTGGC
AAAGTGTATACTATTATTGATGGAAAACAGATTGAAAATCCCAATAAAGAGATAGTAGAGCCTTACTCAG
TAGAAGCATATAATGATTTTGAAGAATTTAGCGTTTTAACTACACAAAACTATGCAAAATTTTATTATGC
AAAAAATAAAAATGGAAGTTCACAGGTTGTCTATTGCTTTAATGCAGATCTAAAATCTCCACCAGACTCT
GAAGATGGTGGGAAAACAATGACTCCAGACTTTACAACAGGAGAAGTAAAATACACTCATATTGCAGGTC
GTGACCTCTTTAAATATACTGTGAAACCAAGAGATACCGATCCTGACACTTTCTTAAAACATATCAAAAA
AGTAATTGAGAAGGGTTACAGGGAAAAAGGACAAGCTATTGAGTATAGTGGTCTAACTGAGACACAATTG
CGTGCGGCTACTCAGTTAGCAATATATTATTTCACTGATAGTGCTGAATTAGATAAGGATAAACTAAAAG
ACTATCATGGTTTTGGAGACATGAATGATAGTACTTTAGCAGTTGCTAAAATCCTTGTAGAATACGCTCA
AGATAGTAATCCTCCACAGCTAACTGACCTTGATTTCTTTATTCCGAATAACAATAAATATCAATCCCTT
ATTGGAACTCAGTGGCATCCAGAAGATTTAGTTGATATTATTCGTATGGAAGATAAAAAAGAAGTTATAC
CTGTAACTCATAATTTAACATTGAGAAAAACGGTGACTGGTTTAGCTGGTGACAGAACTAAAGATTTCCA
TTTTGAAATTGAATTAAAAAATAATAAGCAAGAATTGCTTTCTCAAACTGTTAAAACAGATAAAACAAAC
CTCGAATTTAAAGATGGTAAAGCAACCATTAATTTAAAACATGGGGAAAGTTTAACACTTCAAGGTTTAC
CAGAAGGTTATTCTTACCTTGTCAAAGAAACAGATTCTGAAGGCTATAAGGTTAAAGTTAATAGCCAAGA
AGTAGCAAATGCTACAGTTTCAAAAACAGGAATAACAAGTGATGAGACACTTGCTTTTGAAAATAATAAA
GAGCCTGTTGTTCCTACAGGAGTTGATCAAAAGATCAATGGCTATCTAGCTTTGATAGTTATCGCTGGTA
TCAGTTTGGGGATCTGGGGAATTCACACGATAAGGATAAGAAAACATGACTAG 
 
 
Figure 4.17: Nucleotide sequence of Δspy0125-NTR mutant strain of M1  
                    GAS strain SF370. 
 
The nucleotide sequence of the chromosome is shown after the NTR of spy0125 has 
been deleted. The exact same labelling is used as in Figure 4.14; chromosomal 
sequences are shown in black including start and stop codons highlighted in bold, 
primer sequences used to create the mutant are shown in red with the predicted final 
alanine of the signal peptide is highlighted and in bold type (GCT). Located in between 
the two internal primers highlighted in blue and underlined is the SalI site.  
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ATGAAAAAAACAAGGTTTCCAAATAAGCTTAATACTCTTAATACTCAAAGGGTATTAAGTAAAAACTCAA
AACGATTTACTGTCACTTTAGTGGGAGTCTTTTTAATGATCTTCGCTTTGGTAACTTCCATGGTTGGTGC
TAAGACTGTTTTTGGTTTAGTAGAATCCTCGACGCCAAACGCAATAAATCCAGATTCAAGTTCGGAATAC
AGATGGTATGGATATGAATCTTATGTAAGAGGGCATCCATATTATAAACAGTTTAGAGTAGCACACGATT
TAAGGGTTAACTTAGAAGGAAGTAGAAGTTATCAAGTTTATTGCTTTAATTTAAAGAAAGCATTTCCTCT
CGGATCAGATAGTAGTGTTAAAAAGTGGTATAAAAAACATGATGGAATCTCTACAAAATTTGAAGATTAT
GCGATGAGCCCTAGAATTACGGGAGATGAGCTAAATCAGAAGTTACGAGCTGTTATGTATAATGGACATC
CACAAAATGCCAATGGTATTATGGAAGGCTTGGAACCCTTGAATGCTATCAGAGTTACACAAGAGGCGGT
ATGGTACTATTCTGATAATGCTCCTATTTCTAATCCAGATGAAAGTTTTAAAAGGGAGTCAGAAAGTAAC
TTGGTTAGTACTTCTCAATTATCTTTGATGCGTCAAGCTTTGAAGCAACTGATTGATCCGAATTTGGCAA
CTAAAATGCCAAAACAAGTTCCGGATGATTTTCAGCTAAGTATTTTTGAGTCTGAGGACAAGGGAGATAA
ATATAATAAAGGATACCAAAATCTTTTGAGTGGTGGTTTAGTTCCTACTAAACCACCAACTCCAGGAGAC
CCACCAATGCCTCCAGTCGACCAGCTAACTGACCTTGATTTCTTTATTCCGAATAACAATAAATATCAAT
CCCTTATTGGAACTCAGTGGCATCCAGAAGATTTAGTTGATATTATTCGTATGGAAGATAAAAAAGAAGT
TATACCTGTAACTCATAATTTAACATTGAGAAAAACGGTGACTGGTTTAGCTGGTGACAGAACTAAAGAT
TTCCATTTTGAAATTGAATTAAAAAATAATAAGCAAGAATTGCTTTCTCAAACTGTTAAAACAGATAAAA
CAAACCTCGAATTTAAAGATGGTAAAGCAACCATTAATTTAAAACATGGGGAAAGTTTAACACTTCAAGG
TTTACCAGAAGGTTATTCTTACCTTGTCAAAGAAACAGATTCTGAAGGCTATAAGGTTAAAGTTAATAGC
CAAGAAGTAGCAAATGCTACAGTTTCAAAAACAGGAATAACAAGTGATGAGACACTTGCTTTTGAAAATA
ATAAAGAGCCTGTTGTTCCTACAGGAGTTGATCAAAAGATCAATGGCTATCTAGCTTTGATAGTTATCGC
TGGTATCAGTTTGGGGATCTGGGGAATTCACACGATAAGGATAAGAAAACATGACTAG 
 
 
Figure 4.18 Nucleotide sequence of Δspy0125-ID mutant strain of M1  
                    GAS strain SF370. 
 
The nucleotide sequence of the chromosome is shown after an internal portion of 
spy0125 has been deleted. The exact same labelling is used as in Figure 4.15; 
chromosomal sequences are shown in black including start and stop codons highlighted 
in bold. Primer sequences used to create the mutant are shown in red and in between the 
two internal primers highlighted in blue and underlined is the SalI site.  
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Figure 4.19: Adhesion of wild-type M1 GAS strain SF370 and spy0125 mutants      
                     to HaCaT cells. 
 
Samples were examined using laser scanning confocal microscopy and PMT values for 
each excitation channel were recorded. HaCaT cells are labelled red and bacteria are 
stained green. Panel A: wild-type M1 GAS strain SF370. Panel B: Δspy0125. Panel C: 
Δspy0125-NTR. Panel D: ∆spy0125-ID.  
 
4.7 Analysis of Δspy0125-NTR and ∆spy0125-ID mutants 
 
The two M1 GAS strain SF370 spy0125 mutants were constructed to localise the region 
of Spy0125 responsible for binding to host cells. For adhesion assays the ∆spy0125-
NTR and ∆spy0125-ID mutants were cultured in parallel with two control strains; wild-
type M1 GAS strain SF370 and the Δspy0125 mutant which had been constructed 
previously in the laboratory (Abbot et al., 2007). The four strains were grown to mid-
log phase and added to confluent HaCaT cells on glass coverslips essentially as 
described in chapter 2, section 2.12.2. Prior to staining, cells were blocked in rabbit 
serum before the actin cytoskeleton of the HaCaTs was labelled with phalloidin-TRITC 
(which fluoresces red) and the bacteria were stained using a polyclonal antibody to GAS 
with a FITC conjugate (which fluoresces green). The adhesion assays were repeated on 
three separate occasions with essentially the same results. It can quite clearly be seen in 
panel C, Figure 4.19, that the Δspy0125-NTR mutant still binds to HaCaT cells showing 
that the NTR of Spy0125 is not critical for binding. The ∆spy0125-ID strain (panel D, 
Figure 4.19) exhibited a similar phenotype to that shown for the ∆spy0125 mutant 
(panel B, Figure 4.19), with no binding observed. The binding of the four strains was 
also analysed by assessing the percentage adherence of each strain compared to wild-
type binding, which was considered to be 100%. Leica Qwin software was used to 
count the fluorescence on each image and the percentage adherence was averaged for 
the three repeat experiments. Figure 4.20 clearly shows that the Δspy0125-NTR mutant 
clearly still binds to HaCaT cells at wild-type levels while the ∆spy0125-ID mutant  
A B C D 
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Figure 4.20: Binding of wild-type M1 and spy0125 mutant strains to HaCaT cells. 
 
Relative adhesion is shown with wild-type binding considered 100% and error bars 
indicating variation from three independent experiments. Adhesion of strains containing 
the spy0125-NTR deletion was at the same level as the wild-type, even slightly 
exceeding it. The adhesion of the Δspy0125-ID strain however was essentially the same 
as the Δspy0125 mutant exhibiting no binding.  
 
 
exhibits no binding, similar to the ∆spy0125 mutant. These results taken together 
suggest that the region of Spy0125 responsible for adhesion to host surfaces resides in 
the CTR of the molecule. 
 
4.8 Localisation of Spy0125 at the pilus tip 
 
As discussed in chapter 1 section 1.15, Kang et al. (Kang et al., 2007) confirmed that 
polymerisation of the major subunit, Spy0128, into pili in M1 GAS strain SF370 
involves cleavage of its EVPTG motif between Thr311 and Gly312. This is followed by 
covalent linkage of the carboxyl group of Thr311 to the ε-amino group of Lys161 in the 
next Spy0128 monomer to be incorporated. This process is then repeated many times to 
produce the pilus. It was noted that unlike Spy0130 (which has a canonical LPXTG 
motif), Spy0125 has a similar CWSS (VVPTGV) to Spy0128 (EVPTGV). In addition, 
there is also a modest degree of homology between the C-terminal regions of Spy0125 
and Spy0128 (37% identity). This suggested that Spy0125 could be recognised by SrtC 
and incorporated into the pilus via attachment to Lys161 of Spy0128. To test this 
prediction site directed mutagenesis and allele replacement mutagenesis were combined 
to create a Lys161Ala point mutation in spy0128 in the M1 GAS strain SF370 
chromosome (as described in chapter 3, section 3.5). Unlike section 4.6 where allele 
replacement mutagenesis was used to delete sections of spy0125, it was used here to  
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Figure 4.21 Schematic diagram showing construction of the spy0128 K161A   
                    mutant in the M1 GAS strain SF370 chromosome. 
 
Panel A: Previously, a Δspy0128 strain had been constructed in the laboratory. Panel B: 
The pJP04 construct containing the spy0128 K161A mutant allele was transformed into 
the Δspy0128 strain and using allele replacement the spy0128 gene containing the 
K161A mutation was replaced in the chromosome.   
 
 
introduce the wild-type spy0128 allele (control) and spy0128 K161A mutant allele back 
into the chromosome of an Δspy0128 strain of GAS which had been created previously 
in the laboratory. This process is outlined in the schematic diagram in Figure 4.21. The 
wild-type spy0128 DNA sequence after allele replacement is shown in Figure 4.22 with 
the position of the Lys161 codon highlighted in yellow prior to mutagenesis to Ala 
(GCG). 
 
To examine whether the spy0128 K161A mutation had any effect on its attachment to 
Spy0125, cell wall fractions from the wild-type parent and spy0128 K161A mutant 
were run on two 4-15% gradient SDS-PAGE gels. One was immuno-blotted with anti-
rSpy0128 sera and the second with anti-rSpy0125 antibody. As subunits in Gram 
positive pili are covalently linked, when blotted with the anti-rSpy0128 antibody the 
wild-type M1 GAS strain SF370 pili can be observed as characteristic ‘ladders’ in the 
cell wall fraction, as seen in panel A, Figure 4.23 (lane 2), while no protein is detected  
spy0128 K161A 
 
pJP04 
∆spy0128 
A 
B 
spy0128 K161A 
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CGATATGGCTCCTAGTGTAAAAGCAGGAGATGCTATTTTATTTTATCGCTTATCTCAGACTTATAAAGTA
GAAGAAGCAGTTGTTTATGAGGACTCTAAAACATCTATAACGAAAGTCGGTCGGATTATTGCTCAAGCAG
GTGATGAAGTGGACCTGACAGAACAAGGTGAATTAAAAATTAATGGCCATATTCAAAATGAAGGACTAAC
TTTTATAAAATCAAGAGAAGCTAATTATCCGTATCGAATTGCTGATAATAGTTATTTGATACTCAATGAT
TACTATAGCCAAGAGAGTGAGAATTACCTACAAGATGCAATTGCTAAAGATGCTATAAAAGGCACGATTA
ATACACTTATTCGATTAAGAAACCATTAAGCTAAAGGCTTATTTAAAAAAGGAGAGAAACAATGAAATTA
CGTCACTTACTATTAACGGGAGCAGCCCTAACTAGTTTTGCTGCTACAACAGTTCACGGGGAGACTGTTG
TAAACGGAGCCAAACTAACAGTTACAAAAAACCTTGATTTAGTTAATAGCAATGCATTAATTCCAAATAC
AGATTTTACATTTAAAATCGAACCTGATACTACTGTCAACGAAGACGGAAATAAGTTTAAAGGTGTAGCT
TTGAACACACCGATGACTAAAGTCACTTACACCAATTCAGATAAAGGTGGATCAAATACGAAAACTGCAG
AATTTGATTTTTCAGAAGTTACTTTTGAAAAACCAGGTGTTTATTATTACAAAGTAACTGAGGAGAAGAT
AGATAAAGTTCCTGGTGTTTCTTATGATACAACATCTTACACTGTTCAAGTTCATGTCTTGTGGAATGAA
GAGCAACAAAAACCAGTAGCTACTTATATTGTTGGTTATAAAGAAGGTAGTAAGGTGCCAATTCAGTTCA
AAAATAGCTTAGATTCTACTACATTAACGGTGAAGAAAAAAGTTTCAGGTACCGGTGGAGATCGCTCTAA
AGATTTTAATTTTGGTCTGACTTTAAAAGCAAATCAGTATTATAAGGCGTCAGAAAAAGTCATGATTGAG
AAGACAACTAAAGGTGGTCAAGCTCCTGTTCAAACAGAGGCTAGTATAGATCAACTCTATCATTTTACCT
TGAAAGATGGTGAATCAATCAAAGTCACAAATCTTCCAGTAGGTGTGGATTATGTTGTCACTGAAGACGA
TTACAAATCAGAAAAATATACAACCAACGTGGAAGTTAGTCCTCAAGATGGAGCTGTAAAAAATATCGCA
GGTAATTCAACTGAACAAGAGACATCTACTGATAAAGATATGACCATTACTTTTACAAATAAAAAAGACT
TTGAAGTGCCAACAGGAGTAGCAATGACTGTGGCACCATATATTGCTTTAGGAATTGTAGCAGTTGGTGG
AGCTCTTTACTTTGTTAAAAAGAAAAATGCTTAAATTATTATTATGATAGTAAGACTGATTAAGCTCCTT
GACAAGTTGATAAACGTCATTGTTCTTTGTTTCTTCTTTCTTTGTTTATTGATTGCGGCACTTGGAATCT
ACGATGCTTTAACAGTTTATCAAGGAGCTAATGCTACTAACTATCAACAATATAAGAAAAAGGGTGTTCA
GTTTGACGATTTATTAGCTATTAATTCTGATGTTATGGCATGGCTGACTGTTAAAGGAACGCATATTGAT
TATCCAATTGTACAGGGAGAGAATAATTTAGAATATATCAACAAATCAGTAGAAGGAGAGTACTCCTTAT
CAGGAAGTGTTTTTCTAGATTATCGTAATAAAGTAACTTTTGAAGATAAATACTCATTAATCTATGCACA
TC  
 
 
Figure 4.22: DNA sequence for wild-type spy0128 used to construct the 
                    recombinant plasmid pJP01.  
 
Coding sequences for spy0128 are shown in blue with start and stop codons highlighted 
in bold. Highlighted in yellow is the Lys161 codon targeted for site directed 
mutagenesis to alanine. Adjacent regions of flanking DNA used to replace spy0128 
back into the chromosome are shown in black. Primer sequences used to amplify 
spy0128 and clone into pG+host9 are shown in red. 
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Figure 4.23: Immuno-blots of wild-type M1 and spy0128 mutant cell wall  
                      fractions with anti-rSpy0128 and anti-rSpy0125 sera. 
 
Lys161 of Spy0128 is needed for Spy0125 incorporation at the pilus tip. Panel A: Cell 
wall fractions immuno-blotted with anti-Spy0128 sera. Lane 1: molecular size 
standards. Lane 2: wild-type M1 GAS strain SF370. Lane 3: Δspy0128. Lane 4: 
spy0128 K161A. Panel B: Cell wall fractions immuno-blotted with anti-Spy0125 sera. 
Lane 5: wild-type M1 GAS strain SF370. Lane 6: Δspy0128. Lane 7: spy0128 K161A. 
Lane 8: Δspy0125. Red arrows indicate unincorporated Spy0128 (panel A) and Spy0125 
(panel B) monomers. 
 
 
in the ∆spy0128 mutant (lane 3). The spy0128 K161A mutant in lane 4 is only seen to 
produce a single band indicating a build up of Spy0128 K161A monomer that is unable 
to polymerise into pili. When the cell wall fractions from the same three strains are 
blotted with an anti-rSpy0125 antibody, as seen in panel B of Figure 4.23, a distinctive 
‘ladder’ pattern is observed in the wild-type M1 GAS strain SF370 indicative of 
polymerised pili with Spy0125 incorporated (lane 5). In cell wall samples for the 
Δspy0128 (lane 6) and spy0128 K161A (lane 7) mutants an intense band is detected at 
~94 kDa representing monomeric Spy0125 (as outlined above, this protein runs slowly 
on SDS-PAGE) along with smaller faint bands that correspond to Spy0125 breakdown 
products and a single larger band. As the larger band at ~125 kDa is also present in the 
Δspy0128 sample it therefore cannot correspond to a heterodimer of Spy0128-Spy0125. 
This band is also not observed in the blot with anti-rSpy0128. These data would suggest 
that the incorporation of Spy0125 into pili would be via a transpeptidation reaction 
linking the ε-amino group of Lys161 of Spy0128 to Thr723 of the Spy0125 VVPTG 
motif, positioning it solely at the pilus tip. 
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4.9 Discussion 
 
The results presented in this chapter describe the Spy0125 protein, provide evidence 
that it is located at the tip of the pilus and that this protein is the adhesin, responsible for 
attachment of the bacteria to host cell surfaces. 
 
Recombinant (r)Spy0125 was observed to breakdown into two stable fragments which 
were identified as being the N-terminal third of the protein and the remaining two thirds 
making up the C-terminal region. As mentioned at the end of section 4.4, a proline rich 
region separates the two isolated fragments and is situated directly upstream of the Asn 
– Gln – Pro – Gln – Thr – Thr sequence identified as the first six residues of the C-
terminal fragment. This region contains the following residues (shown in parenthesis); 
                     
- Lys274 – [Pro – Pro – Thr – Pro – Gly – Asp – Pro – Pro – Met – Pro – Pro] – Asn286 – 
 
Proline rich regions are known for being acid labile, especially Asp-Pro bonds 
(highlighted above in red) where the Asp side chain can cleave the peptide backbone (Li 
et al., 2009; Piszkiewicz et al., 1970). The C-terminal fragment, from Asn286 
(determined as the N-terminal residue for this fragment) to Val725 (the final residue of 
rSpy0125) has a mass of 49354.1 Da while the intact mass obtained by FT-ICR MS was 
49769.14 Da. This discrepancy could be accounted for by a variety of reasons. A 
number of the additional residues from the sequences shown above may have been 
present on the N-terminus of the larger breakdown fragment when its mass was 
analysed by FT-ICR MS but under the acidic conditions of the Edman chemistry during 
N-terminal sequencing these residues may have cleaved off, revealing Asn286 to be the 
first residue at the N-terminus. The sample of rSpy0125 containing breakdown products 
used for FT-ICR MS analysis may have harboured several molecules with different N-
termini, also containing additional residues from the sequence shown above from the 
highly labile Pro rich region. This could lead to a determined mass being an average of 
several unresolved species with slightly varying ends, possibly formed as discussed 
above, or a post-translational modification, although the mass difference observed 
suggests that this was not the case. Also, the difference in mass observed here cannot be 
determined precisely by addition or subtraction of residues from the N or C terminus of 
this region. The reason for this discrepancy is not clear and was not explored further 
131 
 
however, as this project aimed to focus on protein function and the data was sufficient 
to show the larger breakdown fragment was composed of the C-terminal two thirds of 
Spy0125.  
 
It has been shown here that deletion of the DNA encoding the N-terminal region of 
Spy0125 in the chromosome by allele replacement, does not abrogate binding of the 
bacteria to HaCaT cells. This would suggest the binding site is contained within the C-
terminal 2/3 of Spy0125. This is supported by data from the Δspy0125-ID mutant where 
an internal portion of Spy0125 has been deleted and this strain fails to adhere to HaCaT 
cells. This result matches the binding phenotype of the Δspy0125 mutant which also 
fails to adhere to cultured HaCaT cells or tonsil explants (Abbot et al., 2007). However, 
blots of cell wall fractions for the Δspy0125-ID mutant confirmed this variant was still 
incorporated into polymerised pili indicating that the region responsible for host 
receptor attachment could be situated within the residues deleted from Spy0125 in this 
mutant (Smith et al., 2010). In contrast, the residues removed in the Δspy0125-NTR 
mutant had no effect on the bacteria’s ability to bind HaCaT cells, suggesting that this 
region is not needed for adhesion. Work done by colleagues in the laboratory, with 
antibodies specific to the NTR and CTR of Spy0125, supported this finding. When 
wild-type M1 GAS strain SF370 were pre-incubated with these sera prior to their 
addition to HaCaT cells, only anti-CTR sera blocked binding (Smith et al., 2010). 
Sequence analysis of Spy0125 homologues reveals that the M5 and M18 strain 
equivalents do not contain an NTR as discussed in this chapter for Spy0125 (see Figures 
4.24 and 4.25). After the predicted signal peptide, these sequences align almost 
identically to the beginning of the Spy0125-CTR that is described here. This opens up a 
number of interesting possibilities. Perhaps the NTR contributed nothing to the binding 
of these proteins to host surfaces and was, therefore, lost during evolution or that pilus 
mediated adhesion is not the critical method of binding in these strains. It is also 
possible that the NTR of Spy0125 does play a role of some form in adhesion to targets 
not present on HaCaT cells and not examined here. The loss of this region for these 
strains would suggest they would need to utilise different methods of binding for host 
attachment. Work has been approached by others in the laboratory to determine the role 
played by pili in M5 GAS strain Manfredo but pili in this strain are quite sparse and 
anti-sera raised to individual subunits was quite poor. This lead to high background  
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M1    1 MKKTRFPNKLNTLNTQRVLSKNSKRFTVTLVGVFLMIFALVT--
SMVGAKTVFGLVESSTPNAINPDSSSEYRWYGYESYVRGHPYYKQFRVAHDLRVNLEGSRSYQVYCFNLKKAFPLG 118 
M28   1 ---MNNKKLQKKQDAPRVSNRKPKQLTVTLVGVFLMLLVLIG-
FEGKVRAAHELVEVPVPIFHNPDPQSDYQWYGYEAYTGGYPKYDLFKTYYHDLRVNLHGSKSYQVYCFNVHKHYPRS 116 
M12   1 ---
MNNKKLQKKQDAPRVSNRKPKQLTVTLVGVFLMFLTLVSSMRGAQSIFGEEKRIEEVSVPKIKSPDDAYPWYGYDSYDSSHPYYERFK
VAHDLRVNLNGSKSYQVYCFNINSHYPNR 117 
M49   1 -------MQKRDKTNYRSANNKRRQTTIGLLKVFLTFVALIG----
IVGFSIRAFGAEEQSVPNRQSSIQDYPWYGYDSYPKGYPDYSPLKTYHNLKVNLEGSKDYQAYCFNLTKHFPSK 109 
M3    1 -------MQKRDKTNYGSANNKRRQTTIGLLKVFLTFVALIG----
IVGFSIRAFGAEEQSVPNKQSSVQDYPWYGYDSYSKGYPDYSPLKTYHNLKVNLDGSKEYQAYCFNLTKHFPSK 109 
M5    1 -------MQKRDKTNYGSANNKRRQTTIGLLKVFLTFVALIG-IVGFS--------------------------------
----------------------------------------  40 
M18   1 -------MQKRDKTNYGSANNKRRQTTIGLLKVFLTFVALIG----IVGFSIRAFGAEEQ--------------------
----------------------------------------  49 
          
  
M1  119 
SDSSVKKWYKKHDGISTKFEDYAMSPRITGDELNQKLRAVMYNGHPQNANGIMEGLEPLNAIRVTQEAVWYYSDNAPISNPDESFKRE
SESNLVSTSQLSLMRQALKQLIDPNLATKMPK 238 
M28 117 SQSFDRKWYKKLDGTAENFDSLAMEPRVRKEELTKKLRAVMYNAYPNDANGIMKDLEPLNAIKVTQEAVWYYSDSAQIN-
PDESFKTEAQSNGINDQQLGLMRKALKELIDPNLGSKYSN 235 
M12 118 KNAFSKQWFKRVDGTGDVFTNYAQTPKIRGESLNNKLLSIMYNAYPKNANGYMDKIEPLNAILVTQQAVWYYSDSSYGN-
IKTLWASELKDGKIDFEQVKLMREAYSKLISDDLEETSKN 236 
M49 110 SDSVRSQWYKKLEGTNENFIKLADKPRIEDGQLQQNILRILYNGYPNNRNGIMKGIDPLNAILVTQNAIWYYTDSAQIN-
PDESFKTEARSNGINDQQLGLMRKALKELIDPNLGSKYSN 228 
M3  110 
SDSVRSQWYKKLEGTNENFIKLADKPRIEDGQLQQNILRILYNGYPNDRNGIMKGIDPLNAILVTQNAIWYYTDSSYISDTSKAFQQE
ETDLKLDSQQLQLMRNALKRLINPKEVESLPN 229 
M5   40 --------------------------------------------------------------------------------
----------------------------------------  40 
M18  49 --------------------------------------------------------------------------------
----------------------------------------  49 
                                                                            
M1  239 QVPDDFQLSIFESEDKGDKYNKGYQNLLSGGLVPTKPPTPGDPPMPPNQPQTT 291 
M28 236 KTPSGYRLNVFESHDKT------FQNLLSAEYVPDTPPKPGE--EPPAKTEKT 280 
M12 237 KLPQGSKLNIFVPQDKS------VQNLLSAEYVPESPPAPGQSPEPPVQTKKT 283 
M49 229 KTPSGYRLNVFESHDKT------FQNLLSAEYVPDTPPKPGE--EPPAKTEKT 273 
M3  230 QVPANYQLSIFQSSDKT------FQNLLSAEYVPDTPPKPGE--EPPAKTEKT 274 
M5   41 -----------------------------------IRAFGAE--EKSTETKKT  56 
M18  50 ----------------------------------------------STETKKT  56 
                                                                          
 
 
Figure 4.24: ClustalW sequence alignment of Spy0125 homologues. 
 
Sequence shown includes residues up to the beginning of the Spy0125-CTR as 
identified in section 4.4 (NQPQTT) highlighted in yellow. Alignment performed using 
ClustalW (Larkin et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
M1  259 
NKGYQNLLSGGLVPTKPPTPGDPPMPPNQPQTTSVLIRKYAIGDYSKLLEGATLQLTGDNVNSFQARVFSSNDIGERIELSDGTYTLT
ELNSPAGYSIAEPITFKVEAGKVYTIID-GKQ 377 
M28 253 ---FQNLLSAEYVPDTPPKPGE--
EPPAKTEKTSVIIRKYAEGDYSKLLEGATLRLTGEDIPDFQEKVFQSNGTGEKIELSNGTYTLTETSSPDGYKIAEPIKFRVVNKKVF
IVQKDGSQ 367  
M12 254 ---
VQNLLSAEYVPESPPAPGQSPEPPVQTKKTSVIIRKYAEGDYSKLLEGATLRLTGEDILDFQEKVFQSNGTGEKIELSNGTYTLTETS
SPDGYKIAEPIKFRVVNKKVFIVQKDGSQ 370 
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M49 246 ---FQNLLSAEYVPDTPPKPGE--
EPPAKTEKTSVIIRKYAEGDYSKLLEGATLKLSQIEGSGFQEKDFQSNSLGETVELPNGTYTLTETSSPDGYKIAEPIKFRVENKKVF
IVQKDGSQ 360 
M3  247 ---FQNLLSAEYVPDTPPKPGE--
EPPAKTEKTSVIIRKYAEGDYSKLLEGATLKLAQIEGSGFQEKIFDSNKSGEKVELPNGTYVLSELKPPQGYGVATPITFKVAAEKVL
IKNKEGQF 361 
M5   41 ---------------IRAFGAE--
EKSTETKKTSVIIRKYAEGDYSKLLEGATLRLTGEDIPDFQEKVFQSNGTGEKIELSNGTYTLTETSSPDGYKITEPIKFRVVNKKVF
IVQKDGSQ 143 
M18  50 --------------------------
STETKKTSVIIRKYAEGDYSKLLEGATLKLAQIEGSGFQEQSFESSTSGQKLQLSDGTYILTETKSPQGYEIAEPITFKVTAGKVFIK
GKDGQF 143 
                                  . :.:.***:***** ************:*:  :  .** : *.*.  *: 
::*.:*** *:* ..* ** :: **.*:*   **    . *. 
 
 
M1  378 IENPNKEIVEPYSVEAYNDFEEFSVLTT---QNYAKFYYAKNKNGSSQVVYCFNADLKSPPDSEDGGKTMTPDFTTG-
EVKYTHIAGRDLFKYTVKPRDTDPDTFLKHIKKVIEKGYREK 493  
M28 368 VENPNKEVGSPYTIEAYNDFDEFGLLS---TQNYAKFYYGKNYDGSSQIVYCFNANLKSPPDSEDHGATINPDFTTG-
DIRYSHIAGSDLIKYANTARDEDPQLFLKHVKKVIENGYHKK 483 
M12 371 
VENPNKEVAEPYSVEAYSDMQDSNYINPETFTPYGKFYYAKNKDKSSQVVYCFNADLHSPPESEDGGGTIDPDISTMKEVKYTHTAGS
DLFKYALRPRDTNPEDFLKHIKKVIEKGYNKK 490 
M49 361 VENPNKEVAEPYSVEAYNDFMDEEVLSG--
FTPYGKFYYAKNKDKSSQVVYCFNADLHSPPDSYDSGETINPDTSTMKEVKYTHTAGSDLFKYALRPRDTNPEDFLKHIKKVIEKGYK
KK 478 
M3  362 VENQNKEIAEPYSVTAFNDFEEIGYLS--
DFNNYGKFYYAKNTNGTNQVVYCFNADLHSPPDSYDHGANIDPDVSESKEIKYTHVSGYDLYKYAATPRDKDADFFLKHIKKILDKGY
KKK 479 
M5  144 VENPNKELGSPYTIEAYNDFDEFGLLS---TQNYAKFYYGKNYDGSSQIVYCFNANLKSPPDSEDHGATINPDFTTG-
DIRYSHIAGSDLIKYANTARDEDPQLFLKHVKKVIENGYHKK 259 
M18 144 
VENQNKEVAEPYSVTAYNDFDDSGFINPKTFTPYGKFYYAKNANGTSQVVYCFNVDLHSPPDSLDKGETIDPDFNEGKEIKYTHILGA
DLFSYANNPRASTNDELLSQVKKVLEKGYRDD 263 
        :** ***: .**:: *:.*: :   :.      *.****.** : :.*:*****.:*:***:* * * .: ** .   
:::*:*  * ** .*:  .*    : :*.::**::::**... 
 
 
M1  494 GQAIEYSGLTETQLRAATQLAIYYFTDSAELDKDK----LKDYHGFGDMNDSTLAVAKILVEYAQDSN-
PPQLTDLDFFIPNNNKYQSLIGTQWHPEDLVDIIRMEDKK-EVIPVTHNLT 607 
M28 484 GQAIPYNGLTEAQFRAATQLAIYYFTDSVDLTKDR----LKDFHGFGDMNDQTLGVAKKIVEYALSDE-
DSKLTNLDFFVPNNSKYQSLIGTEYHPDDLVDVIRMEDKKQEVIPVIHSLT 598 
M12 491 G--DSYNGLTETQFRAATQLAIYYFTDSTDLKTLKTYNNGKGYHGFESMDEKTLAVTKELINYAQDNS-
APQLTNLDFFVPNNSKYQSLIGTEYHPDDLVDVIRMEDKKQEVIPVTHSLT 607 
M49 479 G--DSYNGLTETQFRAATQLAIYYFTDSADLKTLKTYNNGKGYHGFESMDEKTLAVTKELITYAQNGS-
APQLTNLDFFVPNNSKYQSLIGTEYHPDDLVDVIRMEDKKQEVIPVTHSLT 595 
M3  480 G--DTYKTLTEAQFRAATQLAIYYYTDSADLTTLKTYNDNKGYHGFDKLDDATLAVVHELITYAEDVT-
LPMTQNLDFFVPNSSRYQALIGTQYHPNELIDVISMEDKQAPIIPITHKLT 596 
M5  260 GQAIPYNGLTEAQFRAATQLAIYYFTDSVDLTKDR----LKDFHGFGDMNDQTLGVAKKIVEYALSDE-
DSKLTNLDFFVPNNSKYQSLIGTEYHPDDLVDVIRMEDKKQEVIPVTHSLT 374 
M18 264 S--TTYANLTSVEFRAATQLAIYYFTDSVDLDNLADY------
HGFGALTTEALNATKEIVAYAEDRANLPNISNLDFYVPNSNKYQSLIGTQYHPESLVDIIRMEDKQAPIIPITHKLT 375 
        .    *  **..::**********:***.:* .          ***  :   :* ..: :: ** .    .   
:***::**..:**:****::**:.*:*:* ****:  :**: *.** 
 
 
M1  608 
LRKTVTGLAGDRTKDFHFEIELKNNKQELLSQTVKTDKTNLEFKDGKATINLKHGESLTLQGLPEGYSYLVKETDSEGYKVKVNSQEV
ANATVSKTGITSDETLAFENNKEPVVPTG    724 
M28 599 
VKKTVVGELGDKTKGFQFELELKDKTGQPIVDALKTNNQDLVAKDGKYSFNLKHGDTIRIEGLPTGYSYTLKETEAKDYIVTVDNKVS
QEAQSASENVTADKEVTFENRKDLVPPTG    715 
M12 608 
VKKTVVGELGDKTKGFQFELELKDKTGQPIVNTLKTNNQDLVAKDGKYSFNLKHGDTIRIEGLPTGYSYTLKETEAKDYIVTVDNKVS
QEAQSASENVTADKEVTFENRKDLVPPTG    724 
M49 596 
VKKTVVGELGDKTKGFQFELELKDKTGQPIVNTLKTNNQDLVAKDGKYSFNLKHGDTIRIEGLPTGYSYTLKETEAKDYIVTVDNKVS
QEAQSVGKDITEDQKVTFENRKDLVPPTG    712 
M3  597 
ISKTVTGTIADKKKEFNFEIHLKSSDGQAISGTYPTNSGELTVTDGKATFTLKDGESLIVEGLPSGYSYEITETGASDYEVSVNGKNA
PDGKATKASVKEDETVAFENRKDLVPPTG    713 
M5  375 
VQKTVVGELGDKTKGFQFELELKDKTGQPIVNTLKTNNQDLVAKDGKYSFNLKHGDTIRIEGLPTGYSYTLKETEAKDYIVTVDNKVS
QEAQSASENVTADKEVTFENRKDLVPPTG    491 
M18 376 
ISKTVTGTIADKKKEFNFEIHLKSSDGQAISGTYPTNSGELTVTDGKATFTLKDGESLIVEGLPSGYSYEITETGASDYEVSVNGKNA
PDGKATKASVKEDETITFENRKDLVPPTG    492 
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binding on immuno-blots with these sera making results difficult to interpret. A 
potentially interesting experiment to test whether the M5 Spy0125 homologue 
(Spy0104) does indeed bind to host cells such as tonsil explants or HaCaT cells (it could 
be predicted it would mediate adhesion to these targets) would be to replace the spy0125 
gene in the M1 chromosome with the spy0104 gene from M5 GAS strain Manfredo. 
 
The second crucial result discussed in this chapter is that Spy0125 is shown to be 
positioned at the tip of the pilus. The major subunit, Spy0128, is polymerised into 
extended pili by the action of SrtC encoded by spy0129. This enzyme is responsible for 
forming the covalent bond between Thr311 of the CWSS and the free ε-amino group on 
the side chain of Lys161 of the next Spy0128 monomer to be incorporated into the 
pilus. The C-terminal regions of Spy0125 and Spy0128 show a reasonable level of 
sequence homology (37% identity between the two regions), suggestive of a similar 
domain structure. For this reason, when constructing the Δspy0125-NTR and Δspy0125-
ID mutants, care was taken to include this region and the signal peptide with a few 
additional residues to ensure each subunit was incorporated into pili. This region may 
facilitate recognition of both proteins by SrtC and therefore attachment of Spy0125 to 
Spy0128 by this sortase. The western blots shown in this chapter of cell wall 
preparations from the wild-type M1 GAS strain SF370 and spy0128 K161A mutant 
with anti-rSpy0128 sera show no polymerisation of Spy0128 in the K161A harbouring 
strain which is as expected. In the repeat blot with anti-Spy0125 sera (panel B, Figure 
4.23), three bands are quite clearly seen. The band of smaller mass probably 
corresponds to the Spy0125-CTR breakdown product. The two bands of larger mass 
correspond to Spy0125 monomer and an as yet unidentified product (see below). These 
two bands are also present in the lane corresponding to the cell wall fraction of the 
Δspy0128 mutant, suggesting the larger band cannot be a Spy0128-Spy0125 
heterodimer.  In the spy0128 K161A mutant there is no polymerisation of Spy0125 
subunits which implies that K161 of Spy0128 is needed for the attachment of Spy0125 
via Thr723 of its CWSS. Smith et al. (Smith et al., 2010) confirmed this linkage by 
mass spectrometry using pili purified from the wild-type M1 bacteria by tryptic digest 
followed by LC MS/MS analysis. 
 
As mentioned above, the third band with largest mass present on the cell wall blots 
performed using anti-Spy0125 sera (Figure 4.23) is as yet unidentified. It is tempting to 
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speculate that in the absence of Spy0128 monomers, or polymerised monomers at the 
cell surface, Spy0125 is attached covalently to Spy0130 and anchored to the cell wall. 
This is supported by the observation that on a duplicate immuno-blot containing the 
same cell wall fractions as above with anti-Spy0130 sera, a band of similar mass is 
detected at ~125 kDa which would suggest that this band contains Spy0125 joined to 
Spy0130. However, the anti rSpy0130 antibody used in this blot was quite poor and 
high background antibody binding was seen. Further experiments would be needed to 
confirm this potential Spy0130-Spy0125 hetero-dimer linkage, such as using mass 
spectrometry as outlined in Smith et al., 2010. In S. pneumoniae, a similar situation has 
been observed on immuno-blots, where the two minor subunits, RrgC and RrgA, were 
suggested to form a covalently linked hetero-dimer in the absence of the major subunit, 
RrgB as suggested here for Spy0130-Spy0125 (LeMieux et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
136 
 
Chapter 5. Crystallisation and X-ray analysis of Spy0125 
 
5.1 Introduction 
 
The work described in the previous chapter details the molecular characterisation of 
Spy0125. This analysis revealed Spy0125 to be extremely labile in solution and prone 
to degradation at a region defined by a proline rich sequence of residues separating the 
recombinant protein into roughly one and two thirds. These fragments were identified 
by mass spectrometry in conjunction with N-terminal sequencing and this allowed both 
to be re-cloned and expressed. Colleagues in the laboratory produced antibodies to each 
fragment and subsequent experiments revealed that only anti rSpy0125-CTR sera 
inhibited binding of wild-type M1 GAS strain SF370 to target cells. It was noted 
however that rSpy0125-NTR was unstable when stored at 4oC so no further experiments 
were pursued with this fragment. Deletion of the DNA encoding the Spy0125-NTR led 
to no decrease in the binding levels of this mutant when compared to wild-type, which 
strongly suggests that the NTR of Spy0125 is not needed for adhesion. It was also noted 
that Spy0125 homologues from some other M serotypes of GAS were devoid of the 
NTR, suggesting that this region has been lost through evolution, possibly because it is 
not essential. A second mutant, deleting DNA encoding the middle part Spy0125 did 
not bind to the selected cell line and these data confirm the NTR plays little role in 
binding and that the crucial binding interface for the initial host-pathogen interaction is 
contained within the Spy0125-CTR. The major aim for this project was to probe the 
structures of the M1 GAS strain SF370 pili subunits. Work in this chapter focuses on 
the determination and analysis of the Spy0125-CTR X-ray crystal structure which 
reveals a number of exciting features, including evidence suggesting a potentially novel 
mechanism for bacterial adherence to human cells. 
 
5.2 Crystallisation and X-ray analysis of rSpy0125-CTR 
 
Recombinant (r)Spy0125-CTR purified in chapter 4 was used to set up crystallisation 
screens as described in chapter 2, section 2.11.1. Initial crystals of rSpy0125-CTR were 
obtained in 30% (w/v) PEG 5000 MME, 200 mM ammonium sulphate and 100 mM 
MES pH 6.5. Examples of these crystals are seen in panel A, Figure 5.1. Crystal growth 
was optimised by screening the concentration of precipitant against the pH of the buffer. 
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Figure 5.1: Examples of native rSpy0125-CTR crystals. 
 
Panel A: Initial rSpy0125-CTR crystals. Panels B-D: Optimised rSpy0125-CTR 
crystals. 
 
 
Large well formed crystals were grown in 34-36% (w/v) PEG 5000 MME, 100 mM 
ammonium sulphate and 100 mM MES pH 6.0-6.5 and examples of these crystals are 
shown in Figure 5.1, panels B-D. For data collection crystals were harvested in 
Litholoops and transferred to a cryo-protectant solution of paratone-N, to protect them 
from radiation damage, and flash frozen in liquid nitrogen. Initial crystals diffracted X-
rays extremely poorly and although this was improved by growing larger crystals, the 
maximum resolution achieved was usually limited to ~3 Å. A complete diffraction 
dataset was collected from a single cryo-frozen rSpy0125-CTR crystal on beamline IO3 
at Diamond Light Source (DLS, Oxford, UK), consisting of 600 images with an 
oscillation angle of 0.75o on an ADSC Q315 CCD detector, diffracting to a maximum 
resolution of 2.65 Å. The data was processed using iMOSFLM (Leslie, 2006) then 
scaled and reduced with SCALA (Evans, 2006). The data collection statistics are shown 
in Table 5.1. These crystals belonged to the orthorhombic space group P212121 with unit 
cell dimensions of a = 45.81 Å, b = 117.50 Å, c = 177.75 Å and α = β = γ = 90o. 
 
5.3 Isomorphous replacement of rSpy0125-CTR 
 
As discussed in chapter 2, section 2.11.4.1, the isomorphous replacement technique can 
be used to extract phase information. Native PAGE was used to screen for interactions 
between a large number of compounds and rSpy0125-CTR without having to sacrifice 
crystals as outlined in chapter 2, section 2.11.4.1.1 (Boggon and Shappiro 2000). 
rSpy0125-CTR was incubated with many different heavy atom salt solutions on ice for 
A B 
C 
D 
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Table 5.1: Summary of data collection and processing statistics for native  
                 rSpy0125-CTR crystals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Values in parenthesis represent figures for the highest resolution shell. 
 
b Multiplicity and completeness. Given value is for merged data. Values in parenthesis 
are for the highest resolution shell. 
 
c Reflection statistics are as reported in SCALA. Rmerge is calculated as described in 
Evans, 2006. 
 
 
 
10 min and mixtures were analysed by native PAGE (data not shown). Six compounds; 
Cl4K2Pt, KAu(CN)2, K2Pt(NO2)4, KAuCl4, C9H9HgNaO2S and HoCl3.6H2O showed 
band shifts compared to native rSpy0125-CTR suggestive of an interaction and these 
compounds were pursued in soaking experiments. Following soaking, crystals were 
bathed in a cryo-protectant solution of paratone-N and flash frozen in liquid nitrogen as 
before. Data was collected on a number of different derivatives although no heavy atom 
sites could be resolved, indicating that the crystals had not been derivatised or that 
binding sites were disordered. 
 
5.4 Expression and purification of selenomethionine labelled rSpy0125-CTR  
 
Currently the most widely used method of introducing heavy atom scatterers into 
protein crystals is to incorporate them during protein production. This is routinely 
achieved using an E. coli methionine auxotroph expression strain, grown in media  
 Native rSpy0125-CTR 
Wavelength (Å) 0.970 
Space Group P212121 
Resolution range (Å)a 55.00 – 2.65 (2.79 – 2.65) 
Unit cell parameters (Å) a = 45.81, b = 117.50, c = 177.75 
No. of unique reflections 28853 (4136) 
Multiplicityb 16.7 (17.3) 
I/σ(I) 18.6 (8.2) 
Completeness (%)b 99.9 (100.0) 
Rmerge (%)
c 10.7 (41.1) 
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Figure 5.2: Elution profile and peak fraction analysis of rSpy0125-CTR    
                    SeMet purification. 
 
Panel A: rSpy0125-CTR SeMet elution profile at 280 nm. Panel B: Lane 1 contains 
molecular size standards. Lanes 2-10: Coomassie blue stained gel of corresponding 
major peak fractions.  
 
 
 
supplemented with all L-amino acids and L-selenomethionine in place of L-methionine. 
As described in chapter 2, section 2.6.4, B834 (DE3) methionine auxotroph cells were 
transformed with the pJP08 plasmid and grown in LB broth prior to being washed and 
resuspended in minimal media. Prior to the addition of L-selenomethionine a sample of 
culture was harvested and this control was incubated alongside the main culture. During 
incubation, the cell density of the main culture increased as expected while the control 
culture did not, confirming growth depended on incorporation of L-selenomethionine. 
Cells were harvested and lysed by sonication in buffer containing reducing agent to 
ensure incorporated selenium remained reduced prior to recovery of soluble His-tagged 
rSpy0125-CTR selenomethionine (SeMet) labelled protein, using Ni2+ affinity 
chromatography. Peak fractions were analysed by SDS-PAGE and those containing 
large quantities of protein were concentrated and applied to a Hi-Load 16/60 Superdex 
200 gel filtration column to remove impurities. The elution profile for rSpy0125-CTR 
SeMet is shown in panel A, Figure 5.2 revealing a large predominant peak and fractions  
1    2    3     4    5    6     7     8   9    10 
51.1 kDa 
72 kDa 
55 kDa 
36 kDa 
A 
B 
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Figure 5.3: Examples of rSpy0125-CTR SeMet crystals. 
 
Panel A: Initial crystals. Panel B: Large well formed crystals. Panel C: Thin ‘plate’ 
like crystals. Panel D: Both rSpy0125-CTR SeMet crystal morphologies growing in the 
same drop. 
 
 
corresponding to this peak were analysed by SDS-PAGE (panel B, Figure 5.2). 
Fractions containing protein (lanes 4-9, Figure 5.2) were pooled and concentrated to 10 
mg/ml, determined by absorbance at 280 nm using the molar extinction coefficient for 
rSpy0125-CTR of 39770 M-1 cm-1. For use in crystallisation experiments the His-tag 
was removed by digestion with thrombin, followed by removal of the separated His-tag 
(on a His-chelation column) and thrombin (on a benzamidine column) as described in 
the material and methods, section 2.6.7. The digested rSpy0125-CTR SeMet was 
dialysed into gel filtration buffer prior to concentrating as described above. 
 
5.5 Crystallisation of rSpy0125-CTR SeMet 
 
Initial crystals were obtained for rSpy0125-CTR SeMet as described for native 
rSpy0125-CTR and were well formed but very small. The most encouraging crystals 
were obtained in 30% (w/v) PEG 4000, 200 mM ammonium acetate and 100 mM tri-
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sodium citrate pH 5.6. Examples of these crystals are shown in panel A, Figure 5.3. 
Using the hanging drop vapour diffusion technique, screening PEG concentration 
against pH of the buffer, optimised crystals were obtained in 38% (w/v) PEG 4000, 200 
mM ammonium acetate and 100 mM tri-sodium citrate pH 5.6. This condition routinely 
gave rise to large, well formed crystals (panel B, Figure 5.3) but in a small number of 
wells, crystals of different morphology were observed (panel C, Figure 5.3). These 
‘plate-like’ crystals were extremely thin and fragile and the two different crystal forms 
would occasionally grow in the same drop as seen in panel D, Figure 5.3. For data 
collection, intact well formed crystals (such as those shown in panel B, Figure 5.3) were 
harvested in a litho-loop, prior to bathing in a cryo-protectant solution of paratone-N oil 
and flash frozen in liquid nitrogen. Thin ‘plate’ like crystals were broken into pieces and 
a single fragment harvested and frozen in the same manner. 
 
5.6 rSpy0125-CTR SeMet data collection 
 
The data used to solve the rSpy0125-CTR structure was collected on BM14 at the 
European Synchrotron Radiation Facility (ESRF, Grenoble, France), using the 
selenomethionine labelled protein crystals described above. Multi-wavelength 
Anomalous Diffraction (MAD) was chosen for phasing to optimise the anomalous 
signal as only three methionines are encoded in the primary Spy0125-CTR sequence of 
438 residues. Assuming there was full incorporation of SeMet into the protein this 
would represent a weak anomalous signal (common theory suggests at least one 
methionine should be present per 100 residues or 10 kDa). Three wavelength MAD data 
was collected on a single cryo-cooled crystal for both crystal morphologies, after 
excitation spectrums had been measured for each using a Bruker xFLASH SDD 
detector and maximised f” and f’ values were determined by CHOOCH (G. Evans, 
included in the CCP4 suite) to ascertain optimised wavelengths. The experimentally 
determined excitation spectrum for a thin ‘plate’ like crystal is shown in Figure 5.4 and 
a dataset was collected at each wavelength (as determined by CHOOCH) to 2.1 Å, 
consisting of the same 300 images with an oscillation range of 1o on a MAR 225 CCD 
detector. Each dataset was processed in iMOSFLM (Leslie, 2006), then scaled and 
reduced using SCALA (Evans, 2006). The data collection statistics are shown in Table 
5.2. An additional redundant dataset was collected on this crystal at the peak 
wavelength, consisting of 650 images with an oscillation angle of 1o. The data was  
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Figure 5.4: Excitation spectrum at the K edge of selenium for a thin ‘plate’ like 
                   rSpy0125-CTR SeMet crystal. 
 
 
 
processed and scaled as above to a resolution of 1.9 Å and the statistics for this dataset 
are shown in Table 5.2 (Peak ‘2’). The protein crystallised in the triclinic space group 
P1, with unit cell dimensions that remained isomorphous throughout data collection 
(Table 5.2). Unit cell volume calculations were consistent with 2 molecules being 
present in the asymmetric unit. 
 
The large well formed crystals (panel B, Figure 5.3) diffracted to a maximum resolution 
of 2.9 Å and a dataset was collected at each MAD wavelength (as determined by 
CHOOCH) consisting of the same 180 images with an oscillation range of 1o on a MAR 
225 CCD detector. Each dataset was processed and scaled as above and the statistics are 
listed in Table 5.3. These crystals belonged to the orthorhombic space group P212121 
with unit cell dimensions that remained isomorphous throughout the data collection 
(shown in Table 5.3) and α = β = γ = 90o. Unit cell volume calculations were consistent 
with 2 molecules being present in the asymmetric unit.  
 
Following data collection it was clear that the two different crystal morphologies 
belonged to two distinct space groups. Therefore at this stage, the thin ‘plate’ like (P1) 
crystals were renamed A-form crystals and the large well formed (P212121) crystals as 
B-form crystals. 
 
f ” 
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Table 5.2: Summary of data collection and processing statistics for rSpy0125-  
                  CTR SeMet A-form (P1) crystals. 
 
 Peak 
 
Inflection Remote Peak ‘2’ 
Wavelength (Å) 
 
0.978 0.979 0.975 0.978 
Space Group 
 
P1 P1 P1 P1 
Resolution range  (Å)a 
 
 
38.47 – 2.10 
(2.21 – 2.10) 
38.45 – 2.10 
(2.21 – 2.10) 
38.50 – 2.10 
(2.21 – 2.10) 
38.00 – 1.90 
(2.00 – 1.90) 
Unit cell parameters  
(Å, °) 
a = 35.43 
b = 66.28, 
c = 101.75, 
α = 86.19, 
β = 90.04, 
γ = 75.02 
 
a = 35.42 
b = 66.26, 
c = 101.69, 
α = 86.20, 
β = 90.06, 
γ = 75.06 
a = 35.42 
b = 66.27, 
c = 101.63, 
α = 86.36, 
β = 90.12, 
γ = 75.09 
a = 35.48 
b = 66.46, 
c = 101.80, 
α = 86.06, 
β = 90.06, 
γ = 75.08 
No. of unique 
reflections 
 
50476 (7366) 50433 (7361) 50458 (7354) 66113 
(7725) 
Multiplicityb 
 
 
3.3 (3.3), 
1.7 (1.7) 
3.3 (3.3), 
1.6 (1.6) 
3.3 (3.3), 
1.7 (1.7) 
7.0 (6.7) 
I/σ(I)  
 
12.5 (7.2) 16.4 (7.7) 14.0 (6.9) 15.4 (5.0) 
Completeness (%)b 
 
 
97.0 (96.0), 
96.0 (95.1) 
97.0 (96.0), 
96.1 (95.2) 
97.0 (96.1), 
96.1 (95.1) 
93.6 (74.9) 
Rmerge  (%)
c 
 
4.9 (11.5) 3.9 (10.9) 4.2 (12.2) 7.4 (31.8) 
No. of sites (SOLVE) 
 
 6   
FOM 
(SOLVE/RESOLVE) 
 0.33/0.67   
 
 
a Values in parenthesis represent figures for the highest resolution shell. 
 
b Multiplicity and completeness. First given value is for merged data and the second 
represents separated anomalous pairs. Values in parenthesis are for the highest 
resolution shell. 
 
c Reflection statistics are as reported in SCALA. Rmerge is calculated as described in 
Evans, 2006.   
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Table 5.3: Summary of data collection and processing statistics for rSpy0125- 
                  CTR SeMet B-form (P212121) crystals. 
 
 
 
Peak 
 
Inflection Remote 
Wavelength (Å) 
 
0.978 0.979 0.975 
Space Group 
 
P212121 P212121 P212121 
Resolution range  (Å)a 
 
 
56.66 – 2.90 
(3.06 – 2.90) 
56.71 – 2.90 
(3.06 – 2.90) 
56.73 – 2.85 
(3.06 – 2.85) 
Unit cell parameters  
(Å, °) 
 
 
a = 43.10, 
b = 113.32, 
c = 175.36 
α = β = γ = 90o 
 
a = 43.13, 
b = 113.42, 
c = 175.49 
a = 43.06, 
b = 113.46, 
c = 175.64 
Unique reflections 
 
19907 (2830) 19952 (2836) 20994 (2980) 
Multiplicityb 
 
 
7.2 (7.3), 
3.8 (3.8) 
7.2 (7.3), 
3.8 (3.8) 
7.2 (7.3),  
5.8 (3.8) 
I/σ(I) 
 
13.2 (5.2) 13.3 (5.0) 12.8 (4.5) 
Completeness (%)b 
 
100 (100), 
100 (100) 
 
100 (100), 
100 (100) 
100 (100), 
100 (100) 
Rmerge (%)
c 10.6 (35.6) 
 
10.6 (36.5) 11.1 (41.7) 
No. of sites (SOLVE) 
 
 6  
FOM 
(SOLVE/RESOLVE) 
 0.25/0.67  
 
 
a Values in parenthesis represent figures for the highest resolution shell. 
 
b Multiplicity and completeness. First given value is for merged data and the second 
represents separated anomalous pairs. Values in parenthesis are for the highest 
resolution shell. 
 
c Reflection statistics are as reported in SCALA. Rmerge is calculated as described in 
Evans, 2006. 
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5.7 rSpy0125-CTR structure solution  
 
The AutoSol wizard in PHENIX (Adams et al., 2002) was used to solve the two 
rSpy0125-CTR structures as described in chapter 2, section 2.11.5 (using the MAD 
data). Unit cell calculations predicted 2 molecules in the asymmetric unit for each 
crystal form and PHENIX was able to find the 6 Se sites in both. The initial electron 
density map produced by the AutoSol wizard for the A-form crystals using the density 
modified MAD phases to 2.1 Å was easily interpretable and the RESOLVE auto build 
feature was able to produce an initial model comprising 518 residues docked within the 
density and a further 58 residues docked as poly-Ala or poly-Gly chains. These regions 
show connectivity in the electron density where the actual protein sequence cannot be 
traced. The initial electron density map produced by the AutoSol wizard for the B-form 
crystals using the density modified MAD phases to 2.9 Å was also interpretable but due 
to the limited resolution of the data, RESOLVE auto build was only able to place 47 
residues docked in the sequence with a further 500 residues docked as poly-Ala or poly-
Gly chains. 
 
5.8 Refinement and rebuilding  
5.8.1 A-form crystals 
 
The initial model produced by the AutoSol wizard in PHENIX is just that and although 
it had reasonable R factors as defined by phenix.refine it could be improved further. 
REFMAC5 (Murshudov et al., 1997) was used to refine the initial model against the A-
form “peak 2” dataset to 1.9 Å using the ‘SAD data directly’ target function as the f+ 
and f- differences were already separated in the collected data. Since the ‘peak 2’ data 
had the highest resolution and redundancy, it was used for refinement, as it would be the 
most accurate in describing the final model. Interestingly, the ‘peak 2’ dataset could be 
used to solve the rSpy0125-CTR structure by SAD but the maps produced were not of 
the same quality as those produced by the MAD data. The model was then inspected 
and rebuilt with COOT (Emsley and Cowtan, 2004) using both the experimental map 
calculated with the density modified MAD phases and the σ-weighted 2│Fobs│–│Fcalc│ 
and │Fobs│–│Fcalc│ maps from REFMAC5. It was obvious from the initial round of 
refinement that the electron density describing two domains of rSpy0125-CTR was of 
high quality, but there was limited evidence for an ordered third domain (see section 
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5.13). Intriguingly, in the initial maps continuous electron density was observed linking 
the side chains of Lys297-Asp595 and Cys426-Gln575. At this stage water molecules 
were added using ARP/wARP solvent (Langer et al., 2008) which searches for peaks in 
the │Fobs│–│Fcalc│ electron density map greater than 5.4 sigma, and removes water 
molecules placed in the 2│Fobs│-│Fcalc│ electron density below 1 sigma. All water 
molecules were inspected in COOT and those able to form hydrogen bonds with 
adjacent molecules were retained after refinement. A final model was produced via 
iterative cycles of refinement with REFMAC5 and rebuilding in COOT. During the 
final stages of refinement, links were created between the side chains of the residues 
described above and translation, libration and screw-rotation (TLS) restraints were used 
grouping residues Thr290-Glu387 and Pro388-Glu585 in chain A and residues Gln287-
Glu387 and Pro388-Glu585 in chain B. The final model comprised residues Thr291-
Thr603 in chain A, excluding residues Gly316-Ala324 which were disordered, and 
residues Thr291-Asn605 in chain B, excluding residues Asn318-Phe322 which were 
disordered. Final refinement statistics for the A-form rSpy0125-CTR crystal structure 
are given in Table 5.4.  
 
5.8.2 B-form crystals 
 
The initial model produced by the AutoSol wizard in PHENIX was used in conjunction 
with positioning the refined A-form structure into the initial experimental map produced 
using the density modified MAD phases. This was achieved with MOLREP (Vagin and 
Teplyakov, 2010) using the ‘search for model in the map’ performing ‘rotation 
function’. Unlike for the A-form crystals, continuous electron density describing both 
molecules was present enabling manual building of the missing domain in COOT, using 
both the experimental map calculated with the density modified MAD phases and the σ-
weighted electron density maps (2│Fobs│-│Fcalc│ and │Fobs│–│Fcalc│) calculated by 
REFMAC5. Continuous electron density linking the amino acid side chains described 
above (Lys297-Asp595 and Cys426-Gln575) was also found in the initial B-form maps 
in addition to a link between the side chains of Lys610-Asn715. A final model that 
described rSpy0125-CTR was achieved as above with iterative cycles of refinement 
using REFMAC5 and rebuilding in COOT maintaining non-crystallographic symmetry 
(NCS) restraints (tight on main chain, medium on side chain) throughout.  
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Table 5.4: Refinement statistics for rSpy0125-CTR crystal structures. 
 
 
 rSpy0125-CTR, 
A-form 
rSpy0125-CTR, 
B-form 
rSpy0125-CTR, 
Native 
Dataset used Peak ‘2’ 
 
Peak DLS data 
Rwork (%)
a, b 20.6 (23.7) 
 
23.1 (30.9) 22.8 (34.8) 
Rfree (%)
a, b 23.2 (29.6) 
 
27.4 (41.0) 26.8 (42.7) 
RmsBond (Å) 0.015 
 
0.005 0.015 
RmsAngles (o)b 1.41 
 
0.91 1.42 
No. of non-hydrogen atom 
 
5423 
 
6742 6746 
ESU (based on maximum 
likelihood) (Å)b 
 
0.08 
 
0.35 0.30 
Ramachandran outliers (%)c 0 0 0 
 
 
a Values in parenthesis are those for the highest resolution shell. 
 
b Refinement statistics are as reported by REFMAC5 (Murshudov et al., 1997). 
RmsBond and RmsAngle refer to the root-mean-square deviation from ‘ideal’ 
geometric values described in the Refmac dictionary.  Rfree = ∑( | |Fobs – |Fcalc | ) / ∑ |Fobs 
| where |Fobs| are observed structure factor amplitudes for a given reflection and |Fcalc| are 
corresponding calculated structure factor amplitudes obtained from the refined model.  
Rfree uses only random reflections set aside as a ‘test set’ and not used in refinement.  
Rwork is calculated as per Rfree but using the ‘working set’ of reflections.  
 
c As calculated by MOLPROBITY (Davis et al., 2007). 
 
 
During the final stages of refinement, links were created between the side chains of the 
above residues and TLS refinement was used grouping residues Thr290-Glu387 in 
chain A and Gln287-Glu387 in chain B and Pro388-Glu585 and Asn605-Val720 in 
chains A and B, all forming separate groups. The final model comprised residues 
Thr290-Pro719 in chain A, excluding residues Asn318-Ser321 and Ile373-Lys376 
which were disordered and residues 288-720 in chain B, excluding residues Asp317-
Asn320 and Ile373-Lys376 which were disordered. Final refinement statistics for the B-
form rSpy0125-CTR crystal structure are given in Table 5.4. The completed B-form 
rSpy0125-CTR structure is shown in Figure 5.5 with the top domain in green (residues 
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Figure 5.5: Cartoon ribbon representation of the rSpy0125-CTR monomer. 
 
The rSpy0125-CTR monomer is coloured as follows; the top domain (residues Ser390-
His583) in green, the middle domain (residues Gln290-Ile372) in sky blue and the 
bottom domain (residues Thr603-Pro719) in red. Domain linking regions are shown in 
grey. Indicated at the N-terminus of the monomer is Spy0125-NTR. Highlighted in 
boxes are the positions of the intra-molecular bonds; a Lys-Asn isopeptide bond in the 
bottom domain (shown with catalytic Glu residue), a Lys-Asp isopeptide bond in the 
middle domain (shown with catalytic Glu residue) and Cys-Gln thioester bond in the top 
domain (shown with potentially catalytic Tyr residue). Blue dashed lines indicate 
hydrogen bonding between atoms. Highlighted at the C-terminus of rSpy0125-CTR is 
Thr723, which is attached to Lys161 of Spy0128, positioning Spy0125 at the pilus tip. 
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Ser390-His583), the middle domain in blue (residues Thr290-Ile372 and Ile590-
Lys597), the bottom domain in red (residues Thr603-Pro719) with domain linking 
regions in grey. Also highlighted are the positions of the intra-molecular bonds (see 
section 5.11) and the N-terminus of Spy0125-CTR. Domains were assigned based on 
their relative position when Spy0125-CTR is modelled at the tip of the pilus. The 
bottom domain of Spy0125-CTR contains the ‘VVPTG’ sortase recognition motif and 
this would form the ‘bottom’ of the molecule attached to the ‘top’ of Spy0128 
(highlighted in Figure 5.5). 
 
 
5.8.3 Native B-form crystals  
 
PHASER (McCoy et al., 2007) was used to solve the native rSpy0125-CTR structure 
with the data collected at DLS by molecular replacement to 2.65 Å using the final B-
form structure as a homologous search model. A single chain from the final B-form 
model described above in section 5.8.2 was separated into two different input files, one 
containing the ‘middle and top’ domains and the second containing the ‘bottom’ domain 
for rotation/translation searches. A final model that described the rSpy0125-CTR was 
produced as above with iterative cycles of refinement using REFMAC5 (Murshudov et 
al., 1997) maintaining NCS restraints (tight on main chain, medium on side chain) 
throughout and rebuilding in COOT (Emsley and Cowtan, 2004). 
 
The final model comprised residues Thr290-Pro719 in chain A, excluding residues 
Val319-Ser321, Ile373-Lys376 and Glu598-His604 which were disordered and residues 
Pro288-Pro719 in chain B, excluding Ile373-Asp374 which were disordered. Final 
refinement statistics for the native rSpy0125-CTR crystal structure are given in Table 
5.4 and the final electron density map quality for each refined structure is shown in 
Figure 5.6. 
 
 
 
 
 
 
 
 
 
150 
 
 
 
Figure 5.6: Example of the final electron density for rSpy0125-CTR structures. 
 
The 2│ Fobs│-│Fcalc│ electron density is contoured at 1.2 σ calculated with phases from 
the final model. Panel A: A-form map refined to 1.9 Å. Panel B: B-form map refined to 
2.9 Å. Panel C: Map derived from the DLS data refined to 2.65 Å. Note the 
improvement in electron density map quality with increasing resolution. 
 
 
 
5.9 Structure validation  
 
All three structures were checked for geometric and structural validity using COOT 
tools during refinement and MOLPROBITY (Davis et al., 2007) to generate 
Ramachandran plots for the final structures. These plots are a way of visualising the φ 
against ψ dihedral angles of each of the residues present in the structure. 
MOLPROBITY also analyses the conformations of each amino acid in protein 
structures deposited in the PDB and whether the residues present in the structure being 
examined are in acceptable conformations. Ramachandran plots for the three finished 
rSpy0125-CTR structures are shown in Figures 5.7, 5.8 and 5.9. All residues are in 
acceptable conformations and there are no outliers. 
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Figure 5.7: Ramachandran plots for the final refined A-form rSpy0125-CTR 
                   structure as determined by MOLPROBITY. 
 
 
 
Figure 5.8: Ramachandran plots for the final refined B-form rSpy0125-CTR  
                   structure as determined by MOLPROBITY. 
General case Glycine 
Proline Pre-proline 
General case Glycine 
Proline Pre-proline 
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Figure 5.9: Ramachandran plots for the final refined rSpy0125-CTR structure 
                   derived from the DLS data as determined by MOLPROBITY.                     
 
5.10 Analysis of rSpy0125-CTR structures 
 
LSQMAN (Kleywegt et al., 2001) was used to analyse the domains contained within 
each completed structure and determine their similarity. This is achieved by aligning 
structures and generating a root mean square deviation (rmsd) which shows the distance 
of the average displacement of Cα atoms. An rmsd of around ~2.0 Å or lower can be 
considered to show significant structural similarity while two random structures would 
generate an rmsds of greater than 12.0 Å. The middle and bottom domain of rSpy0125-
CTR both form a β–sandwich arrangement. Overlaying the middle domains from each 
of the structures generates an rmsd over the range 0.25-0.50 Å (81-85 equivalent Cα 
positions). Comparison of the bottom domains generates an rmsd of 0.053-0.33 Å (115-
117 equivalent Cα positions) while overlaying the top domains from each of the 
structures generates an rmsd over the range 0.06-0.55 Å (185-194 equivalent Cα 
positions). Note, the lowest rmsd values generated for each overlay is between domains 
from the same crystal, i.e. the A-chain and B-chain from the same asymmetric unit 
(these have already been restrained against each other using NCS restraints during 
General case Glycine 
Proline Pre-proline 
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refinement). The value described here show that domain structure is highly analogous 
between the different structures. A single region Asp439-Val453 however, adopts a 
slightly different conformation in the A-form and B-form crystals. This region is well 
defined in the electron density of both structures however and the most reasonable 
explanation for this minor rearrangement is the differing crystal contacts throughout this 
region. Evaluation of the B-form rSpy0125-CTR model derived from the MAD data 
collected at the ESRF reveals that the electron density covering Pro470-Gln560 in chain 
B is considerably poorer than that describing the rest of the model in both chains. This 
region also displays higher than average B factors (which describe the atomic 
displacement parameters). Despite this, the region refines in the same conformation in 
each chain from each crystal, including chain A of the same asymmetric unit. If this 
region is removed and the model refined, the Rfree value starts to increase indicating that 
deletion of this region makes for a poorer model describing the electron density. 
Therefore this region is retained in the final model. 
 
 
5.11 Intra-molecular bonds 
 
The most fascinating aspects of rSpy0125-CTR revealed by the crystal structures are the 
presence of three internal bonds, one in each domain of the protein. Two are predicted 
to be covalent isopeptide bonds which provide stability to the protein in an analogous 
manner to disulphide bonds and the third is a highly unusual thioester bond that might 
be involved in the binding of Spy0125 to host tissue surfaces (see below). 
 
5.11.1 Lys610-Asn715 intra-molecular isopeptide bond 
 
The C-terminal domain of rSpy0125-CTR (bottom domain) harbours an intra-molecular 
isopeptide bond forming a covalent link between the side chains of Lys610-Asn715. It 
has been shown previously that a conserved glutamate (or aspartate) residue is 
associated with each bond and is essential, as mutation of this residue abrogates 
isopeptide bond formation (Kang et al., 2007). As seen in panel A, Figure 5.10, Glu680 
is in close enough proximity to be able to form hydrogen bonds with both NH on 
Lys610 and C=O on Asn715, and it is probable that this bond is formed as previously 
suggested (Kang et al., 2007). An OMIT electron density map is shown for this region  
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Figure 5.10: The Lys610-Asn715 intra-molecular isopeptide bond. 
 
Residues are shown in stick mode with 2│Fobs│–│Fcalc│ density shown in blue 
contoured at 1.2 σ and positive│Fobs│-│Fcalc│ density in green contoured at 3.5 σ. 
Panel A: Amide linkage formed between the side chains of Lys610 and Asn715. 
Glu680 is also shown and could play a role in bond formation. Panel B: OMIT electron 
density map of the same residues. Connected green density confirms the presence of the 
isopeptide bond. 
 
 
 
 
 
 
in Panel B, Figure 5.10. In this electron density map, isopeptide bond residues have 
been removed from the model, which has then been refined. The presence of positive, 
connected │Fobs│–│Fcalc│ electron density (shown in green), indicates that the omitted 
residues are in the correct conformation in the model. Clusters of hydrophobic residues 
surrounding these bonds have been implicated in creating a suitable environment for 
their formation. In the bottom domain of rSpy0125-CTR, residues Phe623, Phe625, 
Tyr686, Val688 and Phe713 form the hydrophobic cluster. The position of this bond 
within the bottom domain of rSpy0125-CTR is shown in Figure 5.5. 
 
 
Lys610 
Asn715 
Glu680 
3.2 Å 2.9 Å 
Glu680 
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Figure 5.11: The Lys297–Asp595 intra-molecular isopeptide bond. 
 
Residues are shown in stick mode with 2│Fobs│–│Fcalc│ density shown in blue 
contoured at 1.2 σ and positive│Fobs│-│Fcalc│ density in green contoured at 3.5 σ. 
Panel A: Amide linkage formed between the side chains of Lys297 and Asp595. 
Glu347 is also shown and could play a role in bond formation. Panel B: OMIT electron 
density map of the same residues. Connected green density confirms the presence of the 
isopeptide bond. 
 
5.11.2 Lys297-Asp595 intra-molecular isopeptide bond 
 
A second intra-molecular isopeptide bond is found within the middle domain of 
rSpy0125-CTR. Surprisingly, this covalent link is formed between the side chains of 
Lys297-Asp595 rather than between Lys and Asn side chains as outlined above and for 
previously described intra molecular isopeptide bonds, such as those contained within 
Spy0128 (Kang et al., 2007). This is the first time that an intra-molecular isopeptide 
bond between these two residues has been observed. As seen in panel A, Figure 5.11, 
Glu347 is probably acting in an analogous manner as it does in the creation of Lys-Asn 
isopeptide bonds. Glu347 is within a suitable distance to form hydrogen bonds with the 
O moiety of the Lys-Asp isopeptide bond. An OMIT electron density map was 
produced for this region as described above (Panel B, Figure 5.11) and the presence of 
positive │Fobs│-│Fcalc│electron density (shown in green) which is connected, confirms 
the linkage of these side chains in the model. As described for Lys-Asn isopeptide 
bonds, a hydrophobic environment is needed for bond formation and the residues 
involved in forming this cluster are Leu307, Ala310, Leu312, Pro351, Tyr354, Ala 357 
and Met593. 
Glu347 
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Figure 5.12: The Cys426-Gln575 thioester bond. 
 
Residues are shown in stick mode with 2│Fobs│-│Fcalc│ density shown in blue 
contoured at 1.2 σ and positive│Fobs│-│Fcalc│ density in green contoured at 3.5 σ. 
Panel A: The thioester link formed between the side chains of Cys426 and Gln575, with 
local Tyr516 also shown, forming a potential hydrogen bond with Cys426 sulphur. 
Panel B: OMIT electron density map of the same residues. Connected green density 
confirms the thioester linkage. 
 
 
5.11.3 Cys426-Gln575 internal thioester bond 
 
The most fascinating feature revealed by the rSpy0125-CTR structure is the presence of 
continuous electron density between the side chains of Cys426-Gln575 within the top 
domain of the protein. The link between these two residues has been termed an 
isoglutamyl cysteine thioester bond. These residues are located in a shallow cleft that is 
partially solvent exposed, at the end of adjacent β-strands. Unlike the two isopeptide 
bonds described above, this bond could form spontaneously with protein folding 
providing the energy and environment necessary for bond formation (Pangburn, 1992). 
Nearby residues however, could also be crucial for thioester bond formation, with 
Tyr516 able to form a hydrogen bond with the cysteine sulphur. This bond is shown in 
panel A, Figure 5.12 along with Tyr516. Its corresponding OMIT electron density map 
created as above is seen in panel B, Figure 5.12 and the presence of positive │Fobs│-
│Fcalc│ electron density covering these residues suggests the presence of a link between 
Tyr516 
Cys426 
Gln575 
3.2 Å 
Tyr516 
A B 
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the side chains of Cys426 and Gln575 in the final model. The position of the thioester in 
the top domain of rSpy0125-CTR is shown in Figure 5.5. 
 
 
This particular bond has only been found previously in mammalian proteins such as α2-
macroglobulin and complement proteins where it is required to form covalent bonds 
with their target ligands. This raises the possibility that they might be responsible here 
for GAS adhesion (see discussion). The structure of the native complement C3 protein 
revealed that the thioester was shielded from reacting with water or free nucleophiles by 
a pocket of hydrophobic residues (Janssen et al., 2005) and in rSpy0125-CTR residues 
Tyr412, Phe427, Ala429, Pro434, Tyr516 and Leu577 form a protective pocket around 
Cys426-Gln575. 
 
5.12 Initial mass spectrometry of rSpy0125-CTR intra-molecular bonds  
 
The Spy0128 structure contained two Lys-Asn isopeptide bonds and mass spectrometry 
of the intact protein revealed a mass, 34.8 Da lower than that calculated from the amino 
acid sequence (Kang and Baker, 2009). This accounts for the loss of an NH3 molecule 
during the formation of each isopeptide bond. This method was used to investigate the 
mass of rSpy0125-CTR and whether any differences in the experimentally determined 
mass and the calculated mass could be accounted for by the presence of the intra-
molecular bonds described above. A fresh sample of rSpy0125-CTR was prepared for 
FT-ICR MS analysis, which included removal of the His-tag (chapter 2, section 2.6.7). 
The intact mass of rSpy0125-CTR using this technique was 49288.5 Da in the neutral 
state (data not shown). The calculated mass of the Asn286-Thr723, rSpy0125-CTR 
construct, plus the vector encoded Gly-Ser residues left on the N-terminus after 
thrombin digestion is 49342.0 Da, as determined by the ProtParam tool on the ExPASy 
server (Gasteiger et al., 2005). The difference between these two values of 53.5 Da, 
coupled with the experimental error of FT-ICR MS at this mass of 1 Da, could be 
described by the following; one NH3 group (17 Da) is lost during the formation of the 
Lys610-Asn715 isopeptide bond, one H2O (18 Da) is lost during the formation of the 
Lys297-Asp595 isopeptide bond and one NH3 group (17 Da) is lost during the 
spontaneous formation of the Cys426-Gln575 thioester bond.  
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5.13 Discussion 
 
The results presented in this chapter describe the high resolution crystal structure of the 
previously described CTR of Spy0125. In chapter 4, Spy0125 was shown to be the 
adhesin positioned solely at the pilus tip and the Δspy0125-NTR and ∆spy0125-ID 
mutant strains revealed critically, that the Spy0125-CTR contains the host cell binding 
interface.  
 
The A-form structure of rSpy0125-CTR is unusual as it appears to display a non-
continuous crystal lattice (panel A, Figure 5.13) which is, of course, a physical 
impossibility that has occurred due to limitations in modelling dynamic regions in 
protein structures based on crystallographic data. There is significant electron density 
(albeit ‘smeared’) at the modelled C-terminus in each chain suggesting the presence of 
the bottom domain within the crystal; there is also sufficient space for this domain in the 
un-modelled region. Further evidence for the flexibility of this domain is highlighted in 
panel B, Figure 5.13 which shows an overlay (produced using LSQMAN, Kleywegt et 
al., 2001) of both chains in the asymmetric unit of the B-form crystals. It is clear that 
while the top and middle domains of both chains overlay very tightly, the bottom 
domains do not. The movement in the bottom domain can be accounted for by a 
translation of ~14 Å and a slight rotation. Crystal contacts between rSpy0125-CTR 
monomers in the B-form crystals have caused more rigidity allowing electron density 
for this region to be seen. 
 
It had been reported previously that the C-terminal domain (CTD) of Spy0125 had a 
significant degree of sequence similarity with the CTD of Spy0128 (Kang et al., 2007). 
When the structures of these to two domains were aligned (in LSQMAN, using the 
Spy0125-CTR bottom domain and the Spy0128 crystal structure, PDB code 3B2M) an 
rmsd of 1.3 Å was calculated for 96 equivalent Cα positions. An overlay of both 
structures reveals that they are very similar. All β-strands present in rSpy0125-CTR 
bottom domain are in the same positions in Spy0128 CTD, with the major differences 
being an extra three short β-strands and large extensions to two loop regions in Spy0128 
CTD. It was no surprise that the isopeptide bonds present in these domains are located 
in exactly the same position within both structures. Also, these domains both contain the  
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Figure 5.13: Non-continuous lattice in the A-form (P1) crystals. 
 
Panel A: Two clear channels can be seen through the electron density (*) with enough 
space to suggest that the bottom domain is present in this crystal form. Shown in red 
and green are the two molecules in the asymmetric unit. Panel B: Both molecules from 
the B-form asymmetric unit are shown, chain A in green and chain B in red. Top and 
middle domains overlay very tightly but a major translation of 14 Å in the bottom 
domain is clear.  
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sortase recognition motifs and are therefore recognised by the pilin polymerase (SrtC) 
so it follows that these two domains should be structurally similar. 
 
Searches were performed using DALI (Holm and Sander, 1995) to identify any 
potential structural homologues to the middle and top domains of rSpy0125-CTR. The 
middle domain of rSpy0125-CTR was found to be structurally similar to the N2 domain 
of GBS52, a minor pilus subunit from GBS (Krishnan et al., 2007). Structure 
alignments in LSQMAN for these two domains (using the GBS52 crystal structure, 
PDB entry code 2PZ4) generated an rmsd over 65 equivalent Cα positions of 1.59 Å, 
suggesting a similar domain architecture for these two structures even though they share 
little overall sequence similarity. As described above for the bottom domain of 
rSpy0125-CTR, the isopeptide bond identified here in the rSpy0125-CTR middle 
domain, occupies a similar position in both GBS52 and rSpy0125-CTR. However, 
while this bond in GBS52 is formed between the side chains of Lys/Asn residues as 
described previously for Spy0128 and the bottom domain of rSpy0125-CTR, the 
corresponding bond in the middle domain of rSpy0125-CTR is between a Lys/Asp pair 
and has not been found previously. The process of autocatalytic formation of Lys/Asn 
and Lys/Asp intra-molecular isopeptide bonds is shown in Figure 5.14. The intra-
molecular isopeptide bonds discovered in the middle and bottom domains of the 
rSpy0125-CTR structure have both been confirmed in the recombinant protein by mass 
spectrometry and are key features that probably play a stabilising role similar to that 
reported for other proteins (Pointon et al., 2010). Much like rSpy0128, rSpy0125-CTR 
is stable when stored in solution at 4oC for many months, with no clear degradation 
visible on SDS-PAGE. 
 
No proteins were found to contain a domain with any structural similarity with the top 
domain of rSpy0125-CTR, although it is interesting to note the positioning of the top 
domain within the protein as a whole. In rSpy0125-CTR, the Cα backbone runs 
(presumably) from the NTR into the middle domain, up into the top domain and then 
back through the middle domain to the bottom domain (the aspartate residue involved in 
the middle domain isopeptide bond is located on this short linking region). This may 
indicate that a gene, encoding the top domain, has been inserted into a loop in the 
middle domain as parts of amino acid sequence which are distal, yet associated in a 
structure are evidence for a gene insertion event. Indeed, the reverse could also be true  
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Figure 5.14: Schematic representation of autocatalytic intra-molecular  
                     isopeptide bond formation. 
 
Panel A: Chemical reaction diagram for Lys-Asn (i) and Lys-Asp (ii) isopeptide bond 
formation. Panel B: Catalysed by a Glu or Asp residue, the potential reaction 
mechanism for the formation of Lys-Asn isopeptide bonds. Panel C: Catalysed by a 
Glu or Asp residue, the potential reaction mechanism for the formation of Lys-Asp 
isopeptide bonds. The final stage of both reactions is highlighted, with hydrogen bonds 
between atoms indicated by blue dashed lines. Figure adapted from Kang and Baker, 
2010. 
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where DNA encoding the top domain of Spy0125-CTR has been deleted from the 
GBS52 gene. As this thesis was being written the crystal structure of the pilus adhesin, 
RrgA from S. pneumoniae was published which revealed an extremely elongated 
structure and exhibited evidence of ‘indel’ events similar to those described above for 
the possible insertion/deletion of the top domain of Spy0125-CTR. RrgA harbours a 
MIDAS motif in the top domain of the protein for host cell interaction which is very 
different to the potential binding interaction reported here for Spy0125-CTR. The 
position of this motif, in the top domain of the protein is similar to the position of the 
thioester present in the top domain of rSpy0125-CTR. 
 
The most exciting and intriguing feature revealed by the rSpy0125-CTR structure was 
the presence of continuous electron density linking the side chains of Cys426 and 
Gln575, suggestive of an internal thioester within the top domain of the protein. As 
mentioned in section 5.11.3, the only other proteins shown to contain an internal 
thioester bond are the α2-macroglobulin protease inhibitors and the complement 
proteins C3 and C4, which utilise this bond to bind covalently to target molecules upon 
activation (Pangburn, 1992). The thioester contained within the complement proteins 
C3 and C4 is absolutely critical for their ability to bind target molecules such as 
bacterial cell walls, and this event is central to the initiation of the complement system 
and most of its downstream effects. This raises the possibility that the thioester 
observed within the rSpy0125-CTR structure could be involved in covalent binding of 
M1 GAS strain SF370 to human cells. Such covalent interactions have never before 
been reported for a bacterial adhesin and its receptor. 
 
To probe any effects the thioester could have on the ability of M1 GAS strain SF370 to 
bind host cells, a colleague in the laboratory created a spy0125 Cys426Ala mutation in 
the bacterial chromosome. The ability of this mutant to bind HaCaT cells was severely 
compromised compared to wild-type. This suggests that the thioester discovered in the 
top domain of rSpy0125-CTR plays a critical role in the initial attachment of M1 GAS 
strain SF370 to host cells (Pointon et al., 2010). Adhesion was not totally diminished 
however and this could be due to the residues surrounding the thioester providing an 
interface for binding the receptor initially, probably through hydrophobic interactions. 
This initial binding could trigger a conformational change leading to activation of the 
thioester, followed by formation of a covalent bond between the ligand and thioester. 
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This observation would suggest that Spy0125 binding is not indiscriminate but targeted 
to a specific ligand. The thioester clearly plays an important role in adhesion and 
although its precise function is not clear, the covalent linkage of M1 GAS strain SF370 
to its target receptor is an attractive hypothesis. 
 
The thioester in C3, between Cys988-Gln991, forms a thiolactone ring structure and is 
protected from reacting with small nucleophiles or water by a hydrophobic pocket 
around the bond (Janssen et al., 2005). Similarly, a hydrophobic pocket surrounds the 
thioester in rSpy0125-CTR. Whereas the thioester in C3 is formed by residues close in 
primary sequence, in rSpy0125-CTR the bond is formed between residues distant in 
primary sequence, that come into close contact following protein folding. Activation of 
the thioester in C3 occurs with cleavage of a single peptide bond by C3 convertase, 
resulting in C3a and C3b. This triggers a large conformational change in C3b allowing 
His1104 to attack the thioester, forming a free thiolate anion and an acyl-imidazole 
intermediate. The free thiolate then catalyses the transfer of the acyl group of Gln991 to 
an acceptor hydroxyl and this whole process occurs within a fraction of a second 
(Janssen et al., 2005; Gadjeva et al., 1998; Law and Dodds, 1997; Dodds et al., 1996). 
The complement C4 molecule has two isotypes; C4A and C4B. The binding mechanism 
of C4B is also reliant on a histidine residue (His1106). However, the binding of C4A 
(containing an Asp at position 1106) and α2-macroglobulin does not go through an 
intermediate stage and upon their activation, the thioester becomes available to bind 
amino nucleophiles (Law and Dodds, 1997; Carroll et al., 1990). 
 
Mechanisms by which the thioester in Spy0125-CTR may be activated remains a matter 
of speculation as either of the mechanisms described above may apply. Prior to 
activation in C3, His1104 is too far away from the thioester (11.7 Å) to have any effect 
on it but upon cleavage to C3b (Janssen et al., 2005), is able to move in and attack the 
bond. In a similar manner in rSpy0125-CTR, His533 is located 8 Å away from the 
thioester. It is possible upon activation, a conformational change moves His533 to 
within a suitable distance of the thioester to enable it to catalyse the formation of the 
acyl-imidazole intermediate. It would be interesting to test the possible contribution of 
this residue by site directed mutagenesis. Alternatively, it is possible that free amine 
nucleophiles could be enough to resolve the thioester bond in Spy0125-CTR although 
activation probably requires a conformational change to expose the thioester.  
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Sequence alignments of Spy0125 homologues reveal that the residues involved in 
thioester bond formation, including those which form the hydrophobic pocket, and 
His533, are highly conserved. The conservation of these sequences raises the possibility 
that the thioester bond also plays a role in adhesion in these strains. All Spy0125 
homologues belong to FCT types 2, 3 and 4 (chapter 1 section 1.14.1). Other predicted 
pilus adhesins, from GAS FCT type 1 (M6 Spy0157) and FCT type 5 (M4 Spy0114), 
show little sequence homology to the CTR of Spy0125 although they do harbour a 
‘VYCFN’ (thioester cysteine containing) motif. Both also contain a ‘KDQS’ motif 
which is highly similar to the ‘KYQS’ motif (containing Gln575) present in Spy0125-
CTR. In other Gram positive pilus adhesins described to date, only those from 
Corynebacterium diphtheriae (SpaC, SpaF and SpaG) contain any cysteine residues. 
Much larger number of cysteines are present compared to Spy0125 (2 Cys); SpaC 
contains 28 Cys; SpaF contains 6 Cys and SpaG contains 10 Cys but neither of the 
motifs from above are found other than a ‘KGQS’ motif in SpaC. However, this does 
not exclude the possibility that thioester bonds are formed in these adhesins or even 
disulphide bonds, which have been shown to be present in the C. diphtheriae SpaA 
(major pilus subunit) crystal structure (Kang et al., 2009b), although this cannot be 
known until detailed structural or biochemical analyses of these proteins are carried out. 
Cysteine residues are not found in the pilus adhesins of Group B Streptococcus, 
Streptococcus pneumoniae or Bacillus cereus.  
 
The presence of the thioester in rSpy0125-CTR was confirmed by colleagues in the 
laboratory using UV-Vis spectroscopy (Pointon et al., 2010). The next challenge 
however, and this would no small undertaking, is to confirm its presence in native pili at 
the cell surface, identify the mechanism by which the thioester is activated and the 
receptor involved. One possibility for activation could be cleavage of the Spy0125-NTR 
although this is unlikely as the ∆spy0125-NTR mutant still binds at wild-type levels (see 
chapter 4). A more attractive hypothesis is that the surface residues surrounding the 
thioester associate with the receptor, which may not be a strong attraction but could be 
sufficient to expose it to adjacent sites, facilitating strong covalent binding. Further 
experiments would be needed to confirm this however. 
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Chapter 6. General discussion 
 
 
Of the many fascinating characteristics displayed by pili in Gram positive bacteria, one 
of the more intriguing is that although they are expressed by a wide range of different 
species, they are formed in essentially the same manner, covalently polymerised by the 
action of sortases with in most cases, the same number of subunits. This contrasts 
significantly with Gram negative bacteria where pili, that are held together by non-
covalent interactions can be grouped into four distinct types based on their assembly 
pathway. The major types of Gram negative and Gram positive pili are summarised in 
Table 6.1 on page 171. The pili investigated in this thesis are encoded in the FCT-2 
region of the M1 GAS strain SF370 chromosome. To date, nine FCT regions have been 
described and the pili they encode are believed to form in a similar manner with small 
differences in the details. These regions resemble pathogenicity islands (PI) suggesting 
they probably are, or were, mobile and transferred between species and strains within a 
species. Extensive recombination between islands is likely to help pili avoid selective 
pressures exerted by the immune system similar to the M and M-like proteins (Kehoe et 
al., 1996). Evidence for PI status is highlighted by the presence of transposase genes in 
the FCT-2 region of M1 GAS strain SF370 and the very close relationship (over 50% 
sequence homology) implying horizontal transfer of the adhesin from PI-1 of S. 
agalactiae, PI-1 of S. pneumoniae and FCT-6 of M2 GAS. In this instance, pili 
probably confer a specific tissue tropism as both S. agalactiae and M2 GAS strains are 
frequently isolated from the vaginal mucosa (Falugi et al., 2008). Isolation of S. 
pneumoniae from this region of the body has yet to be reported although this probably 
has more to do with the low carriage rates of the rlrA pilus islet and a more specific 
transmission and tissue tropism that involves other adhesive surface proteins (Aguiar et 
al., 2008). It has been noted however, that the FCT region of GAS, although believed to 
be a mobile pathogenicity island, lacks features commonly associated with these 
regions; one has been found in every GAS strain studied to date, situated between two 
conserved genes and the regions are not flanked by tRNA genes commonly associated 
with true pathogenicity islands (Podbielski, 2007). 
 
The work described in this thesis began following the discovery that M1 GAS strain 
SF370 expressed polymeric pili that were attached to the cell wall. Three proteins 
166 
 
composed the pilus, with one forming the shaft (Spy0128) and two ancillary proteins 
whose functions were unknown at the beginning of this Ph.D project. Work described in 
this thesis has shown that one of these proteins acts an adhesin and is situated at the tip 
of the pilus (Spy0125), while parallel studies by colleagues in the laboratory have 
shown the remaining subunit acts as a ‘linker’ molecule attaching the pilus structure to 
the cell wall (Spy0130, Smith et al., 2010). Although pili from Gram negative bacteria 
had been studied extensively for many years, there was relatively little information in 
the literature about Gram positive pili and certainly no structural data concerning these 
proteins. The work presented in this thesis attempted to address these issues. 
 
During the early stages of this project Manetti et al. (Manetti et al., 2007) reported both 
Spy0130 and Spy0125 bound to Detroit pharyngeal cells suggesting both could be the 
adhesin. As mentioned in chapter 4, only antibodies to recombinant (r)Spy0125 blocked 
adhesion of intact M1 GAS strain SF370 to target cells. Subsequent work showed that 
only Spy0125 is positioned at the tip acting as the pilus presented adhesin. Studies by 
others in the laboratory indicated that Spy0130 acted as a ‘linker’ between the last 
Spy0128 subunit incorporated into the growing pilus and the di-alanine cross bridge of 
the lipid II precursor. Consistent with this, work in chapter 3 of this thesis confirmed 
rSpy0130 to be an extremely elongated molecule in solution, probably reflecting its role 
at the cell surface. As discussed previously, a large degree of flexibility should be 
expected as Spy0130 and the pilus structure as a whole would be subjected to 
considerable tensile forces upon binding host surfaces. However, this property was 
probably the primary reason for unsuccessful attempts to crystallise rSpy0130, 
preventing intimate packing of molecules within a crystal. Due to time constraints and 
focussing efforts on Spy0125 crystallisation, attempts to gain insights into the high 
resolution structure of Spy0130 were not pursued. While this thesis was being written 
we learnt that another group had tried to crystallise rSpy0130 without success although 
they were able to solve the X-ray crystal structure of a homologue whose globular 
structure closely matches the SAXS structure for rSpy0130 presented in chapter 3 
(Linke et al., 2010). 
 
The major part of the work described in this thesis focused on Spy0125 when it was 
discovered to be the pilus presented adhesin. rSpy0125 and its breakdown products 
were characterised in chapter 4 and recombinant protein produced in this work was 
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given to colleagues in the laboratory who carried out experiments that suggested 
rSpy0125 N-terminal region (NTR) bound to human tissues but rSpy0125 C-terminal 
region (CTR) did not. This contrasted antibody inhibition experiments where only anti-
sera against rSpy0125-CTR inhibited binding of intact M1 GAS strain SF370. Taken 
together, these data raise doubts over the use of the recombinant proteins so in order to 
examine which of the two regions were more likely to be responsible for adhesion, the 
region of the M1 GAS strain SF370 chromosome encoding Spy0125-NTR was deleted 
using allele replacement. No reduction in binding was observed in the absence of the 
Spy0125-NTR, suggesting any contribution it makes to binding is very small and the 
part of the protein responsible for attachment, resides in the CTR of Spy0125. These 
results confirm the importance of looking at the function of proteins in vivo and not just 
relying on what is observed in the test tube with recombinant proteins. 
 
Not only are pili in Gram positive bacteria formed in the same manner from a similar 
number of subunits, the proteins within them also contain many similar features. These 
include the folding of domains within subunits, even with little homology at the 
sequence level such as between the middle domain of rSpy0125-CTR presented in this 
thesis and GBS52 (rmsd-1.59 Å, both are ancillary proteins that probably play different 
roles in their respective pilus; Spy0125-adhesin, GBS52-cell wall anchor), and the 
presence of intra-molecular isopeptide bonds. These bonds were first observed in the 
crystal structure of Spy0128 in 2007 (Kang et al., 2007) and have since been found in a 
growing number of Gram positive pili proteins, not just restricted to major subunits. The 
RrgA adhesin from S. pneumoniae RlrA pili contains two intra-molecular isopeptide 
bonds, as does rSpy0125-CTR. In all cases where proteins have been demonstrated to 
contain intra-molecular isopeptide bonds, these proteins are extremely stable in 
solution. For example, rSpy0128 and rSpy0125-CTR examined in this project exhibited 
minimal breakdown after storage at 4oC for one year and would even crystallise after 
this length of time. In contrast, both rSpy0130 and rSpy0125-NTR were labile in 
solution. Degradation of rSpy0125-NTR was observed to begin during purification and 
it might be predicted from this that this region does not contain an intra-molecular 
isopeptide bond. Also, the experimentally determined intact masses for the two NTR 
fragments identified from the breakdown of rSpy0125 were so accurate as to suggest no 
intra-molecular bonds were present (no loss of NH3 or H2O was indicated). Work done 
examining the role of the intra-molecular isopeptide bonds in Spy0128 revealed they 
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contributed to the thermal and structural stability of the protein (Kang and Baker, 2009) 
and probably play a similar role in Spy0125-CTR. This is advantageous as they are 
expressed outside of the cell and therefore exposed to potentially harsh environments. A 
role for these bonds in withstanding strong mechanical forces upon adhesion to a host 
receptor has also been suggested (Alegre-Cebollada et al., 2010). As above, this is an 
attractive hypothesis because when Spy0128 monomers are positioned in a head-to-tail 
conformation (like they would be presented in native pili at the cell surface), the intra-
molecular isopeptide bonds are parallel to the long axis of the pili, running throughout 
the polymer creating an extremely strong structure (the covalent linkages within and 
between subunits in Gram positive pili has been described elsewhere as like ‘beads on a 
string’). Prior to this project however, no study had been conducted into their 
importance for host cell attachment. The work described in chapter 3, where mutations 
in each of the bonds were engineered into the GAS chromosome, suggests that intra-
molecular isopeptide bonds are dispensable for M1 GAS strain SF370 attachment to 
HaCaT cells. The pilus phenotypes suggested that although disruption of the critical Glu 
residue significantly altered pilus polymerisation, ultimately all strains bound to HaCaT 
cells at wild-type levels. The extra stability provided by the isopeptide bonds is 
probably needed to withstand the strong tensile forces experienced throughout the pili 
upon attachment to a target surface. In these experiments however, only gentle washing 
forces were applied, highlighted by the presence of background binding in the ∆spy0128 
and spy0128 K161A strains. More significant washing forces would probably be 
experienced by bacteria in the oropharynx by the action of saliva for example, and 
perhaps this could be explored in future experiments. 
 
Perhaps the most fascinating result of this Ph.D project was the discovery of continual 
electron density linking the side chains of Cys426 and Gln575 in the rSpy0125-CTR 
crystal structure, revealing the presence of an internal thioester bond in the top domain 
of the protein. This feature has not been reported previously in any other bacterial 
protein. It is particularly exciting when it is considered that the only proteins identified 
to date which harbour an internal thioester bond are the complement proteins C3 and C4 
and the α-2 macroglobulins. In these instances the thioester is responsible for one 
function; covalent attachment to target molecules via free amine or hydroxyl functional 
groups. Pili in M1 GAS strain SF370 have been shown to be critical for initial binding  
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Figure 6.1: Adhesion of M1 GAS strain SF370 Spy0125 Cys426Ala mutant to 
                   HaCaT cells, reproduced from Pointon et al., 2010. 
 
 
of the bacteria to human tonsil (Abbot et al., 2007) and the presence of a thioester bond 
in the adhesin raises the intriguing possibility that this strain could bind to human 
tissues covalently. Binding via a thioester bond alone could be indiscriminate, to a 
number of different receptors that display the correct functional group. This scenario is 
unlikely however, as GAS displays a specific tissue tropism. Moreover, M1 GAS strain 
SF370 pili do not bind to Hep-2 or A549 cells (Abbot et al., 2007). While this thesis 
was being written, to test the role of the thioester, colleagues in the laboratory produced 
a Cys426Ala mutant strain which exhibited dramatically reduced binding to HaCaT 
cells compared to wild-type GAS (Figure 6.1, reproduced with permission from Pointon 
et al. 2010). Binding is not totally abrogated however. The initial interaction between 
the specific receptor on human cells and Spy0125 (likely a hydrophobic one) could be 
mediated by residues surrounding the thioester and this binding could then slightly open 
the shallow cleft that the bond sits in, exposing it, allowing a more intimate covalent 
interaction to occur. If this were found to be the case, in effect a single, large, covalently 
cross linked polymer would link the bacteria to the host cell, strengthened by the 
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presence of intra-molecular isopeptide bonds in both Spy0125-CTR and Spy0128 all 
facing in the same direction. This would represent an extremely strong and irreversible 
reaction which could be key during the initial stages of an infection in an environment 
such as the oropharynx. Further experiments by colleagues in the laboratory have 
confirmed the presence of the thioester within rSpy0125-CTR using a chemical 
approach. rSpy0125-CTR was treated with methylamine, a small molecule nucleophile 
which was used to break open the thioester and methylate Gln575, specifically in 
combination with iodoacetamide which alkylated the now free thiol, and these 
modifications were confirmed by mass spectrometry analysis. No modifications were 
observed when rSpy0125-CTR was incubated with iodoacetamide alone. Now the goal 
has to be to prove the existence of this bond in native pili at the GAS cell surface. Were 
this to be reported, it would be an extremely exciting result that would pave the way for 
future studies attempting to find out exactly what receptor GAS pili adhere to in the 
initial stages of infection at the skin and pharynx, and potentially provide a target for 
vaccine development. 
 
The potential for this bond also highlights that although Gram positive pili proteins 
display many similar characteristics, they also harbour features unique from one another 
that can only be identified by determining their high resolution structures. Other 
features as yet identified as unique to individual Gram positive pili proteins include the 
disulphide bond found in the C-terminal domain of C. diphtheriae SpaA (Kang et al., 
2009b). As mentioned in chapter 5, there are varying numbers of cysteine residues 
present in pilus adhesins from other Gram positive bacteria ranging from none to 28 in 
SpaC from C. diphtheriae. As more structural information about pilus presented 
proteins and adhesin proteins in general becomes available, it will be interesting to note 
whether a thioester bond as revealed here will be present or whether this feature is 
specific to Spy0125 of GAS and its homologues. 
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